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Purposes: The aims of this thesis were to physicochemically investigate the formation of 
ISCOM matrices and other types of colloidal particles formed in aqueous dispersion as a 
function of different mass ratios of Quil A, cholesterol and phospholipid 
(phosphatidylcholine (PC) or phosphatidylethanolamine (PE)) prepared by the hydration 
method and to investigate the delivery of subunit vaccines to antigen presenting cells using 
these colloids. 
Methods: The hydration method, recently developed for the preparation of ISCOMs or 
ISCOM matrices, was used to produce these colloids and other related structures. Factors 
such as effects of buffer salts, equilibration time and type of phospholipid on the formation 
of ISCOM matrices and other colloidal particles prepared were investigated. The standard 
dialysis method for the preparation of ISCOMs was also used for comparison to prepare 
various colloidal particles. Colloidal particles were characterized by negative staining 
transmission electron microscopy (TEM). Polarized light microscopy (PLM) was used to 
identify samples containing cholesterol crystals. Incorporation of a model antigen 
(modified ovalbumin) into various colloidal particles was investigated by fluorescence 
spectroscopy following analytical sucrose density gradient ultracentrifugation. Physical 
properties of solid Quil A-cholesterol-phospholipid formulations (as powder mixtures or 
compressed to pellets) with or without model antigen were characterized by X-ray powder 
diffractometry (XRPD), differential scanning calorimetry (DSC), scanning electron 
microscopy (SEM), and PLM. Release of model antigen from compressed pellets was 
investigated in vitro. Flow cytometric analysis (FACS) was used to investigate the in vitro 
delivery of antigen incorporated into various colloidal structures to murine bone-marrow 
derived dendritic cells (BMDC). 
Results: Pseudo-ternary diagrams revealed that depending on the mass ratio of Quil A, 
cholesterol and phospholipid, various colloidal particles including ISCOM matrices, 





identified in the different regions of the diagrams. In the presence of these predominant 
colloids, helices and lamellae (hexagonal pattern of ring-like micelles) structures were also 
formed as minor structures. Buffer salts and equilibration time were important factors for 
the formation of ISCOM matrices and liposomes. The type of phospholipid affected the 
morphology of ISCOM matrices and lamellae. ISCOM matrices were predominantly found 
near the phospholipid apex of the pseudo-ternary diagram following sample preparation by 
the hydration method. On the other hand, samples prepared by the dialysis method 
produced ISCOM matrices that were predominantly found near the Quil A apex of the 
pseudo-ternary diagram. No ISCOM matrices could be formed in any binary mixtures 
prepared by the hydration method in contrast to the dialysis method. Worm-like micelles 
could only be formed if samples were prepared by the hydration method. An incorporation 
study demonstrated that the various colloidal particles formed as a result of hydrating 
phospholipid/cholesterol lipid films with different amounts of Quil A are capable of 
incorporating antigen, provided it is amphipathic. Freeze-dried lipid powder mixtures were 
found to contain a lower degree of crystalline cholesterol compared to physically mixed 
powders. Consequently, physically mixed powders (with or without model antigen) and 
pellets prepared from the same powders did not spontaneously form ISCOM matrices and 
related colloidal structures upon hydration as expected from the pseudo-ternary diagram. 
Release of antigen incorporated into ISCOM particles was relatively slower from the pellets 
made using freeze-dried powders in contrast to pellets prepared from the physically mixed 
powders. Using ISCOMs, liposomes and ring-like micelles, it was demonstrated that the 
model antigen incorporated into these particles could be delivered to dendritic cells leading 
to activation and proliferation of transgenic T cells. 
Conclusions: Depending on the mass ratio of Quil A, cholesterol and phospholipid, 
ISCOM matrices and other types of colloidal structures such as liposomes, lipidic/layered 
structures, ring-like micelles, lamellae (hexagonal array of ring-like micelles) and worm-
like micelles prepared by the hydration method could be identified in the different regions 
of pseudo-ternary diagram. All the colloids containing Quil A were capable of 
incorporating an antigen, provided it is amphipathic. Delivery of antigen to DC and 
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Recent advances in biotechnology have resulted in a significant increase in the number of 
subunit vaccines for treatment and therapeutic vaccination against various infectious 
diseases (Lee 2002). This is because traditional vaccines are generally toxic as it has been 
found that some live attenuated vaccines can revert to a more virulent phenotype causing 
some lethal systemic infections especially in immunosupressed individuals (Hoglund et al., 
1989; Morein et al., 1996; O'Hagan et al., 2001; Singh & O'Hagan 2002). Some whole 
killed microorganisms such as Bordella pertussis which contain reactogenic components, 
can cause side effects in some individuals such as pain, swelling at injection site and, 
rarely, brain damage (Singh & O'Hagan 1999). Subunit vaccines are therefore preferred 
over the traditional vaccines because they are relatively safe (Singh & O'Hagan 1999; 
O'Hagan & Valiante 2003). However, it has been shown that isolated subunit antigens, 
whilst immunogenic as part of a microorganism, are almost non-immunogenic in their 
purified form (Kersten et al., 1988a; Morein et al., 1990; Bungener et al., 2002). Therefore 
in order to increase the immunogenic properties of subunit vaccines, lipidic particulate 
systems such as liposomes and protein micelles have been developed (Hoglund et al., 1989; 
Kersten & Crommelin 1995). 
It is thought that the colloidal size of these delivery systems mimics the submicroscopic 
particulate nature of a pathogen carrying several copies of the antigen epitope (Hoglund et 
al., 1989; Morein & Bengtsson 1998; Sjolander et al., 1998). However, the 
immunogenicity of the antigens incorporated into the liposomes or protein micelles is often 
still insufficient (Hoglund et al., 1989; Kersten & Crommelin 2003). Therefore additional 
adjuvants have to be added in order to improve the immunogenicity of the subunit vaccines 
incorporated into these lipid-based particulate systems (Hoglund et al., 1989; Kersten & 
Crommelin 2003). The addition of soluble adjuvants which can be added to liposomes or 
other lipid structures are not however, chemically or physicochemically linked to the 
colloid containing the antigen and thus may be suboptimal for immunestimulation or even 










Colloidal lipidic structures known as Immune-Stimulating Complexes (ISCOMs) have been 
developed as improved adjuvant containing lipidic vaccine delivery systems (Morein et al., 
1984). ISCOMs are symmetrical colloidal particles (40 - 100 nm) composed of 
phospholipid, cholesterol, the saponin-mixture Quil A and an antigen mostly in the form of 
an amphipathic protein (Barr et al., 1998; Morein & Bengtsson 1999; Sjolander et al., 
2001a). A formulation without the incorporated antigen is called ISCOM matrix 
(Rimmelzwaan & Osterhaus 1997; Barr et al., 1998; Ekstrom et al., 1999). ISCOMs 
combine the advantages of a particulate carrier system with the presence of an in-built 
adjuvant (Quil A) (Morein et al., 1984; Barr et al., 1998; Kersten & Crommelin 2003). 
ISCOMs induce a strong immunogenic response, as the adjuvant is part of the colloidal 
structure (Morein et al., 1996; Sjolander et al., 1998). Consequently ISCOMs have been 
found to be more immunogenic than other colloidal systems such as liposomes or protein 
micelles (Kersten et al., 1988a; Hoglund et al., 1989; Cox & Coulter 1997; Bungener et al., 
2002). 
The current standard method for ISCOM preparation is the dialysis method (Kersten & 
Crommelin 1995; Barr et al., 1998; Andersson et al., 1999). This method requires the use 
of additional surfactant (e.g. octylglucoside or N-decanoyl-N-methylglucamine (MEGA-
10)), which is removed by extensive dialysis (Lovgren & Morein 1988; Rimmelzwaan & 
Osterhaus 1997; Johansson & Lovgren-Bengtsson 1999). A much simpler method for the 
preparation of ISCOM matrices called the hydration or lipid film hydration method was 
recently developed in our laboratory (Copland et al., 2000). However, little is known about 
the different mass ratios of Quil A, cholesterol and phospholipids required for the formation 
of ISCOMs using the hydration method, and on the formation of other colloidal structures 
as a result of the use of different mass ratios of these three polar lipids. Furthermore, there 
is little information in the literature concerning the delivery of subunit antigens to antigen 
presenting cells, e.g. to dendritic cells, from a possible variety of colloidal particles 
containing Quil A. 
The aim of this thesis therefore, was to physicochemically investigate the formation of 
ISCOM matrices and other types of colloidal structures formed as a function of different 
3 
mass ratios of Quil A, cholesterol and phospholipid prepared by the hydration method and 
to investigate the delivery of subunit vaccines to antigen presenting cells using these 
colloids (for specific aims, see Section 1.4). Therefore, in the general introduction firstly 
an overview of the immune system relevant to antigen delivery will be presented. The 
second part of the introduction reviews various vaccine adjuvants with a focus on ISCOMs 
and related lipid-based particulate systems. 
1.2 The immune system 
Our environment contains a great variety of infectious microbes such as viruses, bacteria, 
fungi, protozoa and multicellular parasites (Male 1991). These can cause disease, which in 
some cases may eventually result in the death of their host (Roitt et al., 1998). Most 
infections in normal individuals however, are short lived and leave little permanent 
damage. This is due to the immune system, which combats infectious agents (Reeves & 
Todd 1991; Stites et al., 1997; Roitt et al., 1998). Any immune response involves, firstly, 
the recognition of pathogen or other foreign material, and then secondly, a response by 
mounting a reaction against it (Roitt et al., 1998). The immune response may be 
categorized into two groups: innate and adaptive ( or acquired). Innate immunity includes 
immune mechanisms that are present constantly in the organism from birth. Innate 
immunity is the first line of defense against infections; it is a fast and non-specific response, 
and does not have a memory with respect to previous infections (Vitetta et al., 1991). On 
the other hand, acquired immunity is developed only after the invasion of an infectious 
agent. It is highly specific, and has a memory of previous infections leading to a fast 
response when the infection recurs (Male 1991; Roitt et al., 1998; Shen & Louie 1999). 
1.2.1 Organs and cells of the immune system 
Bone marrow, thymus gland, spleen, and lymph nodes are organs that are necessary for the 
normal functioning of the human immune system (McGhee et al., 1992; Stites et al., 1997; 
Banchereau et al., 2000). These organs can be divided into two groups: primary ( central) 





thymus where the lymphocytes are generated (Stites et al., 1997; Raitt et al., 1998). 
Secondary lymphoid organs are the sites where antigens, taken up by the antigen presenting 
cells (APCs) such as the dendritic cells, are delivered and presented to lymphocytes, 
resulting in the initiation of the adaptive immune response (McGhee et al., 1992; Raitt et 
al., 1998; Vandenabeele & Wu 1999). The secondary lymphoid organs comprise of the 
lymph nodes, the spleen, the appendix and the mucosal-associated lymphoid tissues, 
including the tonsils and Peyer's patches of the ileum (McGhee et al., 1992). The 
lymphoid organs are connected by a network of lymphatic vessels in which lymphatic fluid 
moves from organ to organ in a similar manner analogous to the circulation of blood in the 
vascular network. However, unlike blood, lymphatic fluid is devoid of erythrocytes, being 
only enriched with leukocytes (Banchereau & Steinman 1998). 
Immune responses are mediated by a variety of cells, and by the soluble molecules that they 
secrete (Stites et al., 1997; Shen & Louie 1999). The cells of the immune system originate 
from pluripotent stem cells through two main lines of differentiation, i.e. the lymphoid 
lineage which produces lymphocytes and the myeloid lineage which produces phagocytes 
(monocytes, macrophages and granulocytes) and other cells (Figure 1.1) (Raitt et al., 
1998). Although the leucocytes (white blood cells) are central to all immune responses, 
other cells in the tissues also participate, by signaling to the lymphocytes and responding to 
the cytokines released by T lymphocytes and macrophages. Figure 1.2 lists the main cells 
and molecules involved in the immune reactions (Raitt et al., 1998; Shen & Louie 1999; 
Banchereau et al., 2000). The different types of cells important in the immune responses 
are briefly described below. 
Lymphocytes occur as two major types, known as B cells and T cells. All lymphocytes are 
derived from bone marrow stem cells, but T lymphooytes develop in the thymus, while B 
lymphocytes develop in the bone marrow (Stites et al., 1997). These cells are responsible 
for specific recognition of antigens and hence initiate adaptive immune responses (Raitt et 
al., 1998). There are several different types of T cells that have a variety of functions. One 
group interacts with B cells and helps them to divide, differentiate and produce antibody. 











These two groups are called T-helper (Th) cells. A third group ofT cells called T-cytotoxic 
(Tc) cells is responsible for the destruction of host cells which have become infected by 
viruses or other intracellular pathogens (Male 1991) . 
granulocytes 
platelets 
'd ..o ""' haemopoietic 
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dendritic 





or plasma cell 
(terminal stage) 
Figure 1.1 Schematic representation of the origin of cells of the 
immune system from pluripotent haemopoietic stem cell (adapted from 
Roitt et al., 1998). 
Phagocytes are other types of immune cells (Figure 1.2), and are usually found in the areas 
of the body where they are likely to encounter infectious agents. The function of 
phagocytes is to internalize antigens and pathogenic microorganisms and degrade them 
(Shen & Louie 1999). These cells are very effective at presenting antigens to T 
lymphocytes although the most important cell for presenting antigen to T cells are the 
dendritic cells which are described later in this chapter. 
Antigen presenting cells (APCs) are a heteregenous population of leucocytes that present 





within or underneath most mucosal epithelia and in the thymus (Roitt et al., 1998; Shen & 
Louie 1999). Langerhans cells in the skin and in other squamous epithelia migrate as 
'veiled cells', via the afferent lymphatics, into the lymph node paracortex of the draining 
. lymph nodes (Vandenabeele & Wu 1999). Within the paracortex, they interact with many 
T cells and are termed interdigitating dendritic cells (IDCs) (Male 1991; Roitt et al., 1998; 
Banchereau et al., 2000). This migration provides an efficient mechanism for carrying 
antigen from the skin and mucosa to the T cells located in the lymph nodes. These APCs 
are rich in class II major histocompatibility complex (MHC) molecules, which are 
important for presenting antigens to T helper cells. 
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Figure 1.2 Schematic representation of principal components inv;olved in the 
immune response indicating which cells produce which soluble mediators 
(adapted from Roitt et al., 1998). 
1.2.2 Soluble mediators of immune response 
A wide variety of molecules are involved in the development of an immune response. 
These include antibodies and cytokines, produced by lymphocytes, and a variety of other 
molecules such as the complement proteins (Figure 1.2) that are normally present in serum 
(Stites et al., 1997; Roitt et al., 1998; Shen & Louie 1999; Bowers 2001). Antibodies (also 
7 
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called immunoglobulins) are a group of serum molecules produced by B-lymphocytes. All 
antibodies have the same basic structure, but are diverse in the region that binds to the 
antigen (Roitt et al., 1998). The main function of an antibody is to specifically bind to a 
particular antigen and then mediate secondary effects (Heyman 2000). 
Cytokines are diverse molecules involved in signaling between lymphocytes, phagocytes 
and other cells of the body during immune response (Male 1991; Dong et al., 1995; Roitt et 
al., 1998). All cytokines are either proteins, peptides, or glycoproteins (Stites et al., 1997). 
There are different types of cytokines such as interferons, interleukins, and colony 
stimulating factors. Interferons are particularly important in limiting the spread of certain 
viral infections (Shen & Louie 1999). They are produced very early in infection and are the 
first line of resistance to many viruses. Interferons also act on uninfected tissue cells to 
induce a state of resistance to· viral infection. Interleukins are large group of cytokines 
produced mainly by T cells, although some are also produced by phagocytes, or by tissue 
cells (Dong et al., 1995). They have a variety of functions, but most of them are involved 
in directing other T cells to divide and differentiate. Each interleukin acts on a specific, 
limited group of cells that express the correct receptors for that interleukin. Colony 
stimulating factors (CSFs) are cytokines involved in directing the division and 
differentiation of bone-marrow stem cells, and the precursors of blood leucocytes (Reeves 
& Todd 1991). 
1.2.3 Types of immune responses 
There are two types of immune responses, known as humoral and cell-mediated response 
(Kapsenberg et al., 1998; Shen & Louie 1999). The humoral immune response is generated 
and directed by B cells (Stites et al., 1997; Roitt et al., 1998). It involves the formation of 
antibodies in order to eliminate extracellular pathogens. The process starts when the B 
cells are activated by the antigen from an invading microorganism that binds to the B cell 
receptor on the surface of these cells resulting in its internalization. The antigen is then 
processed in intracellular compartments into peptides. The peptides are presented on the 






This complex is recognized by antigen-specific helper T cells through T cell receptors. The 
interaction between the antigen-bound B cells and the helper T cells leads to the expression 
of the B-cell stimulatory molecule, CD40 ligand (CD40L) on the T cells, which binds to the 
CD40 receptor on B cells (Bachmann & Zinkemagel 1997; Bowers 2001). The interaction 
of the T cell with the B cell through T cell receptors and specifically CD40L results in the 
secretion of interleukin cytokines which drive proliferation and differentiation of nai:ve B 
cells into antibody-secreting cells (Stites et al., 1997; Roitt et al., 1998; Shen & Louie 
1999; Bowers 2001). 
The process of cell-mediated immunity has been described in detail in the literature 
(Kapsenberg et al., 1998). Cell-mediated immune response is required to destroy 
intracellular microorganisms. The generation of cell-mediated immunity occurs when T 
cells (specifically those known as CD4+ and CD8+) are activated by APCs. The CD8+ and 
CD4+ T cells can recognize the class I MHC and class II MHC molecules respectively 
(Stites et al., 1997; Kapsenberg et al., 1998; Roitt et al., 1998). Unlike B cells, the T cells 
can recognize an antigen only when the antigen is presented by APCs (Roitt et al., 1998). 
The APCs internalize the antigens and process them into peptide fragments. These 
fragments are presented on the surface of the APCs in form of MHC-peptide complex 
(Kapsenberg et al., 1998). 
1.3 Vaccine adjuvants 
Adjuvants (from Latin, "adjuvare" = "help") can be defined as substances used in 
combination with a specific antigen to enhance the immune response (Gupta & Siber 1995). 
A variety of adjuvants have been identified and investigated over the years. Adjuvants can 
be categorized according to their origins (i.e. whether they are derived from mineral, 
bacterial, plant, or synthetic products), and according to their proposed mechanism 
(Jennings 1995; Cox & Coulter 1997). The following section categorizes the adjuvants into 
five groups based on a combination of their origins and mechanism of action (Allison & 












1.3.1 Inorganic compounds 
Inorganic compounds that have been used as adjuvants include aluminium hydroxide, 
aluminium phosphate and calcium phosphate (Vogel & Powell 1995; Cox & Coulter 1997). 
Other mineral salts such as cerium nitrate, zinc sulfate, colloidal iron hydroxide and 
calcium chloride have been used but their immunological effect has been found to be 
relatively poor compared with aluminium salts (Gupta & Siber 1995). Aluminum salts 
have been widely used in human and veterinary vaccines, and until recently were the only 
type of adjuvants approved for human vaccine formulations (O'Hagan 1998; Singh & 
O'Hagan 2002). They are insoluble, colloidal particles with a size ranging from 100 to 
1000 nm (Cox & Coulter 1997). Aluminium adjuvants have been described as difficult to 
manufacture in a physicochemically reproducible way (Gupta et al., 1995). It is however 
important to prepare vaccine adjuvants in a simple and reproducible manner so that such 
vaccines are readily available for their intended use. 
The adjuvant effect of inorganic compounds is reported to result from a combination of 
many mechanisms involving formation of a depot at the injection site from which the 
antigen is released slowly, stimulation of immune cells through activation of the 
complement system, induction of eosinophilia and activation of macrophages, and efficient 
uptake by APCs (Gupta et al., 1995; Vogel & Powell 1995; Morein et al., 1996). The 
major advantage of using aluminium adjuvants was the development of earlier, higher and 
longer-lasting immunity after primary immunization compared to soluble vaccines (Gupta 
et al., 1993). There are numerous reports showing superiority of aluminium adsorbed 
tetanus and diphtheria vaccines over antigens in solution, particularly after the first dose or 
primary immunization (Levine 1972; Bomford 1989; Gupta et al., 1993). However, 
aluminium adsorbed vaccines did not show any advantage over soluble preparations for the 
booster or secondary response although the reasons for this are not known (Gupta et al., 
1995). 
Since aluminium adjuvants (i.e. aluminium hydroxide and aluminium phosphate) are non-












granulomas such as erythema, subcutaneous nodules and contact hypersensitivity (Gupta et 
al., 1995). A further disadvantage is that recent reports appear to suggest that the antigens 
adsorbed onto aluminium salts are probably desorbed to a larger extent in vivo than 
previously thought (Chang et al., 2001). The desorption of antigens from aluminium salts 
may compromise their adjuvant effect. Other limitations of aluminium adjuvants include 
their ineffectiveness for certain antigens (Gupta & Siber 1995) and induction of mainly 
humoral immunity by eliciting primarily a Th2-type response (Audibert & Lise 1993). The 
inability of aluminium adjuvants to elicit cytotoxic T-cell responses, may be a major 
limitation, particularly for vaccines against intracellular parasites and viral infections 
(Gupta & Siber 1995). Aluminium adjuvants cannot be frozen or lyophilized, as this 
causes the collapse of the colloidal gel resulting in aggregation and precipitation (Gupta & 
Siber 1995). 
Calcium phosphate is a natural component of the interstitial fluid, bones and teeth and 
therefore vaccines based on this organic salt are reported to be relatively safe and non-toxic 
(Bell 2002). However, compared to aluminum salts, their adjuvant activity is relatively 
poor (Cox & Coulter 1997) and limits their use as effective adjuvants. 
1.3.2 Oil-based or emulsion adjuvants 
Examples of oil-based adjuvants are the water-in-oil emulsions known as Freund's 
adjuvants and oil-in-water emulsions such as "MF59" that contain mineral oil and squalene 
as the oil phase (Gupta & Siber 1995; Ott et al., 2000; Iorio et al., 2003). Freund's 
adjuvants are recognized as the most potent adjuvants and are frequently used as the "gold 
standard" in vaccine development studies. Freund's adjuvants containing mineral oil, a 
surfactant (typically mannide monooleate (Arlacel A)), and heat-killed mycobacteria 
(Mycobacterium tuberculosis or Mycobacterium butyricum), are referred to as Freund's 
complete adjuvant (FCA) (Gupta & Siber 1995; Lindblad 2000). Freund's incomplete 
adjuvant (FIA) is the same as FCA except that killed mycobacterial cells or cellular 
components are absent (Jennings 1995). Both FCA and FIA contain the antigen in the 








The adjuvant effect of emulsions is believed to enhance the immune response by increasing 
the stability of the antigen compared to antigen in solution, and by forming a depot that 
slowly releases the antigen for a prolonged period (Garti & Aserin 1996). Mineral oil can 
cause irritation and inflammation that attracts immune cells to the injection site and hence 
also increase the immune response (Gupta & Siber 1995). FCA, in particular, has been 
reported not only to localize the antigen at the site of injection, but also to disseminate it to 
lymph nodes, which may be important for its adjuvant activity (Waksman 1979). FCA is a 
potent adjuvant that stimulates both humoral and cell-mediated immunity (Jennings 1995). 
However, its toxicity has limited its use as an adjuvant for human vaccines (Gupta & Siber 
1995; Jennings 1995). The toxicity occurs because the mineral oil cannot be metabolized 
and the mycobacterial elements can elicit severe granulomatous reactions (Jennings 1995). 
Concerns about the toxicity of FCA for animal use have also been reported (Claassen et al., 
1992). Therefore attempts have been made to purify components of mycobacteria with 
adjuvant activity. The most promising derivatives of mycobacteria include murabutide, 
threonyl N-acetyl muramyl-L-alanyl-D-isoglutamine (threonyl-MDP), and muramyl 
tripepetide (Gupta & Siber 1995). However, the effectiveness of these derivatives still 
requires further investigation (Lindblad 2000). 
FIA vaccines have been previously used in humans, especially with influenza and killed 
poliomyelitis antigens enhancing their immunogenecity (Salk & Salk 1977; Gupta et al., 
1993). However, like FCA, their use is currently restricted to animal studies due to severe 
local reactions at the site of injection (particularly granuloma and cyst formation), and 
Arlacel-A induced cancer in mice (Gupta & Siber 1995). Consequently, various kinds of 
emulsions with different oils have been evaluated in a search for a stable, non-toxic and 
effective adjuvant for human vaccines. Examples of such emulsions are oil-in-water 
emulsions in which unlike Freund's adjuvants, the antigen is blended with a minimal 
volume of oil and the droplets formed are then emulsified in a saline solution containing the 
surfactant (Allison & Byars 1990). The surfactants commonly used to stabilize oil-in-water 
emulsions include fatty-acid esters of polyhydric alcohols such as members of the Tween 




Recently, an oil-in-water emulsion referred to as "MF-59" appears to be a promising 
vaccine adjuvant although much work still needs to be done to determine its use as human 
influenza vaccine (Ott et al., 2000). This emulsion contains the components, squalene 
(4.3% w/v), Tween 80 (0.5% w/v) and Span 85 (0.5% w/v). Squalene which occurs 
naturally and is a terpenoid cholesterol precursor is considered safe for human use 
(O'Hagan 1998; Ott et al., 2000) . 
1.3.3 Bacterial products and their derivatives 
Examples of bacterial products and their derivatives that have been used as adjuvants 
include liposaccharides, diphosphoryl lipid A, monophosphoryl lipid A, trehalose 
dimycolate, cholera toxin and muramyl dipeptide (Allison & Byars 1990; Gupta & Siber 
1995; Morein et al., 1996; Cox & Coulter 1997; Singh & O'Hagan 2002). In general, 
although these molecules are adjuvants on their own, they are often added to emulsions and 
other adjuvant systems as immunostimulators in order to enhance the immunogenecity of 
such systems (Gupta & Siber 1995; Jennings 1995; Ott et al., 2000; Singh & O'Hagan 
2002). For example, as described in Section 1.3.2, some of these substances such as 
muramyl dipeptide and trehalose dimycolate are the purified components of Mycobacteria, 
and are used as Freund's adjuvants. The adjuvant activity of bacterial products and their 
derivatives is not clearly understood but they are believed to act generally as mitogens and 
function by stimulating natural killer (NK) cells and cells of the monocyte/macrophage 
lineage (Singh & O'Hagan 2002). 
1.3.4 Cytokines 
Examples of cytokines are interferons, interleukins, and colony stimulating factors. These 
molecules and their role in immune response were described in Section 1.2.2. Because of 
their involvement in the immune response, they are used as adjuvants to mediate both 
humoral and cellular responses (Dong et al., 1995). The main disadvantages with some of 
the cytokines are low chemical stability, high toxicity and high cost (Reeves & Todd 1991; 









affected by their chemical stability within tissues (Reeves & Todd 1991). Cytokines used 
in patients with renal cell carcinoma were associated with severe adverse effects related to 
interleukin induced capillary leakage syndrome (Shen & Louie 1999). 
1.3.5 Particulate delivery systems 
Particulate delivery systems that have been used as vaccme adjuvants include 
microparticles, nanoparticles, liposomes, and ISCOMs (Allison & Byars 1990; Cox & 
Coulter 1997; Kersten & Crommelin 2003). Since the development of ISCOMs two 
decades ago (Morein et al., 1984), these colloidal structures have received much attention 
in the immunological field (Sjolander et al., 1990; Barr et al., 1998; Kersten & Crommelin 
2003). This is because of their ability to induce both humoral and cellular responses with 
or without antigens (Morein 1991; Sjolander et al., 1998; Beacock-Sharp et al., 2003), and 
also being an excellent carrier of a variety of viral, microbial and parasital antigens 
(Hoglund et al., 1989; Barr & Mitchell 1996; Spickler & Roth 2003). In addition, ISCOMs 
are physically stable compared to other lipid particles such as liposomes (Hoglund et al., 
1989; Kersten & Crommelin 1995). Lipid-based particles related to ISCOMs are the 
liposomes and liposome-like structures except that these particles lack Quil A as part of 
their structure (Kersten & Crommelin 1995; Gluck 1999; Singh & O'Hagan 2003). 
1.3.5.1 Liposomes 
Liposomes are vesicles formed from the swelling of phospholipids such as 
phosphatidylcholine or phosphatidylethanolamine in aqueous dispersion (Knight 1981; 
Kersten & Crommelin 2003). These vesicles are composed of lipid bilayers separated by 
aqueous layers (Figure 1.3). They can be unilamellar or multilamellar with a size in the 
range from 20 nm to more than 10 µm (Kersten & Crommelin 1995). The size of large 
liposomes can be reduced by various methods including extrusion of the dispersions 
through filter membranes (Berger et al., 2001), sonication (Szoka & Papahadjopoulos 
1981) or pH adjustment (Gains & Hauser 1983). Liposomes are physically unstable and 




is known to increase the rigidity of their bilayer membranes, and hence improve their 
physical stability (Kersten & Crommelin 1995). The charge of liposomes can be 
manipulated by incorporation of charged lipids or by the charge of the phospholipid used 
(New 1990). The charge of liposomes may be important for the incorporation and 
immunological interactions with charged antigens including subunit vaccines and DNA-
based antigens (Birchall et al., 1999; Perrie et al., 2002). 
Figure 1.3 Schematic representation of a unilamellar liposome 
(adapted from (Smyth 2000). 
Liposomes can be prepared by a large number of methods (Szoka & Papahadjopoulos 
1981; New 1990). Two of the most common methods for the preparation of liposomes are 
the hydration of phospholipid films by shaking, and the detergent dialysis or detergent 
removal method (Kersten & Crommelin 2003). The simplest method is the hydration 
method in which thin films of phospholipids with or without cholesterol are hydrated by 
water or buffer in a large round-bottomed flask by gentle shaking (Bangham et al., 1965). 
This method is also known as the Bangham method (New 1990). In the detergent removal 









by subsequent removal of the detergent (often by dialysis) (Allen 1983; Weder & 
Zumbuehl 1983). These two methods are also of interest, as the preparation methods for 
ISCOMs were developed based on either detergent removal (Morein et al., 1984) or the 
hydration of phospholipids (Copland et al., 2000) (see Chapter 2, for a detailed discussion 
on the preparation methods for ISCOMs and related colloidal particles). 
Due to the presence of both aqueous internal compartments and lipid bilayers in the 
liposome structure, liposomes can incorporate any type of antigen regardless of its 
hydrophilicity (New 1990; Kersten & Crommelin 2003). As such, liposomes have been 
widely used as carriers of antigens and adjuvants (Alving 1991; Kersten & Crommelin 
1995; Busquets et al., 2003). However, despite being excellent carrier of a variety of 
antigens, the entrapment efficiency for macromolecules including proteins and peptides is 
often low, particularly for hydrophilic compounds (New 1990; Rogers & Anderson 1998; 
Kersten & Crommelin 2003). Furthermore, unlike ISCOMs, liposomes on their own are 
only weakly immunogenic (Hoglund et al., 1989; Kersten & Crommelin 2003), and 
therefore high amounts of soluble adjuvants usually have to be added to increase their 
immunological activity. However, the addition of soluble adjuvants not linked to 
liposomes containing the antigen may be suboptimal for immunestimulation or even result 
in undesirable side effects (Kersten & Crommelin 1995). 
Liposome-like structure can be defined as a collection of particles (mainly of submicron 
size) with a bilayer structure (Kersten & Crommelin 2003). These particles are therefore a 
variation on the classical phospholipid-based liposomes described above. Examples of 
liposomes-like structures are transfersomes, virosomes, archaesomes, and cochleates 
(Kersten & Crommelin 2003). These structures are briefly described below. 
1.3.5.2 Transfersomes 
Transfersomes are defined as 'ultradeformable' liposomes usually prepared with 
phosphatidylcholine as the phospholipid and bile salts (Cevc 1996). Their unique feature is 





et al., 1995; Paul et al., 1995; Cevc 2003). Epicutaneous and non-invasive administration 
of transfersomes carrying model antigens such as albumin, tetanus toxoid, and integral 
membrane gap junction proteins (GJP) have been reported to induce antigen-specific 
antibody titres similar to those produced by the injection of subcutaneous vesicle 
preparations (Paul et al., 1995). Similar results have been reported for interferons and 
interleukins incorporated into transfersomes which were also topically applied (Hofer et al., 
1999). 
When transfersomes were compared with normal liposomes, protein solutions, and mixed 
micelles, only transfersomes induced a measurable immune response to epicutaneously 
applied antigens (Paul et al., 1995). From these results it was suggested that transfersomes 
were able to cross the skin barrier without difficulty relative to the other delivery systems 
and hence resulted in strong interactions between the transfersomes and the APCs in the 
skin especially the dendritic cells. These cells were considered to play an important role in 
the presentation and processing of cutaneous antigen (Paul et al., 1995). Since there is a 
need for needle-free immunization procedures in order to improve patient compliance 
(Babiuk et al., 2000; Cevc 2003), transfersomes may be expected to play an important role 
in this regard due to their enhanced penetration properties (Kersten & Crommelin 2003). 
1.3.5.3 Virosomes 
Virosomes are structures that resemble small unilamellar liposomes but contain a receptor-
binding protein of enveloped viruses (typically influenza haemoglutin (HA)) on the vesicle 
(Gluck & Wegmann 1997). The presence of HA may be important because it acts as a 
targeting device by binding to sialic acid residues present on APCs (Kersten & Crommelin 
2003). As described in Section 1.2.3, antigens are internalized and processed by the APCs 
into peptide fragments which are presented on the surface of the APCs in form of MHC-
peptide complex to induce immune response (Kapsenberg et al., 1998). Similarly, after 
endocytic uptake of virosomes, the acidic environment in the endosome induces a 
conformation change in the HA. As a result, the virosome becomes fusogenic and fuses 






surface of the APCs becomes possible. Co-incorporation of other membrane antigens in 
the virosome structure often induces an enhanced immune responses against these antigens 
(Kersten & Crommelin 2003). 
In humans, virosome-based vaccines containing hepatitis A and influenza antigens have 
been found to possess enhanced immunogenicity compared to alum-adsorbed vaccine for 
hepatitis A or commercial subunit or whole virion influenza vaccines (Gluck 1999). These 
vaccines were reported to be safe and did not produce any antiphospholipid antibodies 
against the liposome components of the virosome. Hepatitis B, tetanus toxoid, diphtheria 
toxoid, and nucleic acids have also been incorporated into virosomes (Gluck 1999). 
Recently, virosomes have been reported as powerful adjuvants in the induction of Tc 
responses against human tumor associated antigens (Adamina et al., 2003). 
1.3.5.4 Archaeosomes 
Archaesomes are liposome-like structures formed by phospholipids derived from lipid 
membranes of archaeobacteria (Kersten & Crommelin 2003). The saturated, branched C-
20, C-25 and C-40 phytanyl chains of these phospholipids form liposomes with unique 
properties with respect to physical and chemical stability, and uptake by APCs (Patel & 
Sprott 1999). Compared with liposomes, archaesomes are less sensitive to oxidative stress, 
high temperature, alkaline pH, phospholipases and bile salts (Patel & Sprott 1999). 
Immune responses comparable to immunization with Freund's adjuvants (particularly 
FCAs) and superior to conventional liposomes have been reported after immunization with 
archaeosomes (Krishnan et al., 2000; Conlan et al., 2001). The potent adjuvant activity of 
archaeosomes is reported to be due to the recruitment and activation of macrophages and 
dendritic cells (Krishnan et al., 2001 ). 
1.3.5.5 Cochleates 
These are liposome-like structures with a non-vesicular bilayer morphology (Kersten & 
Crommelin 2003). They are prepared using phosphatidylethanolamine, negatively charged 
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phosphatidylserine and cholesterol (Gould-Fogerite et al., 1998). Calcium ions are added 
to the lipid mixtures which intercalate with the bilayers resulting in a rolled up bilayer sheet 
without internal volume (Gould-Fogerite et al., 1998; Kersten & Crommelin 2003). 
Results obtained with protein- and DNA-cochleates demonstrated that such particulate 
systems were highly effective vaccines when given via mucosal or parenteral routes, 
including oral, intranasal, intramuscular, or subcutaneous administration (Gould-Fogerite et 
al., 1998). High, long lasting, mucosal and circulating antibody titres as well as strong cell-
mediated immune responses were generated. Protection from challenge with live viruses 
following oral or intramuscular administration of the cochleates has also been demonstrated 
(Gould-Fogerite et al., 1998). 
Their mode of adjuvant activity is not well understood, but it possibly includes the 
formation of a depot from which antigen is slowly released, efficient targeting of antigen to 
lymphoid organs, and APCs and modulation of the properties of the induced response 
(Gould-Fogerite et al., 1998). Although cochleates contain calcium ions which may act as 
adjuvants, the immunological properties of the cochleates in the absence of antigens or 
other adjuvants have not been investigated. This is in contrast to ISCOM matrices (i.e. 
ISCOMs without antigens or other adjuvants) which are able to induce strong humoral and 
cell-mediated immune responses due to the presence of Quil A in their structure which is 
lmown to be a strong adjuvant (Behboudi et al., 1995; Villacres-Eriksson et al., 1997; 













1.3.6 ISCOMs as vaccine adjuvants 
ISCOMs have been developed as improved vaccine delivery systems over other lipid-based 
vaccine adjuvants such as liposomes (Morein et al., 1984). A liberal definition of the term 
ISCOMs was suggested by Kersten as "all saponin-lipid complexes prepared for use as an 
adjuvant or an antigen vehicle" (Kersten 1990). However, this definition, has not been 
widely adopted (Barr & Mitchell 1996). Rather, it is generally understood that ISCOMs 
are composed of the saponin adjuvant Quil A, cholesterol, phospholipid and the subunit 
antigen, usually an amphipathic protein (Barr et al., 1998; Sjolander et al., 1998; Morein & 
Bengtsson 1999; Kersten & Crommelin 2003). ISCOMs also form in the absence of 
protein and these structures are termed ISCOM matrices (Morein & Bengtsson 1999), 
indicating that the polar lipids are the structural elements in these colloidal particles. 
ISCOMs have a characteristic open cage-like morphology that appears to consist of about 
20 regularly ordered subunits (Ozel et al., 1989; Kersten & Crommelin 2003), and have a 
size in the range of 40-100 nm (Kersten et al., 1991). The morphology of ISCOMs or 
ISCOM matrices is best observed by negative staining transmission electron microscopy 
(Ozel et al., 1989; Kersten & Crommelin 1995; Rimmelzwaan & Osterhaus 1997; 
Andersson et al., 2000) and a typical electron micrograph of an ISCOM structure is shown 
in Figure 1.4 (Demana et al., 2004c). 
Although Quil A is not required in order to form liposomes, ISCOMs cannot be formed 
without Quil A (Kersten & Crommelin 2003). ISCOMs not only differ from liposomes in 
terms of presence or absence of Quil A, but also in terms of their physical and chemical 
stability (Hoglund et al., 1989). Some of the differences in the physical characteristics of 
liposomes and ISCOMs are summarized in Table 1.1 (Copland 2003). 
Currently, two models are used to describe the morphology of the ISCOM matrix (and also 
of the antigen containing ISCOMs, which appears structurally similar, albeit that 
sometimes the diameter of ISCOMs increases upon inclusion of the antigen into the 
ISCOM matrix (Kersten et al., 1991). In the one model, the ISCOMs are believed to 
consist of about 20 subunits, and that the holes in the structure (visible as the darker regions 
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in the negative staining electron micrographs) are due to the space between these subunits 
(Ozel et al., 1989). In the other model, the subunits are believed to be ring-like micelles 
(Kersten et al. , 1991 ). The darker regions are thus the centers of the subunits, rather than 
the space between them. It is believed that the subunits are held together by hydrophobic 
interactions, but steric factors and hydrogen bonding may also play a role. The two models 
are further described in Chapter 2. 
Figure 1.4 Negative staining transmission electron micrograph of 
ISCOM matrices (Demana et al., 2004c ). 
The physical stability of ISCOMs is in remarkable contrast to that of liposomal dispersion. 
It has been reported that the morphology and immunological property of IS CO Ms were not 
affected after 3 years storage as a sterile suspension in physiological buffer (Sundquist et 
al., 1988). It is believed that one of the factors, maintaining the stability of these structures 
is the fact that the ISCOM particles have negative surface potential at physiological pH due 




Table 1.1 Comparison of characteristics ofliposomes and ISCOMs 
(adapted from Copland 2003). 
Liposomes ISCOMs 
Thermodynamic Unstable Thought to be stable 
stability 
Size Highly variable (nm - µm) Uniform (approx 40 - 100 nm) 
Structure Closed bilayered structure with Open 'cage-like' structure 
variable numbers of layers formed from subunits 
Internal cavity Aqueous, isolated from Aqueous, continuous with 
external phase external phase 
Entrapment of Lipophilic and hydrophilic Only amphiphilic molecules 
compounds compounds may be entrapped may be incorporated 
(antigen) 
Surface potential Variable due to phospholipid Negative due to charge of 
composition sapomn 
Location of antigen Mainly internal Surface 
Inclusion of Optional Critical 
cholesterol 
Inclusion of Quil A Optional Critical 
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1.3.6.1 Composition of ISCOMs 
1.3.6.1.1 QuilA 
Quil A saponins are isolated from the cortex of the South American tree Quillaja saponaria 
Molina by aqueous extraction followed by dialysis, ion~exchange chromatography and gel 
filtration (Hoglund et al., 1989). The chemical structure of Quil A is a complex mixture of 
many structurally related bisdesmosidic triterpenoid glycosides (Higuchi & Komori 1987; 






Figure 1.5 Proposed structure of a purified Quil A fraction, referred 
to as QS III (adapted from Barr et al., 1998). 
The different components of Quil A, however, differ mainly in the composition of their 
sugar moieties (Higuchi & Komori 1987). Quillaja saponins have a five-ringed quillaic 
acid backbone with two carbohydrate chains, consisting of two to five sugar units, attached 
to the 3' and 28' carbons of the quillaic acid molecule (Higuchi & Komori 1987). 
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Therefore, Quil A consists of hydrophobic aglycone triterpene and hydrophilic regions due 
to sugar moieties with multiple hydroxyl groups. This structure results in Quil A behaving 
as a surfactant forming micelles in water at concentration of 0.03% (Ozel et al., 1989). 
Quil A is very stable and in the dried state ( e.g. as a lyophilized powder) can be kept for 
years at room temperature (Hoglund et al., 1989). In solution and after addition to vaccines 
stored at 5 °C, no chemical degradation of Quil A was detected after 1 year (Hoglund et al., 
1989). The glycosidic bonds in the triterpenoid molecule of Quil A may, however, be 
sensitive to extreme pH values (Hoglund et al., 1989; Kensil 1996). Quil A is also stable in 
micellar form presumably due to labile ester bonds that are buried in the hydrophobic 
micellar environment (Cleland et al., 1996). 
Quil A is a potent adjuvant that has been used in veterinary vaccines since the 1970s 
(Hoglund et al., 1989; Barr et al., 1998). However, despite the beneficial adjuvant 
properties, its widespread use is hampered by the fact that Quil A shows haemolytic 
activity upon parenteral administration (Kensil 1996; Barr et al., 1998). The surfactant 
properties of Quil A have been suggested as a cause for its toxicity (Kensil 1996). 
The toxicity of Quil A is very much reduced if it is bound in the ISCOM structure because 
the appearance of free Quil A is largely avoided (Kersten 1990; Barr et al., 1998; Sjolander 
et al., 1998; Morein & Bengtsson 1999). In order to further reduce the toxicity of the 
saponin source for the formation of ISCOMs, Quil A has been separated into more than 20 
fractions which have been investigated for their undesired haemolytic activity, adjuvant 
properties, and their ability to form ISCOMs (Kersten 1990; Kensil 1996; Barr et al., 
1998). Some of these fractions (e.g. QS 21) or combinations of certain Quil A fractions 
(e.g. ISCOPREP 703) are promising candidates to formulate ISCOMs with high 
immunogenecity and strongly reduced hemolytic activity (Kensil 1996; Barr et al., 1998), 
and are currently undergoing human clinical trial investigations (Kersten & Crommelin 
2003). 
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1.3.6.1.2 Cholesterol and phospholipids 
As shown in Table 1.1, inclusion of both phospholipids and cholesterol is critical for the 
formation of ISCOMs or ISCOM matrices. Long before ISCOMs were proposed as a novel 
delivery system for antigens, it was known that saponins interact with polar lipids, 
particularly cholesterol and to a lesser extent phospholipids (Dourmashkin et al., 1962; 
Glauert et al., 1962; Bangham & Home 1964; Lucy & Glauert 1964). ISCOMs containing 
antigen and prepared by the dialysis method are known to form with Quil 
A:cholesterol:phospholipid mass ratios of 5:1:1, whereas ratios of 6:1:1 are required for 
ISCOM matrices (Kersten et al., 1991). On the other hand, the formulation of ISCOM 
matrices by the hydration method appears to require a Quil A:cholesterol:phospholipid 
mass ratio of 4: 1 :6 (Copland et al., 2000). Phospholipids are believed to fluidize the 
ISCOM structure and thus allowing amphipathic molecules to be inserted into the ISCOM 
structure (Lovgren & Morein 1988). 
1.3.6.1.3 Antigen 
In contrast to liposomes, not all antigens are suitable for inclusion into the ISCOM matrix 
(Barr & Mitchell 1996; Konnings et al., 2002). Typically, the antigens incorporated into 
ISCOMs are proteins or glycoproteins that have some hydrophobic transmembrane regions, 
with which they are anchored in the viral membrane or the cell wall of the bacteria 
(Hoglund et al., 1989). If the antigen is too hydrophilic, it cannot be incorporated into 
ISCOMs, due to their lack of a closed internal hydrophilic compartment that liposomes 
have (Morein et al., 1990; Kersten et al., 1991; Konnings et al., 2002). On the other hand, 
if the protein is too lipophilic, it tends to aggregate thus not allowing its incorporation into 
the ISCOM matrix (Kersten & Crommelin 1995; Morein et al., 1995). Various strategies to 
modify hydrophilic proteins so that they could be incorporated into ISCOM matrices have 




1.3.6.2 Preparation methods for ISCOMs 
Three different preparation methods are described in the literature for the formation of 
ISCOMs. In the centrifugation and dialysis methods, the components necessary to form 
ISCOMs are mixed in the presence of a non-ionic surfactant, which is subsequently 
removed (Hoglund et al., 1989; Barr & Mitchell 1996). The removal of the detergent 
brings about the formation of ISCOMs. These preparation methods are analogous to the 
formation of liposomes using the detergent removal technique described in Section 1.3.5.1. 
The other method which was recently developed for the preparation of ISCOMs is called 
hydration or lipid film hydration method (Copland et al., 2000). This method is based on 
hydration of a cholesterol/phospholipid film with an aqueous solution of Quil A, with or 
without antigen. The method is analogous to the classical Bangham method for the 
preparation of liposomes also described in Section 1.3.5.1. The preparation methods for 
ISCOMs or ISCOM matrices are discussed in detail in Chapter 2. 
1.3.6.3 Immune responses to ISCOM formulations 
A large number of studies have investigated the adjuvant properties of ISCOMs and several 
reviews have been written on this topic (Hoglund et al., 1989; Barr & Mitchell 1996; 
Morein & Bengtsson 1998; Sjolander et al., 1998; Kersten & Crommelin 2003). Most of 
these studies have used ISCOMs prepared with Quil A but it would appear from recent 
studies that ISCOMs prepared from purified fractions retain their immunostimulatory 
effects (Rimmelzwaan & Osterhaus 1997; Barr et al., 1998; Sjolander et al., 1998). From 
the reported studies, it can be concluded that ISCOMs have effects on many aspects of the 
immune system and efficiently promote both humoral and cell mediated immune responses. 
The immunostimulatory effects of ISCOMs have not only been reported following 
parenteral immunization (subcutaneous or intraperitoneal), but also following oral or nasal 
administration (Morein et al., 1998; Mowat et al., 1999). The action of ISCOM as an 
adjuvant may be mediated through effects on antigen presentation, targeting or immune 
modulation (Barr & Mitchell 1996). These effects are briefly described below. 
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1.3.6.3.1 Antigen presentation and targeting 
One important property of adjuvants is their ability to act on APCs, including increased 
targeting, uptake, and presentation of antigen, expression of costimulatory molecules, and 
production of cytokines (Barr et al., 1998). Oily adjuvants, aluminium salts, and possibly 
ISCOMs appear to function through a depot effect in which the antigen is trapped at the site 
of administration and attracting cells of various kinds including APCs (Watson et al., 1992; 
Villacres-Ericsson 1993). Direct uptake of ISCOMs by APCs (macrophages) following 
intraperitoneal injection has been demonstrated using electron microscopy (Watson et al., 
1989). In these experiments, it was found using labeled influenza protein incorporated into 
ISCOMs that the antigen adhered to macrophage cell membranes, and high levels of 
antigen were retained in draining lymph nodes and in the spleen. 
It has been suggested that the higher uptake of ISCOMs by dendritic cells compared to 
protein micelles may be associated with the interaction of the ISCOM-saponin 
carbohydrates with a recently described molecule known as DEC-205, which is an integral 
membrane protein homologous to the macrophage mannose receptor and related receptors 
which is capable of binding carbohydrate/glycoprotein ligands although the actual natural 
ligands of the molecule are yet to be determined (Jiang et al., 1995). Targeting of DEC-
205 has been shown to enhance endocytosis leading to the more efficient presentation of 
antigens to T cells (Jiang et al., 1995; Mahnke et al., 2000). 
The antigen incorporated into ISCOMs is probably presented to the immune system as 
ISCOMs particles (van Binnendijk et al., 1992). ISCOMs may enter the APC cells via 
endosomal vesicles as intact particles than fusing with the endosomal membranes and 
deliver antigen to the cytosol for degradation and loading of class I MHC in the 
endoplasmic reticulum for T cell induction (van Binnendijk et al., 1992). Just like for 
liposomes, degradation of antigen must also occur within endosomes for class II MHC 
presentation (Harding et al., 1991) because of the known potency of ISCOMs in the 
induction ofhumoral and cell-mediated immune responses (Morein 1991; Barr et al., 1998; 






1.3.6.3.2 Modulation of T cell responses 
Recently, the ability of adjuvants to alter the nature of immune responses has received 
considerable attention (O'Hagan et al., 2001; Singh & O'Hagan 2002). For example, the 
influence of adjuvants on the pattern of cytokines produced by Th cells is of great interest 
because of the importance of different Th cell subsets for generation of protective immunity 
against certain infectious diseases (Barr et al., 1998). Many studies have demonstrated the 
potential of ISCOMs in activating murine Th cells to secrete Th-1 like cytokines such as 
interleukin-2 (IL-2) and interferon-gamma (IFN--y) (Villacres-Eriksson et al., 1992; Maloy 
et al., 1995b; Sjolander et al., 1997a; Smith et al., 1998). Spleen cells from mice receiving 
influenza-ISCOMs produced higher levels of IL-2 and IFN-'Y after restimulation than cells 
primed with influenza antigen in Freund's complete adjuvant (Sjolander et al., 1997a). 
Administration of ovalbumin in ISCOMs resulted in an antigen-specific up-regulation of 
the secretion of IL-2 and IFN-'Y compared to ovalbumin without adjuvant, or in aluminium 
hydroxide (Villacres-Ericsson 1993). 
ISCOMs are also able to induce Th2 cytokines with some proteins (Maloy et al., 1994; 
Sjolander et al., 1998). Type 2 cytokines are thought to provide help for the production of 
antibody and hence may have a significant effect on the level of protection obtained 
following vaccination against particular diseases, for example those involving extracellular 
micro-organisms and parasites, such as nematodes (Barr et al., 1998; Sjolander et al., 
1998). 
Despite the remarkable capacity of ISCOMs to stimulate the immune response, to date 
there is no licensed human vaccine. However, human applications have progressed to 
clinical trials using ISCOMs and ISCOM matrix prepared from purified saponin 
(ISCOPREP 703 or QS 21) and containing influenza viral proteins (Rimmelzwaan et al., 
2000; Kersten & Crommelin 2003). Clinical studies have not only confirmed the ability of 
ISCOMs to induce early high antibody responses compared to a conventional vaccine but 
to also result in the efficient induction of T cell responses. The ability of ISCOMs to 
induce significant and sustained levels of T cell activity in humans makes them a promising 
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adjuvant for future use in vaccines directed against chronic infections disease and also in 
cancer immunotherapy. 
1.4 Aims of the thesis 
As discussed above, there is a growing interest in the use of colloidal particles as subunit 
vaccine delivery systems, especially ISCOMs because they combine the advantages of a 
particulate carrier with the presence of a built-in adjuvant, Quil A. Since ISCOMs were 
developed in the mid 1980s (Morein et al., 1984), the predominant method that has been 
used to prepare ISCOMs is the dialysis method. Recently, a much simpler method for the 
preparation of ISCOM matrices called the hydration or lipid film hydration method was 
developed in our laboratory (Copland et al., 2000). However, little is known about the 
composition of ISCOMs and related colloidal structures containing Quil A, phospholipid 
and cholesterol prepared by this new method. In addition, factors such as type of 
phospholipid, type of aqueous medium (buffer) or length of equilibration time that may 
influence formation of ISCOMs and other colloidal particles prepared by the hydration 
method have not been investigated. Investigation into a possible controlled delivery of 
antigens from ISCOMs and other related colloidal particles as small implants (pellets) has 
also never been attempted. Furthermore, little is known with regard to the immunological 
properties and delivery of subunit vaccines to dendritic cells from ISCOMs and related 
colloidal systems prepared by the hydration method. 
Therefore, using the hydration method for the preparation of ISCOM matrices, the specific 
objectives of this study were: 
1. to identify combinations of aqueous mixtures of Quil A, cholesterol and 
phospholipid which result in the formation of ISCOM matrices and other colloidal 
particles by constructing pseudo-ternary diagrams. A further aim was to compare 
the pseudo-ternary diagrams produced following preparation of ISCOMs and other 
colloidal structures by the hydration and dialysis method (Chapter 2) 
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2. to investigate protein or antigen incorporation into ISCOMs and other colloidal 
structures prepared by the hydration method (Chapter 3) 
3. to investigate the possibility of preparing solid pellets containing Quil A, 
cholesterol and phospholipid for the controlled release of sub-unit antigens in 
colloid carriers (Chapter 4) 
4. to investigate the delivery of subunit vaccines incorporated into ISCOMs and 
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Colloidal particles such as liposomes allow for the encapsulation of labile antigenic 
proteins and peptides in a multimeric particulate form. However, liposomes due to the lack 
of sufficient inherent immunogenicity usually require the use of additional adjuvants if they 
are to be effective in stimulating an immune response (Kersten & Crommelin 1995). The 
addition of soluble adjuvants in order to increase immunogenicity are not, however, linked 
to the colloid containing the antigen and may thus be less than optimal for 
immunestimulation (Kersten & Crommelin 1995). ISCOMs have been developed as 
improved lipidic vaccine delivery systems (Morein et al., 1984). The advantages of 
ISCOMs as strong adjuvants and carrier of amphipathic antigens over the other lipid 
particulate adjuvants such as liposomes have been reviewed (Hoglund et al., 1989; Barr & 
Mitchell 1996; Rimmelzwaan & Osterhaus 1997; Morein & Bengtsson 1999; Sjolander et 
al., 2001a; Kersten & Crommelin 2003), and were described in Chapter 1. There are 
currently three different methods for the preparation of ISCOMs. These methods are 
briefly discussed below in terms of their advantages and disadvantages including factors 
that may affect preparation of ISCOMs by the hydration method. 
2.1.1 Preparation methods for ISCOMs 
The three different preparation methods described in the literature for the formation of 
ISCOMs are based on centrifugation, dialysis, and hydration. In the dialysis and 
centrifugation methods, the lipid components required for the formation of ISCOMs or its 
matrices (i.e. Quil A, cholesterol and phospholipid with or without antigen) are mixed in 
the presence of a non-ionic surfactant, which is subsequently removed. The removal of the 
non-ionic surfactant brings about the formation of ISCOMs. The dialysis technique is by 
far the most extensively used method for the preparation ofISCOMs (Kersten et al., 1991; 
Sjolander et al., 1997a; Andersson et al., 2000; Robson et al., 2003b). 
Recently, a novel and much simpler process for the preparation of ISCOM matrices called 






is based on the classical Bangham method used for the preparation of liposomes (Bangham 
et al., 1965), whereas the dialysis method is comparable to the detergent-removal-technique 
to produce liposomes (Weder & Zumbuehl 1983). We have since refined this methodology 
by introducing a freeze-drying step in order to promote intimate mixing of Quil A, 
cholesterol and phospholipid (Demana et al., 2004c). 
2.1.1.1 Centrifugation method 
In this method, purified viruses are disintegrated using a non-ionic surfactant. The viral 
proteins together with cholesterol and phospholipid are solubilised by the surfactant, and 
the resulting micellar solution is centrifuged through a thin layer of 10% sucrose and 0.5% 
non-ionic detergent ( e.g. Triton X-100) on top of a sucrose gradient (20-50 % w/w sucrose) 
containing Quil A (Hoglund et al., 1989). Upon ultracentrifugation, ISCOMs are formed 
and can be collected from the gradient. This method is particularly useful when surfactants 
with low critical micelle concentration (CMC) are used because they can efficiently be 
removed from the ISCOMs formulation by gradient ultracentrifugation (Hoglund et al., 
1989). The centrifugation method appears to be quite simple but it is rarely used 
presumably because of the tedious nature of preparing and collecting sucrose bands 
containing ISCOMs, and also the requirements of high-speed centrifuges. A schematic 
diagram of the centrifugation method is shown in Figure 2.1. 
2.1.1.2 Dialysis method 
Another way of removing the non-ionic surfactant molecules from the mixture of the 
ISCOM components is by extensive dialysis (Figure 2.1). Surfactants such as 
octylglucoside or N-decanoyl-N-methylglucamide (MEGA 10) are often used as non-ionic 
detergents. The disadvantage with this method is that dialysis has to be performed over 
long periods e.g. at least three days against a suitable buffer (Reid 1992; Sjolander et al., 
1997a; Johansson & Lovgren-Bengtsson 1999; da Fonseca et al., 2000). The molecular 
weight cut-off of the dialysis membrane is typically between 1,000 or 10,000 (Lovgren & 




matrices by mass ratio of Quil A:cholesterol:phospholipid is 6: 1: 1 (Kersten et al., 1991 ). 
For the antigen-containing ISCOMs, the mass ratio of Quil A:cholesterol:phospholipid is 
5:1:1 (Kersten et al., 1991). With these three polar lipids, non-ionic surfactant at a mass 
ratio of approximately 1 :7 (i.e. polar lipid:surfactant) can be used to solubilise the ISCOM 
components (Kersten et al., 1991). 
2.1.1.3 Hydration method 
In this method, dried thin films of phospholipid and cholesterol are prepared in a large-
round bottom flask by evaporation of a solution of the lipids in an organic solvent such as 
chloroform (Copland et al., 2000; Konnings et al., 2002; Demana et al., 2004c ). The lipid 
films are hydrated with an aqueous solution of Quil A with or without antigen (Konnings et 
al., 2002). For the formation of ISCOMs the use of a higher ratio of phospholipid to 
cholesterol than in the other methods was necessary. ISCOMs or its matrices could be 
prepared by this method when the mass ratio of QuilA:cholesterol:phospholipid is 4: 1 :6 
(Copland et al., 2000; Konnings et al., 2002). In contrast, a high Quil 
A:cholesterol:phospholipid mass ratio of 6: 1: 1 must be used for the dialysis method as 
described above (Kersten et al., 1991). If these specified ratios were not used, ISCOM 
matrices could not be formed (Kersten et al., 1991; Copland et al., 2000). These 
differences are important in the formulation of ISCOM matrices as particulate antigen 
delivery systems or as adjuvants because they show that the same composition of the three 
polar lipids would appear to form different colloidal structure if prepared by different 
methods. It is therefore of paramount importance to investigate the different mass 
combinations of the three polar lipids required in the formation not only of ISCOMs or 
ISCOM matrices but also other related colloidal particles. Such an investigation is 
necessary because different colloidal particles containing Quil A in their structure may be 
used in vaccination as adjuvants or as carrier of a variety of antigens or proteins. 
The main advantage of the hydration method is that it is a relatively simple technique and 
the procedure is less time consuming than the dialysis method (Copland et al., 2000). The 
preparation of ISCOMs by dialysis or centrifugation is rather labor intensive, and requires a 
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lot of resources that may be costly. However, using the hydration method, mixing of the 
polar lipid components may be suboptimal because additional surfactants are not used to 
solubilise the lipids, unlike in the dialysis or centrifugation methods. Consequently, the 
formation of ISCOMs may be limited due to poor mixing of ISCOMs components. To 
minimize the problem of poor mixing, the lipid mixtures could be freeze-dried (Demana et 
al., 2004c) since this technique has been reported as a good "molecular mixing" method 
(Betageri & Makarla 1995). A schematic diagram showing the preparation of ISCOMs by 
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Figure 2.1 Schematic showing preparation of ISCOMs by the 
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Figure 2.2 Schematic showing preparation ofISCOMs by the hydration method. 
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2.1.2 Factors influencing polar lipid/water systems 
Since phospholipids are required in the formulation of ISCOMs together with Quil A and 
cholesterol (De Vries et al., 1990; Kersten & Crommelin 1995; Rimmelzwaan & Osterhaus 
1997; Copland et al., 2000), the factors that affect swelling behavior of phospholipids in 
aqueous medium are important because they may impact on the formation of ISCOMs 
especially when these colloids are prepared by the hydration method. Two factors that are 
well known to have an effect on the swelling of phospholipids during hydration are buffer 
salts and equilibration time (Bangham et al., 1965; Gulik-Krzywicki et al., 1969; Hauser 
1984; New 1990). Buffer salts not only affect swelling of phospholipids but are also 
known to affect the aggregation behavior of many surfactants in aqueous medium (Mazer et 
al., 1979; Kem et al., 1991; Lin et al., 1994). Different types of phospholipids are known 
to behave differently in aqueous systems (Cullis & de Kruijff 1979), and hence this aspect 
requires investigation for the phospholipid-based colloidal systems prepared by the 
·hydration method. 
2.1.2.1 Buffer salts 
Although phospholipids in excess water do swell and form multilamellar liposomes (Knight 
1981; New 1990; Kersten & Crommelin 1995), their swelling behavior is limited 
depending on the net charge of their molecules, and also the presence of electrolytes in the 
aqueous medium (Gulik-Krzywicki et al., 1969; Hauser 1984). Uncharged or isoelectric 
lipids such as phosphatidylcholine do show no or limited swelling in water whereas lipids 
with a net charge such as phosphatidylserine show continuous swelling (Gulik-Krzywicki 
et al., 1969; Hauser 1984). The phase behavior of neutral and isoelectric lipids with the 
characteristic limited swelling in water can be converted to that of pure charged lipids by 
the use of buffer salts (Hauser 1984). This is because the continuous swelling process 
itself is a purely electrostatic phenomenon (Hauser 1984). Other studies have also 
indicated that a low buffer salt concentration prevents multilamellar stacks of phospholipids 





The exact physico-chemical reason for the swelling behavior of phospholipids and the 
effect of ions on it is not well understood, but has generally been described in terms of an 
equilibrium between the repulsive forces of the double-layer potential and the attractive van 
der Waals forces between opposing bilayers (Hauser 1984). 
Apart from the effects of buffer salts on the swelling behavior of phospholipids, other 
surfactants that do not swell in aqueous media but form micelles in a stepwise fashion such 
as bile salts are also affected by electrolytes (Mazer et al., 1979; Lin et al., 1994). Their 
micelle size, shape, aggregation number and polydispersity were found to be dependent, 
amongst other factors, on the concentration of buffer salts (Mazer et al., 1979). Often 
surfactants are known to form micelles above a critical micelle forming concentration 
(CMC) (Ozel et al., 1989; Nichols & Ozarowski 1990; Shikata et al., 1990; Acharya & 
Kunieda 2003). The CMC of surfactants is generally lowered in the presence of buffer 
salts, especially in the case of ionic surfactants (Mazer et al., 1979; Knight 1981; Shikata et 
al., 1990; Iampietro & Kaler 1999; Beck et al., 2000). The lowering of the CMC promotes 
aggregation of micelles resulting in micelles growth (Mazer et al., 1979; Imae et al., 1985; 
Shikata et al., 1990; Buwalda et al., 1999). Since Quil A has a negative charge due to the 
presence of glucuronic acid in its structure (Higuchi & Komori 1987; Kersten et al., 1991), 
the aggregation of Quil A micelles into ISCOMs in the presence of cholesterol and 
phospholipid may be affected by the presence of buffer salts. It is therefore important 
during preparation of ISCOMs by the hydration method to investigate the effect of buffer 
salts on the formation of colloidal structures. 
2.1.2.2 Equilibration time 
It is well known that phospholipids after only a short equilibration period may fail to swell 
(Knight 1981; New 1990) and that unilamellar liposomes on storage do swell and fuse to 
form multilamellar liposomes (Szoka & Papahadjopoulos 1981; Strauss et al., 1986; New 
1990; Kersten & Crommelin 1995). Thus, large multilamellar vesicles, typically several 
micrometers in size, represent a thermodynamically more stable form of phospholipids 
(Szoka & Papahadjopoulos 1981; Hauser 1984; Kersten & Crommelin 1995). It is also 
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known that equilibration time for surfactant/phospholipid systems which involve formation 
of mulitilamellar liposomes is generally a very slow process which may take hours to 
several weeks (Lichtenberg et al., 1979; Jackson et al., 1982; Vinson et al., 1989; Almgren 
2000; Roth et al., 2000). The Bangham method is a simple procedure to prepare 
multilamellar liposomes by hydrating dried thin films of phospholipids with water or buffer 
solution on gentle agitation such as by hand-shaking (Bangham et al., 1965; Knight 1981; 
New 1990). As described above the preparation of ISCOMs by hydration is related to the 
Bangham method and may involve the formation of multilamellar liposomes. Therefore 
investigation on the equilibration time for the preparation of ISCOMs by hydration is very 
important considering that Quil A itself is a surfactant. 
The interaction of surfactants with phospholipids has been suggested to occur in three 
stages (Lichtenberg et al., 1979). In stage I, at low concentrations of surfactants, the 
molecules are distributed between the phospholipid bilayers and solution until such point as 
sufficient surfactants have been added to saturate all the bilayers. The penetration of 
surfactants in the bilayer might change the bilayer configuration of the phospholipid phase 
depending on the nature of the surfactants (Patemostre et al., 1988; Walter et al., 1991; 
Almgren 2000; le Maire et al., 2000; Lichtenberg et al., 2000). In stage II, additional 
surfactants induce the formation of mixed micelles, which promote gradual lipid 
solubilisation resulting in the coexistence of mixed lipid-surfactant micelles and lipid 
bilayers saturated with surfactant. Stage III is defined as that point where all the 
phospholipid bilayers have disappeared and only mixed phospholipid-surfactant micelles 
are present. This mechanism is very slow especially for multilamellar liposomes because 
the bilayers of phospholipids get "peeled off' by surfactants, one after another in a pseudo-
first-order fashion (Lichtenberg et al., 1979). It is for this reason that a freeze-drying step 
has been introduced in the hydration method to prepare ISCOMs in order to improve 
mixing of Quil A and the other lipid components, and hence shorten the equilibration 
period (Demana et al., 2004c ). 
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2.1.2.3 Type of phospholipid 
Although a typical mass ratio of Quil A, cholesterol and phospholipid for the preparation of 
ISCOMs by dialysis have been reported (Kersten et al., 1991), there have been conflicting 
reports in the literature with regard to whether phospholipids are required as the structural 
components of ISCOM matrices (De Vries et al., 1988; Lovgren & Morein 1988; Hoglund 
et al., 1989; Kersten et al., 1991). Some authors reported that phospholipids were not 
essential for the formation of the ISCOM structure but are only required for the insertion of 
amphipathic antigens into ISCOM matrices (Lovgren & Morein 1988). Thus, the only 
polar lipids required for the formation of ISCOMs structure are Quil A and cholesterol 
(Morein et al., 1984; Lovgren & Morein 1988; Hoglund et al., 1989). However, De Vries 
et al suggested that phospholipids together with cholesterol and Quil A are the basic 
structural components of ISCOM structure (De Vries et al., 1988). This suggestion was 
supported by the observation that ISCOMs including membrane glycoproteins of the 
measles virus could only be formed following the inclusion of cholesterol and phospholipid 
in the formulation mixture (De Vries et al., 1988). This finding, however, does not assist in 
answering the question if phospholipids are a requirement in the formation of the protein 
free ISCOM matrix. 
Lovgren et al tested nine different lipids including phospholipids for their ability to interact 
with Quil A in order to form an ISCOM matrix structure (Lovgren & Morein 1988). This 
work was important considering that long before ISCOMs were made, it was shown that 
Quil A has the ability to penetrate and bind to a number of polar lipids, to form soluble 
lipid complexes (Bangham & Home 1962; Dourmashkin et al., 1962; Glauert et al., 1962; 
Lucy & Glauert 1964). The nine different lipids tested were cholesterol, 
phosphatidylcholine, palmitic acid, myristic acid, phosphatidylethanolamine, 
phosphatidylserine, phosphatidylglycerol, sphingomyeline, and cerebroside (Lovgren & 
Morein 1988). Their results showed that apart from cholesterol, none of the remaining 
eight different lipids tested on their own were able to interact with Quil A to produce an 
ISCOM matrix structure. It was concluded that only Quil A and cholesterol were the 
crucial components of the ISCOM matrix structure. However, without phospholipids, and 
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in particular phosphatidylcholine, amphipathic proteins could not be inserted into such 
ISCOM matrix structure. From this finding, it was concluded that phospholipids are only 
necessary when amphipathic antigens have to be incorporated but are not necessary to 
produce an ISCOM matrix structures (Lovgren & Morein 1988). It was hypothesized that 
phospholipids may act by fluidizing the rather rigid Quil A-cholesterol structure thus 
facilitating the insertion of amphipathic peptides or proteins into the structure through 
hydrophobic interactions. 
The studies of Kersten et al contradicted those mentioned above because in the absence of 
phospholipids, ISCOM matrix structures could not be formed by this group (Kersten et al., 
1991). Instead mixtures of Quil A and cholesterol in the absence of phospholipids formed 
individual ring-like micelles and associated hexagonal pattern of ring-like micelles 
described as "lamellae" structures. It was suggested that these contradicting findings were 
possibly due to differences in the experimental protocols employed, and specifically the 
additional surfactant which is used to help solubilise the polar lipid components of ISCOMs 
(Kersten et al., 1991). The surfactants most often used in the dialysis experiments are 
octylglucoside and MEGA-10 (Figure 2.3). The differences in the experimental protocols 
employed based on the removal of these surfactants by dialysis are summarized in Table 
2.1. 
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The reason suggested for the contradicting reports was based on the rate of surfactant 
removal during dialysis (Kersten & Crommelin 1995). It is possible that the dialysis time 
used by Lovgren et al was insufficient for complete removal of the relatively large MEGA-
10 molecule through the low molecular weight cut off dialysis membrane. 
Surfactants with a high CMC are easier to remove by dialysis than surfactants having a low 
CMC (Weder & Zumbuehl 1983; Kersten & Crommelin 1995). It is therefore likely that 
the time to remove MEGA-10 completely by dialysis will be considerably longer than the 
time to remove octylglucoside because of the higher CMC of octylglucoside. 
Phospholipid-free ISCOMs were found possibly due to MEGA-10 acting as a residual 
surfactant in the colloidal structure which would take over the role of phospholipids 
(Kersten & Crommelin 1995). Neither group however, determined the amount of residual 
surfactant left in the preparations. 
Table 2.1 Differences in ISCOM preparation using the dialysis method by different 
groups. 
Reference (Kersten et al., 1991) (Lovgren et al., 1988) 
Surfactant Octylglucoside MEGA-10 
CMC(mM) 23.2 6.2 
Molecular mass 292.4 349.5 
Initial surfactant concentration (%) 4 20 
Molecular mass cut-off dialysis 10,000 1,000 
membrane 
Dialysis time 24 h 18-36 h 
Number of bulk solution changes 2 x 1 litre Not specified 
during dialysis 
Temperature used during surfactant 4°c 25 °C (first 6-12 h); 4 °C 




Although Kersten et al concluded that phospholipids are essential as structural lipid 
components ofISCOM matrices, the type ofphospholipid used was also found to influence 
the morphology of ISCOMs (Kersten et al., 1991). Phospholipids that have often been 
used in the preparation of ISCOMs are phosphatidylcholine and phosphatidylethanolamine 
(Kersten & Crommelin 1995; Konnings et al., 2002) (Figure 2.4). 
Phosphatidylethanolamine is less popular than phosphatidylcholine presumably because of 
its high cost. Using phosphatidylcholine, ISCOM-like structures, which were irregular in 
morphology have been reported whereas phosphatidylethanolamine produced ISCOMs 
with more uniform morphology and size. The differences in the morphology of the 
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Figure 2.4 Structures of phosphatidylcholine (A) and phosphatidylethanolamine (B). 
The arrow indicates differences in the head group between the two phospholipids. 
Phospholipids such as phosphatidylethanolamine exhibit a 'cone' shaped structure in which 
the polar headgroup is at the smaller end of the cone (Figure 2.5) (Cullis & de Kruijff 1979; 
Kitson et al., 1992). Surfactants display an 'inverted cone' shape structure where the cross-
sectional area of the polar region is larger than that of the acyl chain (Cullis & de Kruijff 
1979). Phospholipids such as phosphatidylcholine adopt a more cylindrical shape which is 
most easily accommodated in the familiar bilayer phase (Cullis & de Kruijff 1979). With 






phosphatidylethanolamine molecules may increase the hydrophobic interactions resulting in 
closer contact of ring-like micelles (Kersten et al., 1991). 
In combination with proper Quil A/cholesterol mixtures, phosphatidylethanolamine 
therefore may provide the driving force for the transition of the individual ring-like 
micelles to spherical ISCOM structures with uniform morphology and size (Kersten et al., 
1991). The lack of a cone-shaped configuration in phosphatidylcholine would result in the 
formation ofISCOM-like structures with a less uniform morphology (Kersten et al., 1991). 
All findings of Kersten et al., (Kersten et al., 1988, 1991, 1995) described above and those 
of other investigators (Morein et al., 1984; De Vries et al., 1988; Lovgren & Morein 1988; 
Hoglund et al., 1989; Sjolander et al., 1997a; Andersson et al., 2000) were reported 
following preparation of colloidal dispersions by the dialysis method. It remains to be 
investigated if the same will hold true for the hydration method. Furthermore, despite the 
widespread use of the dialysis method to prepare ISCOMs in the past two decades, not 
much is known about the different types of colloidal structures that can be formed as a 
result of different combinations of Quil A, cholesterol and phospholipid in aqueous media 
using this technique. In addition, since the findings reported by Kersten et al, suggesting 
that phospholipids are essential for the ISCOM matrix structure (Kersten et al., 1991), there 
has not been any study conducted using the dialysis method to investigate the role of 
varying ratios of the different polar lipids in the formation of colloidal structures . 
Therefore, an investigation into aqueous systems of Quil A, cholesterol and phospholipid 
prepared by dialysis is necessary to determine the role of phospholipids in the ISCOM 
matrix structure, to identify different combinations of the polar lipids required for the 
formation of ISCOM matrices and other colloidal particles, and to compare the resulting 























Figure 2.5 Phases and the corresponding dynamic molecular shapes of 
different types oflipids (adapted from Cullis et al., 1979). 
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2.1.3 Proposed models of the ISCOM structure 
Currently two models exist to describe the morphology of the ISCOM matrix (and also of 
antigen containing ISCOMs). The first model was suggested on the basis that Quil A and 
cholesterol are the only required components of an ISCOM matrix structure. In this model, 
ISCOMs are believed to consist of about 20 globular subunits that are orientated such that 
pores are formed between the subunits (Ozel et al., 1989). The Quil A-cholesterol micelles 
are believed to have a pentagonal dodecahedron arrangement exhibiting two-, three-, and 
five-fold symmetry (Figure 2.6). This model correlates well with the visual appearance of 
ISCOM particles by negative staining transmission electron micrographs produced by this 
group. However, the limitation with this model is that it does not take into account the 
various forces behind the aggregation of a discrete number of (presumably symmetrical) 
subunits into the well defined ISCOM structure (Kersten et al., 1991). 
An alternative model was proposed taking into account the role of phospholipids together 
with cholesterol and Quil A as the structural components of the ISCOM matrix (Figure 2.7) 
(Kersten et al., 1991). In this model, ISCOMs are considered to be multi-micellar 
structures, shaped and stabilized by hydrophobic interactions, electrostatic repulsion, steric 
factors and possibly hydrogen bonds (Kersten et al., 1991). The individual micelles are 
considered to be relatively flat, ring-shaped structures, the center offering space for one of 
the two bulky sugar chains of the Quil A. The observation that a higher Quil A:cholesterol 
mass ratio in the absence of phospholipids formed individual ring-shaped micelles further 
supported this model (Kersten et al., 1991). In addition, increasing hydrophobicity of 
micelles by lowering Quil A:cholesterol mass ratios formed a hexagonal pattern of these 
ring-shaped micelles (lamellae) (Kersten et al., 1991). From the observation of lamellae, it 
was suggested that by increasing the phospholipid amount, it is possible to fluidize these 
structures resulting in the formation of ISCOMs (Kersten et al., 1991). However, this 
suggestion was considered to be the limitation with this model and was recently criticized 
as it can be shown using Euler's formula that it is not possible to form a spherical structure 
such as ISCOMs from the morphology of individual hexagons (Copland 2003). Without 






architecture of the ISCOM subunits and the manner in which they combine to form the 
characteristic cage-like structural appearance in the electron microscope. 
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Figure 2.6 A model of the proposed pentagonal dodecahedron ISCOM structure formed 
by about 20 globular subunits as viewed along the two-, three-, and five-fold symmetry 






Figure 2.7 A model of the proposed ISCOM structure formed from ring-like subunits. 
A. Possible structure of Quil A-cholesterol ring-like micelles, with a hydrophobic 
core. B. Aggregation of the Quil A-cholesterol ring-like micelles forming hexagonal 
pattern referred to as lamellae. C. Proposed ISCOM matrix formed with the addition 
of cone-shaped phospholipid (phosphatidylethanolamine) to the Quil A-cholesterol 
ring-like micelles. The hydrophilic groups are shaded: 8 belonging to the Quil A 
molecule, the hydroxyl group in cholesterol and the ethanolamine phosphate in the 
cone-shaped phosphatidylethanolamine ( adapted from Kersten et al., 1991 ). 
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2.2. Chapter aim 
As discussed above, the recent developments to prepare ISCOMs or ISCOM matrices by 
the hydration method (Copland et al., 2000) are significant in the formulation of particulate 
vaccine/adjuvant delivery systems because of the relatively simple nature of this method, 
and the fact that no additional surfactants are required compared with the standard dialysis 
method. However, little is known about the mass ratios of the polar lipids required to form 
ISCOMs and other related colloidal particles by the hydration method. Furthermore, 
factors which may influence the formation of ISCOMs and other colloidal particles using 
the hydration method such as buffer salts, equilibration time and type of phospholipid have 
not been investigated. The mechanism in which ISCOMs or ISCOM matrices are formed 
when prepared by the hydration method is unknown. Based on the recent developments to 
prepare ISCOM matrices by the hydration method, the aims of this study were to construct 
pseudo-ternary diagrams for Quil A, cholesterol and phospholipid in aqueous systems in 
order: 
1. to identify combinations that result in the formation ofISCOM matrices 
2. to identify other colloidal particles produced by the three compounds Quil A, 
cholesterol and phospholipid 
3. to investigate the effects of buffer salts, equilibration time and type of 
phospholipid as these three factors may affect formation of ISCOMs and other 
colloidal particles, and hence the nature of the pseudo-ternary diagram 
4. to characterize colloidal structures formed in the vicinity of the ISCOM matrix 
region of the pseudo-ternary diagrams and structures which transformed into 
ISCOM matrices upon extended equilibration times in order to get further 
insight into the possible mechanism of IS COM formation and structure 
5. to compare pseudo-ternary diagrams of the colloidal systems following 





2.3 Materials and methods 
2.3.1 Materials 
Quil A was obtained from Superfos Biosector, Denmark. Cholesterol (purity approx. 
95%), L-a.-phosphatidylethanolamine from bovine brain (purity approx. 98%), L-a.-
phosphatidylcholine from egg yolk (purity approx. 99%), octylglucoside (purity approx. 
98%) and sodium chloride (purity approx. 99%) were purchased from Sigma-Aldrich Pty 
Ltd, Missouri, USA. Tris (hydroxymethyl) methylamine (purity approx. 98%) was 
purchased from BDH Laboratory Supplies, Pool, England. A 1,000 Da molecular weight 
cut-off dialysis membrane (Regenerated Cellulose Tubing) was purchased from Spectrum 
Laboratories Inc., California, USA. Distilled deionised water having a conductivity of less 
than 0.1 µ,S was used throughout (Milli-Q Water system, Millipore Corporation, 
Massachussetts, USA). All other chemicals and solvents were of at least analytical grade. 
2.3.2 Preparation of colloidal dispersions 
2.3.2.1 Hydration method 
Various amounts of phosphatidylcholine or phosphatidylethanolamine and cholesterol were 
dissolved in 0.5 ml chloroform and evaporated to dryness at 45°C for 1 h (Rotavapor Rl 10, 
Biichi, Switzerland). The lipid films formed were hydrated for 2 h at room temperature 
with 3 ml Tris buffer (140 mM, pH 7.4) containing various amounts of Quil A. The total 
polar lipid concentration in each sample (Quil A, cholesterol, and phosphatidylcholine or 
phosphatidylethanolamine) was 6.7 mg/ml. The samples were subsequently freeze-dried for 
24 h (Freezone 6, Model 79340, Labconco, Missouri, USA) at a condenser temperature of -
82°C and pressure of less than 10-1 mbar. The freeze-dried samples were rehydrated with 3 
ml water and stirred using a magnetic stirrer for 2 h. A total of 66 different samples was 




2.3.2.2 Dialysis method 
The dialysis method was performed as described by Kersten et al (Kersten et al., 1991) and 
other groups for the preparation of ISCOMs (Andersson et al., 2000; Blomqvist et al., 
2003). Various amounts of phospholipids (phosphatidylcholine or 
phosphatidylethanolamine) and cholesterol were dissolved in 0.5 ml chloroform and 
evaporated at 45°C for 1 h (Rotavapor RllO, Biichi, Switzerland). To the dried lipid film, 
different amounts of Quil A together with octylglucoside ( 40 mg/ml) in 3 ml Tris buffer 
(140 mM, pH 7.4) were added so that the total polar lipid (Quil A, cholesterol, and 
phosphatidylcholine or phosphatidylethanolamine) concentration in each sample was 6.7 
mg/ml. The resulting micellar solutions were subsequently stirred using a magnetic stirrer 
for 2 h at room temperature before placing in dialysis tubing. The samples were dialyzed 
against 7 changes of 1 1 Tris buffer (140 mM, pH 7.4) at 4°C for 3 days to remove 
octylglucoside. A total of 66 different samples was prepared in triplicate, giving an overall 
total of almost 200 samples per pseudo-ternary diagram. 
2.3.3 Characterization of colloidal dispersions 
Dispersions were investigated within a day of preparation and after storage in a fridge ( 4 
0 C) for a period of one or two months. 
2.3.3.1 Transmission electron microscopy (TEM) 
Carbon-coated copper grids were glow-discharged (Edwards E306A Vacuum Coater, 
England) and 10 µl of sample adsorbed onto these grids. The samples were negatively 
stained using 10 µl of filtered 2% phosphotungstic acid, pH 5.2 as a contrast agent. 
Although it cannot be excluded that the staining agent might affect the morphology of the 
structures viewed in the TEM, reproducible visualization of the morphology of ISCOMs, 
liposomes and other colloidal structures has been demonstrated for negatively stained 
samples by various groups (Zillig et al., 1988; Ozel et al., 1989; New 1990; Kersten et al., 
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1991; Wagner & Hewlett 1999; Konnings et al., 2002; Demana et al., 2004c). The 
morphology inferred from negatively stained samples has also been found to be consistent 
with that from other microscopical techniques such as freeze-fracture electron microscopy 
(Kunitake et al., 1981; Kersten et al., 1988b). The effect of phosphotungstic acid on the 
morphology of the structures observed in this study was therefore considered to be 
minimal. 
Samples were investigated using a Phillips CMlOO transmission electron microscope at an 
acceleration voltage of 100 kV and viewed at a magnification of x135,000. The size of the 
colloidal structures was determined using AnalySIS® software (Soft Imaging Systems, 
Reutlingen, Germany). At least 1000 particles per sample were observed and measured, 
and from this the prevalence of different colloidal structures was estimated and expressed 
as percentage of all the colloidal particles present in the sample. Pseudo-ternary diagrams 
were established and the estimated prevalence of different colloidal structures in the 
samples investigated, based on transmission electron microscopical investigation, is 
presented in the pseudo-ternary diagrams. Colloidal particles that comprised less than 5 % 
of the total colloidal particles counted in a specific sample were classed as minor colloidal 
structures. These minor colloidal structures are not presented in the pseudo-ternary 
diagrams. All pseudo-ternary diagrams were generated using GIMP software (Free 
Software Foundation, Inc., Massachusettes, USA) and Microsoft Excel program (Microsoft 
Corporation, Washington, USA). 
2.3.3.2 Polarized light microscopy (PLM) 
All formulations were examined using a phase contrast light microscope (Model 218502, 
Nikon, Japan) equipped with polarizer and analyzer (Optiphot, Nikon, Japan) to determine 








2.4.1 Pseudo-ternary diagrams of aqueous mixtures of Quil A, cholesterol and 
phospholipid prepared by the hydration method 
The pseudo-ternary diagrams of mixtures of Quil A, cholesterol and phosphatidylcholine 
dispersed in water and characterized within one day of preparation and following 2 months 
of storage at 4 °C as well as the type and propensity of the structures observed therein are 
shown in Figures 2.8 and 2.9 respectively. Similar pseudo-ternary diagrams of mixtures of 
Quil A, cholesterol and phosphatidylcholine dispersed in Tris buffer (140 mM, pH 7.4) and 
characterized within one day of preparation and following 2 months of storage at 4 °C are 
shown in Figures 2.10 and 2.11 respectively. Pseudo-ternary diagrams prepared using 
phosphatidylethanolamine as the phospholipid in Tris buffer (140 mM, pH 7.4) and 
characterized within one day of preparation and following 1 month of storage at 4 °C are 
shown in Figures 2.12 and 2.13 respectively. The phase diagram in Figure 2.13 remained 
unchanged after 2 months of storage of samples at 4 °C . 
Depending on the mass ratio of Quil A, cholesterol and phospholipid in the systems, 
I 
various colloidal particles including ISCOM matrices, liposomes, lipidic/layered structures, 
ring-like and worm-like micelles were observed. Other colloidal particles were also 
observed as minor structures in the presence of these predominant colloids including 
helices, and lamellae (hexagonal pattern of ring-like micelles). The prevalence and 
distribution of these structures in the samples used for the construction of the pseudo-
ternary diagrams was influenced by the presence of buffer salts and equilibration time. The 
results in Figure 2.13 show that nature and prevalence of the colloidal systems was not 
affected by equilibrating the samples for 1 or 2 months at 4 °C, suggesting that a 1-month 
period may be sufficient to reach the equilibrium state of the colloidal systems. The area 
in which ISCOM matrices were observed as the predominant colloidal structures in the 
pseudo-ternary diagram increased over time from samples, which initially contained a high 
concentration of ring-like micelles suggesting that these colloidal structures may be 





In comparing pseudo-ternary diagrams of aqueous systems containing phosphatidylcholine 
(Figure 2.10 - 2.11) with those produced using phosphatidylethanolamine as the 
phospholipids (Figure 2.12 - 2.13), differences in the prevalence and distribution of 
colloidal particles could be observed. Surprisingly, the area in the pseudo-ternary diagrams 
in which ISCOM matrices were the predominant colloidal structures was relatively larger 
for ternary systems containing phosphatidylcholine than for the same systems containing 
phosphatidylethanolamine. These results suggest that the type of phospholipid has an 
influence on the nature of pseudo-ternary diagram. The results in pseudo-ternary diagrams 
also show that the area representing crystals of cholesterol is slightly smaller for systems 
containing phosphatidylcholine than for the respective systems containing 
phosphatidylethanolamine, suggesting a slightly better solubilisation of cholesterol in the 
mixtures containing phosphatidylcholine. These results are similar to others in which 
cholesterol was reported to be slightly better solubilised in the bilayers of 
phosphatidylcholine compared with phosphatidylethanolamine (Cheetham et al., 1989; 
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Figure 2.8 Pseudo-ternary diagram for mixtures of Quil A, cholesterol and 
phosphatidylcholine hydrated in water and characterized within one day of preparation. 
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Figure 2.9 Pseudo-ternary diagram for mixtures of Quil A, cholesterol and 
phosphatidylcholine hydrated in water and equilibrated for 2 months at 4 °C. Samples were 
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Figure 2.10 Pseudo-ternary diagram for mixtures of Quil A, cholesterol and 
phosphatidylcholine hydrated in Tris buffer (140 mM, 7.4) and characterized within one day 
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Figure 2.11 Pseudo-ternary diagram for mixtures of Quil A, cholesterol and phosphatidylcholine 
hydrated in Tris buffer (140 mM, 7.4) and equilibrated for 2 months at 4 °C. Samples were 
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Figure 2.12 Pseudo-ternary diagram for mixtures of Quil A, cholesterol and 
phosphatidylethanolamine hydrated in Tris buffer (140 mM, 7.4) and characterized within one day 
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Figure 2.13 Pseudo-ternary diagram for mixtures of Quil A, cholesterol and 
phosphatidylethanolamine hydrated in Tris buffer (140 mM, 7.4) and equilibrated for 1 
month at 4 °C. A similar phase diagram was obtained after 2 months of storage at 4 °C . 




4.1.1 Aqueous systems containing only a single lipid component 
Figures 2.14 A and B show electron micrographs of aqueous dispersions of Quil A and 
phosphatidylcholine respectively. Figure 2.14 C shows an electron micrograph of 
phosphatidylcholine hydrated in buffer, and Figure 2.14 D shows a polarized light 
micrograph of a crystal of cholesterol dispersed in water. Quil A forms micelles in the 
absence of other components in water or buffer. It has a reported CMC in water of 0.03% 
(Ozel et al., 1989). In aqueous systems of phosphatidylcholine, a mixture of lipidic 
particles (predominantly) and some bilayered structures were observed whereas 
phosphatidylcholine m buffer predominantly formed liposomes. With 
phosphatidylethanolamine, similar results as for the phosphatidylcholine were obtained. In 
systems containing only cholesterol, crystals were observed, which were birefringent when 
viewed under polarized light. 
2.4.1.2 Pseudo-binary Quil A/cholesterol samples (worm-like micelles) 
In systems containing Quil A and cholesterol, worm-like micelles, as shown in Figure 2.15 
A, were observed. These worm-like Quil A/cholesterol micelles were observed in all 
systems containing these two components. However, in systems where the ratio of Quil 
A:cholesterol was smaller than 9: 1, these worm-like micelles were found together with 
cholesterol crystals. 
2.4.1.3 Pseudo-binary Quil A/phospholipid samples (lipidic/layered structures) 
An electron micrograph of lipidic/layered structures is shown in Figure 2.15 B and C. The 
sample has a Quil A:phosphatidylcholine mass ratio of about 2: 1. In addition to non-
bilayer morphology, layered structures in form of stacks (Figure 2.15 B and C, arrow) were 
observed when viewed by TEM. A closer examination of the colloidal particles revealed 
that both the non-bilayer and layered structures belong to the same lipidic particles, and 
their different appearance is due to their orientation within the sample when viewed by 
TEM. The nature of lipidic/layered structures was not affected by equilibration period and 
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presence of buffer salts although the prevalence of lipidic particles in form of layered 
structures was relatively higher in samples prepared in buffer solutions than in those 
prepared in water (Figure 2.15 C). Mixtures of Quil A and phosphatidylethanolamine also 
produced lipidic/layered structures. 
2.4.1.4 Pseudo-binary phospholipid/cholesterol samples (liposomes, lipidic particles 
and cholesterol crystals) 
Depending on the use of buffer or water as the hydrating solution or subjecting the samples 
to prolonged storage time, mixtures containing phosphatidylcholine or 
phosphatidylethanolamine and cholesterol formed either predominantly liposomes or lipidic 
particles. Multilamellar liposomes were promoted by the use of buffer salts, and also 
following an extended equilibration time irrespective of the hydrating medium. The 
morphology of lipidic particles or liposomes was the same as shown in Figures 2.14 B and 
C respectively. 
2.4.1.5 Pseudo-ternary Quil A/cholesterol/phospholipid (ring-like micelles, lamellae, 
ISCOM matrices and helices) 
The aqueous mixtures containing Quil A, cholesterol and phospholipid formed individual 
ring-like micelles, hexagonal pattern of ring-like micelles (lamellae ), ISCOM matrices and 
helices (Figures 2.16 A to D respectively) depending on the mass ratio of lipid components. 
The prevalence of these structures was affected by buffer salts and equilibration time. 
These effects are discussed in section 2.5. 
Although ISCOM matrices and lamellae structures could be detected in the aqueous 
mixtures of Quil A, cholesterol and phosphatidylcholine (Figure 2.16), it was generally 
found that the prevalence of ISCOM-like structures (i.e. ISCOMs of irregular shape and 
size) (Figure 2.17 A), and not well formed lamellae structures (Figure 2.17 B) was greater 
in such mixtures than in the same systems prepared using phosphatidylethanolamine as 




appearance of other colloidal structures (worm-like micelles, ring-like micelles, 
lipidic/layered structures, helices and liposomes). Similar results have been previously 
reported by other investigators with respect to observation of ISCOM-like structures 







Figure 2.14 Electron micrographs of single lipid component systems. A: Quil A hydrated 
in water (Quil A micelles), B: Phosphatidylcholine, hydrated in water (lipidic particles), 








Figure 2.15 Electron micro graphs of pseudo-binary systems. A: Quil A:cholesterol, mass 
ratio 1:1 (worm-like micelles), B: Quil A:phosphatidylcholine, mass ratio 2:1, within one 
day of preparation (lipidic/layered structures), C: Quil A:phosphatidylcholine, mass ratio 
2:1, after 2 months storage at 4 °C (lipidic/layered structures). Arrows indicate layered 





Figure 2.16 Electron micrographs of pseudo-ternary systems. A: Quil 
A:cholesterol:phosphatidylcholine, mass ratio 1:3:1 (ring-like micelles), B: Quil 
A:cholesterol:phosphatidylcholine, mass ratio 1 :3: 1 (lamellae as minor colloidal 
structure), C: Quil A:cholesterol:phosphatidylcholine, mass ratio 2: 1 :2 (IS COM 
matrices), D: Quil A:cholesterol:phosphatidylcholine, mass ratio 2: 1 :2 (helices as 






Figure 2.17 Electron micrographs of pseudo-ternary systems prepared by the 
hydration method. A: Quil A:cholesterol:phosphatidylcholine, mass ratio 1: 1 :3 
(mixture of ISCOM matrices and ISCOM-like structures). The arrows indicate 
irregularily shaped ISCOM-like structures. B: Quil 
A:cholesterol:phosphatidylcholine mass ratio 2:7: 1 (lamellae ). A well formed 
hexagonal pattern of lamellae is indicated by the arrow. The rest of the micrograph 
shows lamellae patterns that were not well formed. The micrograph is 
representative of lamellae structures observed when phosphatidylcholine is used in 
the mixture. In contrast ternary mixtures containing phosphatidylethanolamine 
usually produced well formed lamellae. 
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2.4.2 Comparison of pseudo-ternary diagrams of aqueous mixtures of Quil A, 
cholesterol and phospholipid prepared by the hydration and dialysis method 
Pseudo-ternary diagrams of aqueous mixtures of Quil A, cholesterol and 
phosphatidylcholine prepared by the dialysis method and characterized within one day of 
preparation and following 1 or 2 months of storage at 4 °C are shown in Figures 2.18 and 
2.19 respectively. Similar pseudo-ternary diagrams of aqueous mixtures of Quil A, 
cholesterol and phosphatidylethanolamine prepared by the dialysis method and 
characterized within one day of preparation and following 1 or 2 months of storage at 4 °C 
are shown in Figures 2.20 and 2.21 respectively. 
A comparison of pseudo-ternary diagrams for the hydration method (Figures 2.10 - 2.13) 
(hydration) and the dialysis method (Figures 2.18 - 2.21) shows that the same groups of 
colloidal particles including ISCOM matrices, liposomes, lipidic/layered structures and 
ring-like micelles were found as the predominant colloids irrespective of whether dialysis 
or hydration method was used. However, the prevalence of colloidal particles obtained in 
the pseudo-ternary diagrams of colloidal systems produced by the dialysis method are 
clearly different from the pseudo-ternary diagrams prepared by the hydration method, 
especially with respect to the region in which ISCOM matrices were the predominant 
structures. Furthermore, in contrast with ISCOM matrices produced by the hydration 
method (Section 2.4.1), the formation of the same colloids when prepared by the dialysis 
appears not to be strongly affected by prolonged storage of 1 or 2 months at 4 °C. 
For pseudo-binary mixtures containing Quil A and cholesterol and prepared by the 
hydration method, only worm-like structures were observed (Figure 2.15 A). In contrast, 
pseudo-binary mixtures containing Quil A and cholesterol and prepared by the dialysis 
method produced ring-like micelles. These ring-like micelles shown in Figure 2.22 A, were 
identical in morphology and size to those presented in Figure 2.16 A but the latter could 
only be formed as a result of pseudo-ternary mixtures of Quil A, cholesterol and 
phospholipid following the hydration method. With the ring-like micelles formed in the 




matrices as minor colloidal structures were also observed especially at higher Quil 
A:cholesterol mass ratios (Figure 2.22 B). With lower Quil A:cholesterol mass ratios, the 
ring-like micelles were observed as lamellae structures (Figure 2:22 C) similar to those 
shown in Figure 2.16 B, which could only be formed in the presence of phospholipid if 
prepared by the hydration method. 
Another difference found was that although helices were observed in both dialysis and 
hydration methods as minor colloidal structures, more helical micelles were found with the 
samples prepared by the dialysis method. Indeed, helices were frequently found alongside 
with ISCOM matrices or ISCOM-like structures, when prepared by the dialysis method. 
In comparing pseudo-ternary diagrams following the hydration and dialysis methods, the 
area in which cholesterol crystals were observed was relatively larger in the systems 
prepared by the hydration method than in systems prepared by dialysis suggesting a better 
solubilisation of cholesterol using the dialysis method. These differences described above 
on the comparison of pseudo-ternary diagrams of aqueous mixtures of Quil A, cholesterol 
and phospholipid prepared by the lipid-film hydration and dialysis methods are discussed in 
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Figure 2.18 Pseudo-ternary diagram for mixtures of Quil A, cholesterol and 
phosphatidylcholine hydrated in Tris buffer (140 mM, 7.4) and characterized within one 
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Figure 2.19 Pseudo-ternary diagram for mixtures of Quil A, cholesterol and 
phosphatidylcholine hydrated in Tris buffer (140 mM, 7.4) and equilibrated for 1 or 2 
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Figure 2.20 Pseudo-ternary diagram for mixtures of Quil A, cholesterol and 
phosphatidylethanolamine hydrated in Tris buffer (140 mM, 7.4) and characterized within one 
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Figure 2.21 Pseudo-ternary diagram for mixtures of Quil A, cholesterol and 
phosphatidylethanolamine hydrated in Tris buffer (140 mM, 7.4) and equilibrated for 






Figure 2.22 Electron micrographs of pseudo-binary systems. A: Quil 
A:cholesterol, mass ratio 4: 1 (ring-like micelles), B: Quil A:cholesterol, mass 
ratio 4: 1 (ISCOM matrices as minor colloidal structure), C: Quil A:cholesterol, 
mass ratio 1:4 (lamellae). All samples were prepared by the dialysis method. 
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2.4.3 Possible mechanism for the formation of ISCOM matrices prepared by 
the hydration method 
Characterization of all colloidal structures formed in the vicinity of the ISCOM matrix 
region of the pseudo-ternary diagrams and structures which transformed into ISCOM 
matrices upon extended equilibration times irrespective of the type of phospholipids used, 
suggests that there are two mechanisms by which ISCOM matrices may be formed when 
these colloids have been prepared by the hydration method. One possible mechanism is the 
formation of ISCOM matrices from the aggregation of ring-like micelles. The other 
mechanism is the formation of ISCOM matrices from liposomes. The second mechanism 
was frequently observed in systems containing high concentrations of liposomes upon 
increasing Quil A addition. Electron micrographs supporting the existence of two different 
mechanisms for ISCOM formation in pseudo-ternary systems of Quil A, cholesterol and 
phospholipids are shown in Figures 2.23 and 2.24 (Demana et al., 2004e). The liposomal 
mechanism is further discussed in section 2.5 and is also compared with the formation of 
ISCOM matrices by the dialysis method. 
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Figure 2.23 Electron micrographs of a pseudo-ternary system prepared by the hydration 
method demonstrating the possible formation of ISCOM matrices from the aggregation of 
ring-like micelles. Ring-like micelles are presented above in the first electron micrograph 
(A), and some of these are observed to aggregate (see arrows) possibly by hydrophobic 
interactions. The presence of ring-like micelles alongside ISCOM matrices in the same 
pseudo-ternary mixture of Quil A, cholesterol and phospholipid, mass ratio 2: 1 :2 suggests that 
ring-like micelles are the subunits of ISCOM matrices (B and C). The morphology and size 
of the ring-like micelles on their own or in the aggregated form of the ISCOM matrix 
structure is similar (A - D), and hence further supporting the mechanism ofISCOM formation 
from the ring-like micelles. ISCOM matrices are also shown on their own with hardly any 
isolated ring-like micelles present to illustrate the disappearance of individual ring-like 
micelles as a result of their association into ISCOM matrices (D). All arrows in the 
micrographs indicate aggregation of ring-like micelles due to micelle-micelle interaction, 





Figure 2.24 Electron micrographs of a pseudo-ternary system prepared by the hydration 
method demonstrating the possible formation of ISCOM matrices from liposomes. A 
multilamellar liposome is shown above containing ring-like micelles present in the 
bilayers (A). Some of the ring-like micelles in the bilayers appear to have aggregated 
resulting in the formation of ISCOM matrices (B, arrow). The liposome may be 
saturated with ISCOM matrices, and these colloidal structures appear to budd off from 
the bilayers (C). The budding off of ISCOM matrices from the area of bilayers results 
in the disappearance of such bilayers due to their incorporation into ISCOM matrix 
structure (D, arrow). This "liposomal mechanism" was frequently observed in pseudo-
ternary systems rich m phospholipid such as formulations with Quil 
A:cholesterol:phosphatidylethanolamine, mass ratio 1 :2:7 (Demana et al., 2004e). 
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2.5 Discussion 
Systems prepared by the hydration method 
Quil A forms micelles in the absence of other components in water or buffer. It has a 
reported CMC in water of 0.03% (Ozel et al., 1989). Aqueous systems of cholesterol 
produced crystals as shown in Figure 2.14 D. In aqueous systems of phosphatidylcholine 
or phosphatidylethanolamine alone, a mixture of lipidic particles (predominantly) and some 
bilayered structures (liposomes, typically < 40%) were observed whereas these 
phospholipids in buffer formed predominantly liposomes. The nature of the structures 
formed in these single lipid component systems did not change with equilibration time or 
when buffer was used as the medium for lipid-film hydration except for samples containing 
phosphatidylcholine or phosphatidylethanolamine. In these samples, the presence of buffer 
salts or prolonged storage time promoted the formation of bilayered structures, which is in 
agreement with previous results (Gulik-Krzywicki et al. 1969; Hauser 1984; New 1990). 
As discussed in Section 2.1.2, the swelling process of phospholipids which results in the 
formation of bilayered structures is an electrostatic phenomenon (Hauser 1984), and may 
thus be influenced by the addition of buffer salts. 
In pseudo-binary systems containing only Quil A and cholesterol, worm-like micelles, as 
shown in Figure 2.15 A, were observed which are very different in appearance from Quil A 
micelles. These worm-like Quil A/cholesterol micelles were observed in all systems 
containing these two components. However, in pseudo-binary systems where the ratio of 
Quil A:cholesterol was smaller than 9: 1, these worm-like micelles were found together with 
cholesterol crystals indicating that the solubilisation of cholesterol by Quil A was not 
complete. As the prevalence of cholesterol crystals decreased upon increasing the Quil 
A:cholesterol ratio, it would appear that these worm-like micelles have a defined Quil 
A/cholesterol composition. Neither the presence of buffer salts nor an extended 
equilibration time influenced the nature of the structures formed in the pseudo-binary 





The addition of Quil A to systems containing phosphatidylcholine or 
phosphatidylethanolamine in the absence of cholesterol resulted in the formation of 
lipidic/layered structures. As described in Section 2.4.1.3, lipidic particles appeared either 
as colloids that do not have a detectable bilayer structure when investigated by TEM, or as 
layered structures in the form of multilamellar stacks (Figure 2.15 B and C, arrow) having 
a layer thickness similar to that observed for liposomes (- 6 nm) and thus suggesting that 
these layered structures might be bilayer fragments of vesicular structures. A closer 
examination of the colloidal particles seems to indicate that the layered structures and non-
bilayer particles are basically the same, and their appearance is dependent on their 
orientation in the sample when viewed by TEM. The morphology of lipidic particles is 
similar to those in previous reports for the interaction between Quil A and phospholipid 
(De Vries et al., 1990) except that the layered morphology has not been previously 
reported. Interestingly, hardly any or at best only a few liposomes were observed in 
samples containing Quil A even at low ratios of Quil A:phospholipid. Thus, Quil A would 
appear to hinder vesicle formation despite forming bilayer structures with phospholipid 
possibly by altering the lipid packing. Upon increasing the ratio of Quil A:phospholipid, 
lipidic/layered particles became fewer in number and smaller in size being replaced by 
micelles of a similar appearance to those observed in the system containing only Quil A. 
The nature of the structures formed in these pseudo-binary mixtures of Quil A/phospholipid 
did not change with incubation time or when buffer was used as the medium for lipid-film 
hydration. However, the prevalence of lipidic particles in the form of layered structures 
appeared to be higher in the presence of buffer salts or following storage in water systems 
(Figure 2.15 C). This is again likely due to the effect of ions and time on the swelling 
behaviour of phospholipids (Gulik-Krzywicki et al., 1969; Hauser 1984; New 1990). 
Pseudo-binary mixtures containing phosphatidylcholine or phosphatidylethanolamine and 
cholesterol formed liposomes and lipidic particles. At high phospholipid concentrations the 
predominant structures were lipidic particles with some liposomes. The occurrence of 
liposomes in the systems decreased with increasing concentration of cholesterol due to less 
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phospholipid being present in the systems. Likewise, the prevalence of cholesterol crystals 
increased with increasing concentration of cholesterol. Furthermore, crystals were evident 
in all samples, which had been prepared in water and analyzed within one day (Figure 2.8). 
Hydration of the dried lipid films using buffer or an extended equilibration time again 
promoted the formation of liposomes (multilamellar vesicles) at the expense of lipidic 
particles which were no longer evident in the samples. Cholesterol crystals only appeared 
in cholesterol/phospholipid pseudo-binary systems hydrated with buffer or equilibrated for 
a prolonged period at a cholesterol:phospholipid weight ratio of about 2:3 or higher (Figure 
2.9 - 2.13). This is in agreement with previous literature, reporting the maximum solubility 
of cholesterol in phospholipid bilayers to be about 33% w/w (Bourges et al, 1967; Freeman 
& Finean 1975; Collins & Phillips 1982). 
In the pseudo-ternary mixtures containing Quil A, cholesterol, and phosphatidylcholine, 
excess cholesterol was present as crystals in all systems where the weight fraction of 
cholesterol was greater than 60% and in systems containing more than 40% cholesterol if 
the concentration of phosphatidylcholine and Quil A was less than 30% respectively. 
Cholesterol crystals were also apparent in systems containing up to 50% of Quil A, but 
only if the weight fraction of phosphatidylcholine was small (Figure 2.10). Thus, the 
presence of both phosphatidylcholine and Quil A promoted the solubilisation of cholesterol 
or its incorporation into colloidal structures. Similar results were also found in the pseudo-
ternary mixtures containing phosphatidylethanolamine as the phospholipids except that the 
area representing presence of cholesterol crystals in the pseudo-ternary diagrams is slightly 
smaller for systems containing phosphatidylcholine than for the respective systems 
containing phosphatidylethanolamine. This difference may be due to slightly better 
solubilisation of cholesterol in the bilayers of phosphatidylcholine compared with 
phosphatidylethanolamine (Cheetham et al., 1989; Huang et al., 1999). 
In pseudo-ternary systems containing > 50% of Quil A, worm-like micelles, as observed in 
the pseudo-binary Quil Ncholesterol systems, were present together with ring-like 
micelles. Lipidic/ layered structures were also observed in some samples with relatively 





50% of cholesterol, ring-like micelles having a diameter of about 10 nm were the dominant 
colloidal structure, sometimes appearing exclusively and sometimes appearing together 
with lamellae (hexagonal pattern of ring-like micelles which present a minor structure, with 
a size greater than 1 µm). The TEM micrographs (Figure 2.16 A and B) show the ring-like 
micelles and associated lamellae structures from a sample with a Quil 
A:cholesterol:phosphatidylcholine mass ratio of 1:3:1. The ring-like micelles are similar in 
size and morphology to those described by other groups and result from the solubilisation 
of cholesterol by the Quil A micelles (Kersten & Crommelin 1995). Lamellae were 
previously observed in systems having a high concentration of cholesterol and are believed 
to be a result of the increased lipophilicity imparted onto the mixed micelles by cholesterol, 
thereby promoting micelle association in aqueous systems (Kersten & Crommelin 1995). 
The tendency of pseudo-ternary systems to form ring-like and/or worm-like micelles did 
not seem to be affected by the presence of buffer salts. However, at low Quil A 
concentrations, hydration using buffer appeared to promote the formation of liposomes at 
the expense oflipidic particles resulting in systems containing both liposomes and ring-like 
micelles. In contrast, an extended equilibration period (1 or 2 months at 4 °C) had a 
significant effect on the pseudo-ternary systems, which tended to form ring-like micelles at 
a Quil A concentration of less than 60%. In these pseudo-ternary systems, the predominant 
colloidal structures were ISCOM matrices (Figure 2.16 C), which in some samples 
appeared together with helices (Figure 2.16 D) (the formation of ISCOM matrices and 
helices are discussed in the following paragraphs). Thus an extended equilibration time 
transformed pseudo-ternary systems containing predominantly ring-like micelles into 
pseudo-ternary systems containing predominantly ISCOM matrices. The disappearance of 
ring-like micelles and lamellae structures from these pseudo-ternary systems upon storage 
suggests that these colloids could be involved in the formation of ISCOM matrices. At 
higher Quil A weight fractions, ISCOM matrices co-existed with ring-like micelles and 
even worm-like micelles. At low Quil A concentrations and high phosphatidylcholine or 





In pseudo-ternary systems containing more than 30% phosphatidylcholine and less than 
50% Quil A, samples were found to contain ISCOM matrices. These were particularly 
evident in systems containg 40-70% phosphatidylcholine, 20-40% Quil A and 10-30% 
cholesterol. Figure 2.16 C is an electron micrograph of a sample containing ISCOM 
matrices observed in a sample containing 40% phosphatidylcholine, 40% Quil A and 20% 
cholesterol. A close examination of the micrographs showed that the samples comprise 
spherical ISCOM matrices together with more irregularly shaped ISCOM-like structures. 
This may be due to the use of phosphatidylcholine as phospholipid instead of 
phosphatidylethanolamine. 
As described in Section 2.4.1.5, ISCOM-like structures (i.e. morphologically less defined 
ISCOM matrices) were observed more frequently in pseudo-ternary systems containing 
phosphatidylcholine than in phosphatidylethanolamine containing systems. This result was 
not unexpected because it has been previously reported that ISCOMs prepared from 
phosphatidylcholine containing systems tend to be more heterogeneous in size and 
morphology (Kersten et al., 1991). ISCOM regions following the hydration method after 
two months of storage at 4 °C were larger for phosphatidylcholine than for 
phosphatidylethanolamine systems (37 % and 31 % of the total area of the pseudo-ternary 
diagram for Figure 2:11 and 2:13 respectively). Another difference observed was that the 
hexagonal pattern of ring-like micelles in the cholesterol rich samples were well formed 
and more frequently observed in phosphatidylethanolamine containing pseudo-ternary 
systems than in the respective phosphatidylcholine containing systems (Section 2.4.1.5). 
These findings may again be due to differences in the polarity of the head group of the 
phospholipids (Kersten et al., 1991). 
When< 30% phosphatidylcholine or phosphatidyethanolamine was present in the pseudo-
ternary systems, no ISCOM matrices were observed. This is consistent with previous 
reports (De Vries et al., 1990; Kersten & Crommelin 1995; Copland et al., 2000), 
documenting the requirement of phospholipids for ISCOM formation but is in contrast to 








essential for ISCOM formation. These conflicting results possibly arise due to the different 
methods that were used to prepare ISCOMs (a discussion of the results obtained by the 
hydration and dialysis method is presented further below). 
When buffer was used to hydrate the dried lipid film, the prevalence of ISCOM matrices in 
the samples was higher than when water was used. A comparison of the pseudo-ternary 
diagram for samples hydrated in water (Figures 2.8 and 2.9) and samples hydrated in buffer 
(Figures 2.10 and 2.11) showed that some samples which did not produce ISCOM matrices 
in water produced ISCOM matrices upon hydration of the samples in buffer. This may be a 
result of buffer salts being better able to promote the swelling of phospholipid films. It is 
also known that ISCOMs can only form when Quil A is present above its CMC (Ozel et al., 
1989). Since buffer salts generally lower the CMC of surfactants and hence promote 
aggregation of micelles compared to water systems (Mazer et al., 1979; Knight 1981; Imae 
et al., 1985; Shikata et al., 1990; Iampietro & Kaler 1999; Beck et al., 2000), it is possible 
that the aggregation of micelles was promoted in the presence of buffer resulting in the 
increased formation of IS COM matrices. 
A startling difference was observed between the pseudo-ternary systems examined 
immediately following preparation and following an extended equilibration period (Figures 
2.8 to 2.13). The prevalence of ISCOM matrices was markedly increased following 
prolonged storage to the extent that many samples contained only ISCOM matrices as 
colloidal particles. These samples not only arose from systems which already contained 
some ISCOM matrices when observed within a day of preparation, but also from samples 
in which ISCOM matrices were not immediately apparent. Systems producing only 
ISCOM matrices following extended equilibration time tended to develop from systems, 
which initially contained either ring-like micelles together with lamellae structures or 
ISCOM matrices together with ring-like micelles and lipidic/layered structures. In systems 
containing high concentrations of cholesterol, ISCOM matrices were observed together 
with cholesterol crystals, although their concentration appeared to have decreased 




In samples found to contain ISCOM matrices, helical micelles were also observed as minor 
colloidal particles (Figure 2.16 D). Helices have been observed by a number ofresearchers 
in aqueous systems of bile salt, cholesterol and phospholipid (Konikoff et al., 1992; Tao et 
al., 1993; Kaplun et al., 1994; Konikoff et al., 1994; Tazuma et al., 1994; Ochi et al., 1996; 
Wang & Carey 1996; Ringel et al., 1998). It has recently been shown that helices are not 
unique to bile salt containing systems, but are a general property of a whole range of 
multicomponent systems, which contain a micelle-forming surfactant, bilayer-forming 
amphiphiles, and a sterol (Zastavker et al., 1999). It is therefore not unexpected that 
helices can form from the mixture of Quil A, phosphatidylcholine and cholesterol. 
Helices are believed to be tilted bilayers of chiral amphiphiles, in which the constituent 
molecules have orientational but no positional long range order (Zastavker et al., 1999). It 
is believed that the packing of cholesterol (or other sterol molecules) and the micelle-
forming surfactant in the bilayer portion of the phospholipid together with the molecular 
chirality in the system is the driving force behind helix formation (Chung et al., 1993; 
Nandi & Bagchi 1996; Selinger et al., 1996; Komura & Zhong-can 1998). It has also been 
previously reported that bilayers of phosphatidylcholine can have a helical configuration if 
the phospholipid is mixed with another acidic phospholipid in the presence of ca2\Lin et 
al., 1982), or is mixed with diacetylenic compounds (Thomas et al., 1999). Helical bilayers 
have also been reported for phospholipid-nucleoside conjugates (Yanagawa et al., 1989). It 
is now generally accepted that the morphology of the helix assembly is strongly dependent 
on the chirality of the molecules used (Kaplun et al., 1994; Nandi & Bagchi 1996; Wang & 
Carey 1996; Ringel et al., 1998; Thomas et al., 1999; Zastavker et al., 1999) and therefore 
the helix itself is a chiral structure (Nandi & Bagchi 1996). Since Quil A has many chiral 
centers and is a mixture of many structurally related bisdesmosidic triterpenoid glycosides 
(Kensil et al., 1991a), it is possible that a particular configuration of Quil A molecules, in 
the presence of phosphatidylcholine and cholesterol, will determine whether ISCOM 
matrices or helices are formed . 
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Systems prepared by the dialysis method 
In comparing the systems prepared by hydration and dialysis methods, significant 
differences were observed. In pseudo-binary systems containing only Quil A and 
cholesterol, and prepared by the hydration method, worm-like micelles were observed as 
the only colloidal structure (Figure 2.15 A). In contrast, the same systems prepared by 
dialysis produced predominantly ring-like micelles (Figure 2.22 A). In addition to these 
ring-like micelles, ISCOM matrices as minor colloidal structures were observed especially 
at higher Quil A:cholesterol mass ratios. The presence of ISCOM matrices in pseudo-
binary systems of Quil A and cholesterol prepared by dialysis that were not observed in 
these systems prepared by hydration is interesting. It is in agreement with results reported 
by others who proposed that ISCOM matrices could form in the absence of phospholipids 
(Lovgren & Morein 1988). However, as described above, the formation of ISCOM 
matrices in pseudo-binary systems containing only Quil A and cholesterol is in contrast to 
reports by other investigators who have suggested that the presence of phospholipid 
together with cholesterol and Quil A is essential for ISCOM matrix formation (De Vries et 
al., 1990; Kersten & Crommelin 1995; Copland et al., 2000). In the dialysis method, 
octylglucoside as an additional surfactant was used in this study, whereas the hydration 
method does not require the use of any additional surfactant. It has been suggested that 
formation of ISCOM matrices can occur in the absence of a phospholipid due to a residual 
amount of surfactant left with the samples during the dialysis process (Kersten & 
Crommelin 1995). It would seem clear from the present investigation using the hydration 
method, which does not involve the use of additional surfactants, that ISCOM formation 
does require the presence of an additional polar lipid component to Quil A and cholesterol. 
As stated above, the existence of worm-like micelles in systems containing only Quil A and 
cholesterol prepared by hydration which were not found in samples prepared by dialysis is 
a major difference between the two methods of preparations. The PLM showed cholesterol 
crystals in all pseudo-binary systems containing Quil A and cholesterol prepared by 
hydration (Figures 2.8 - 2.13). Relatively, fewer cholesterol crystals were observed in 
similar samples prepared by dialysis, and in some of these pseudo-binary mixtures, crystals 




is solubilized into Quil A/octylglucoside micelles and upon removal of octylglucoside 
promotes the formation of ring-like micelles. Increasing the cholesterol:Quil A mass ratio 
for systems prepared by dialysis resulted in ring-like micelles associating into a hexagonal 
pattern previously described as lamellae structures (Kersten et al., 1991) (Figure 2.22 C). 
In contrast, only worm-like micelles and cholesterol crystals were observed in pseudo-
binary systems of Quil A and cholesterol prepared by the hydration method suggesting that 
in the absence of an additional surfactant, the ability of Quil A to solubilise cholesterol is 
limited. 
The regions of the pseudo-ternary diagrams in which ISCOM matrices were observed as 
the predominant colloidal structures also differed between the two methods of preparation. 
For samples prepared by dialysis, ISCOM matrices were predominantly found near the Quil 
A apex of the pseudo-ternary phase diagram (> 50% Quil A). These results are in 
agreement with data published by other research groups (Kersten et al., 1991; 
Rimmelzwaan & Osterhaus 1997; Sjolander et al., 1997a; Mowat et al., 1999; Andersson et 
al., 2000). In contrast, for samples prepared by hydration, ISCOM matrices were 
predominantly found near the phospholipid apex of the pseudo-ternary phase diagram (> 
50% phospholipid). The morphology of the ISCOM matrices prepared by the two methods 
appeared similar when viewed by TEM (Figures 2.16 D and 2.22 B). It remains to be 
investigated whether the chemical composition of the ISCOMs prepared by the two 
methods is similar. 
As previously suggested for pseudo-binary Quil A/cholesterol systems, if residual 
octylglucoside plays (at least partly) the role of phospholipids and thereby promotes 
ISCOM formation in pseudo-binary systems, then it is equally likely that octylglucoside 
can play the role of phospholipids in other pseudo-ternary systems and hence result in a 
shift of the region in the pseudo-ternary diagram in which ISCOM matrices are observed 
into areas of lower phospholipid concentration, ie towards the Quil A apex. Octylglucoside 
may also play a role in the pseudo-ternary systems having a relatively high concentration of 
phospholipids in promoting formation of liposomes and ring-like micelles instead of the 




observed in pseudo-ternary systems prepared by hydration at much higher phospholipid 
ratios than in pseudo-ternary systems prepared by dialysis, again suggesting that 
octylglucoside may become involved in structure formation. Alternatively, the difference 
noted between the two methods of preparation may result from the loss of Quil A during 
dialysis. Qui! A is a heterogeneous mixture containing saponins of different molecular 
weights (Barr et al., 1998). It may be possible that saponins with a low molecular weight 
can pass through the 1,000 molecular weight cut-off membrane and are therefore lost as a 
partner to form ISCOM matrices. Consequently, this would lead to an insufficient effective 
concentration of Quil A, especially in formulations with a low weight percentage of the 
saponin mixture. A low concentration of Quil A would result in the formation of colloidal 
structures other than the ISCOM matrices such as liposomes . 
· The regions in the pseudo-ternary diagrams in which ISCOM matrices were observed 
increased following an extended equilibration time particularly for samples prepared by the 
hydration method. The widespread distribution of ISCOM matrices in samples after an 
extended equilibration period therefore not only implies that this equilibration period is 
important to prepare ISCOMs by hydration but also that ISCOMs are a thermodynamically 
more stable colloidal structure than the initially detectable colloids from which they have 
formed. On other hand, the regions in which ISCOM matrices were the main colloidal 
structures after dialysis were not much affected by equilibration time. 
Surprisingly, the total area within the pseudo-ternary diagram in which ISCOMs were the 
predominant colloidal structure was significantly smaller following the dialysis method 
than following the hydration method (31 % for hydration method (Figure 2.13) and 18 % 
for dialysis method (Figures 2.21) of the total area of the pseudo-ternary diagrams after 1 or 
2 months of storage at 4 °C, using phosphatidylethanolamine as phospholipid. As 
described above, since phosphatidylethanolamine produces ISCOM matrices of uniform 
size and morphology by both hydration and dialysis methods in contrast with the use of 
phosphatidylcholine, which produces often ISCOM-like structures, the differences 
described above are not likely to be due to formation of ISCOM-like structures but may 






Characterization of all colloidal structures formed in the vicinity of the ISCOM matrix 
region of the pseudo-ternary diagrams and structures which transformed into ISCOM 
matrices upon extended equilibration times appears to suggest that there are two 
mechanisms in which ISCOM matrices may be formed when these colloids have been 
prepared by the hydration method. One possible mechanism is the formation of ISCOM 
matri'ces from the aggregation of ring-like micelles (Figure 2.23). The other mechanism is 
the formation of ISCOM matrices from liposomes (Figure 2.24) (Demana et al., 2004e). 
Individual ring-like micelles appear to associate and aggregate into ISCOM matrices due to 
micelle-micelle interactions. On the other hand, for the liposomal mechanism ISCOM 
matrices appear to bud off from the phospholipid bilayers (Figure 2.24). This phenomenon 
was frequently observed in ternary systems containing cholesterol with high concentrations 
of phospholipids upon increasing the Quil A concentration . 
The mechanism of ISCOM formation from liposomes could possibly occur as follows: 
since cholesterol has been reported to be located in the bilayer portion of the liposome 
(Costanzo et al., 1994; Huang et al., 1999), Quil A may interact with cholesterol to form 
ring-like structures in the bilayer (Bangham & Home 1964; Lucy & Glauert 1964) (Figure 
2.24 A). The ring-like micelles in the presence of phospholipid may then aggregate due to 
various forces such as hydrophobic interactions and possibly also by hydrogen bonding, 
electrostatic repulsion, and steric factors (Kersten et al., 1991) resulting in the formation of 
ISCOM matrices (Figure 2.24 B-D). These colloidal structures could then break away from 
the liposome to minimize the free energy of the system (Figure 2.24 C and D). 
With the dialysis method, the formation of ISCOM matrices is different from those 
prepared by the hydration method because they could only be formed from mixed micelles 
of octylglucoside, Quil A, cholesterol and phospholipid (phosphatidylcholine or 
phosphatidylethanolamine ). Upon removal of octylglucoside, the other lipid components 
spontaneously interact with each other resulting in the formation of ISCOM matrices 
(Morein et al., 1984; Hoglund et al., 1989; Rimmelzwaan & Osterhaus 1997; Andersson et 
al., 2000). However, it is interesting to observe that even using the dialysis method, for 




ISCOM matrices were observed after octylglucoside removal, the formation of ISCOM 
matrices appears to be from liposomes in a similar manner to the "liposomal mechanism" 
described for the hydration method above. This finding further supports the possible 
existence of a mechanistic pathway for the formation of ISCOM matrices from liposomes 
regardless of the method. A pathway of formation of ISCOM matrices from helices is less 
likely because the latter were described as alternative colloids to ISCOMs due to chirality 
of the molecules used in the mixtures (Demana et al., 2004c) although it cannot be totally 







The construction of pseudo-ternary diagrams for the three components typically used for 
the preparation of ISCOM matrices, namely Quil A, phosphatidylcholine ( or 
phosphatidylethanolamine) and cholesterol, has demonstrated that these three components 
can also form a number of other colloidal structures depending on the mass ratio of the 
three components present in the system. Interestingly, the relative abundance of specific 
colloidal particles was affected by the aqueous medium used for lipid film hydration and 
also by the equilibration period. Buffer solution promoted the formation of ISCOM 
matrices and liposomes while a prolonged equilibration promoted the formation of ISCOM 
matrices to an extent that almost all pseudo-ternary systems containing less than 50% of 
Quil A formed ISCOM matrices following a 2 month storage at 4°C. The widespread 
distribution of ISCOM matrices in samples prepared by the hydration method after an 
extended equilibration period not only implied that equilibration period is important to 
prepare ISCOM matrices by this method but also that ISCOM matrices appear to be the 
thermodynamically stable colloidal form for the majority of pseudo-ternary aqueous 
systems of Quil A, cholesterol and phospholipid. These investigations have thus further 
confirmed that ISCOM matrices can be prepared by hydration of dried 
phosphatidylcholine:cholesterol films, a method that is similar to the Bangham method 
(Bangham et al., 1965) for the preparation of liposomes, and have identified preferred 
weight ratios of the components for ISCOM matrix formation by this method. 
The study further demonstrated that the type of phospholipid had an influence in the 
appearance of colloidal structures m the pseudo-ternary diagram. 
Phosphatidylethanolamine produced ISCOM matrices of uniform size and morphology 
compared to phosphatidylcholine, which often produced irregular ISCOM-like structures. 
Similar results were also found with lamellae structures. The type of phospholipid 
investigated however, did not affect other colloidal structures. It was demonstrated that 
formation of ISCOM matrices requires the presence of all three components (Quil A, 
cholesterol and phosphatidylcholine or phosphatidylethanolamine) as ISCOM matrices 







does not require the use of an additional surfactant. The existence of worm-like micelles in 
pseudo-binary systems containing only Quil A and cholesterol prepared by the hydration 
method which were not found in samples prepared by the dialysis method implied that in 
the absence of an additional surfactant, Quil A solubilised cholesterol to an extent 
insufficient to allow the formation of ring-like micelles. 
The existence of helices as a minor colloidal structure in ISCOM matrix rich samples may 
be a result of a the preferred configuration of a component of Quil A having a particular 
chiral configuration and interacting with the phospholipid/cholesterol bilayers. Although it 
may be possible that they are also involved in the formation of the IS COM matrix structure, 
based on the analysis of all pseudo-ternary diagrams, two possible mechanisms in which 
ISCOM matrices are formed when prepared by the hydration method were proposed. In 
one mechanism ISCOM matrices could be formed directly from the aggregation of ring-like 
micelles. In the other mechanism ISCOM matrices are formed from the liposomes 
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The construction of pseudo-ternary diagrams of aqueous mixtures of Quil A, cholesterol 
and phospholipid prepared by either the hydration method or the dialysis method (Chapter 
2) showed that various types of colloidal particles including ISCOM matrices, liposomes, 
micelles (ring-like and worm-like), lamellae and lipidic/layered structures were observed in 
different regions of the pseudo-ternary diagram, depending on the ratio of the three polar 
lipids used in the formulation (Demana et al., 2004e; Demana et al., 2004c ). However, not 
much is known about the incorporation of antigen or protein into ISCOM matrices and 
related colloidal particles containing Quil A prepared by the hydration method. Moreover, 
the impact of incorporation of antigen into the various types of colloidal particles produced 
by the aqueous mixtures of Quil A, cholesterol and phospholipid on the pseudo-ternary 
diagram is not known. Even for colloidal structures prepared by the dialysis method, only 
the incorporation of proteins into ISCOM matrices is described in the literature (Kersten et 
al., 1991). It is therefore important to investigate the incorporation of protein into other 
colloidal particles containing Quil A in more detail considering that it has been suggested 
that these colloids might also be useful as future antigen carriers (Konnings et al., 2002; 
Demana et al., 2004c ). Initially, the type of proteins that have been incorporated into 
ISCOMs will briefly be reviewed, with the aim to identify which type of protein may be 
useful for incorporation into ISCOM matrices prepared by the hydration method and other 
related colloidal structures. 
3.1.1 ISCOMs containing amphipathic molecules 
From the results of dialysis experiments for the preparation of ISCOMs, it is well known 
that these colloidal structures can be formed with amphipathic molecules derived from 
membranes of a variety of viruses such as herpes simplex virus type 1 (HSV-1 ), 
cytomegalovirus (CMV), hepatitis B virus (HBV), Epstein-Barr virus (EBV) and rabies and 
influenza viruses (Claassen et al., 1992; Villacres-Eriksson et al., 1993; Barr & Mitchell 
1996; Sjolander et al., 2001a). Amphipathic molecules derived from the cell membranes of 









Plasmodium falcipurum have also been incorporated into ISCOM matrices (Morein & 
Simons 1985; Sundquist et al., 1996; Barr et al., 1998; Andersson et al., 2000). When 
ISCOMs include antigens derived from purified organism or cell membranes, the molecules 
that are incorporated into ISCOMs are proteins or glycoproteins which are normally 
anchored by a hydrophobic transmembrane sequence in the cell or viral membrane (Morein 
& Simons 1985; Trudel et al., 1987; Kersten et al., 1988a; Mougin et al., 1988; Sundquist 
et al., 1988; Claassen & Osterhaus 1992). 
The manner in which amphipathic molecules integrate into ISCOM matrices has been 
studied using the major outer membrane pore protein (porin or PI) of Neisseria gonorrhoea 
(Kersten et al., 1988b). By analyzing enzyme and cyanogen bromide cleavage fragments 
of PI obtained from bacterial membranes, ISCOMs with PI incorporated, or from PI 
solution, it was found that the orientation of PI in the ISCOM matrices was fairly similar to 
its orientation in the outer membrane of the bacterium and different from that of PI in 
solution. The study also showed that the amphiphilicity of the molecule could affect the 
incorporation of PI suggesting that the balance of hydrophobic and hydrophilic regions in 
the protein is important and that the presence of a hydrophobic transmembrane sequence 
alone is insufficient for insertion of molecules into ISCOM matrices. One limitation of this 
study is that the PI molecule is a somewhat atypical molecule with an uncommon 
arrangement of three antiparallel ,6-sheets that form barrel-like channels through the 
bacterial outer membrane (Barr & Mitchell 1996). 
An unexpected selective incorporation of a particular membrane protein into ISCOM 
matrices has been observed by Mougin et al (Mougin et al., 1988). The F glycoprotein of 
measles virus could be incorporated well into ISCOMs and liposomes in contrast to the H 
glycoprotein that was poorly incorporated into ISCOMs but was entrapped well into 
liposomes. Interestingly, a good antibody response was generated to both the F and H 
glycoproteins following immunization with measles- ISCOMs (Mougin et al., 1988). 
It has been possible to incorporate simultaneously more than one type of amphipathic 
molecules into the same ISCOM structure (Trudel et al., 1987; Kersten et al., 1988b; 
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Mougin et al., 1988; Pyle et al., 1989; Akerblom et al., 1993; Rimmelzwaan et al., 1994). 
Regardless of molecular weight, level of glycosylation or tertiary structure of incorporated 
proteins, ISCOMs that are generated are usually indistinguishable from the ISCOM matrix 
when examined by electron microscopy (Hoglund et al., 1989; Ozel et al., 1989; Kersten et 
al., 1991; Claassen & Osterhaus 1992) or sedimentation rate (Lovgren & Morein 1988). 
This is somewhat surprising if a substantial amount of protein is incorporated into 
ISCOMs, but may be explainable by only a partial entry of the molecule into the ISCOM 
structure or may simply reflect the low number of molecules actually incorporated into 
ISCOM matrices (Barr & Mitchell 1996). This latter point is supported by the fact that 
when high levels of influenza haemogluttin (HA) are incorporated into ISCOM matrices, 
'spikes' of HA could be visualized on the surface of the ISCOMs by electron microscopy 
(Barr & Mitchell 1996). 
The partial entry of protein molecule or the actual number of molecules incorporated into 
ISCOMs would depend on the nature of the specific antigen and the method of association 
or incorporation as the protein structure would have an effect on hydrophobic interactions 
and possibly hydrogen bonding, electrostatic interactions, and steric factors between a 
particular antigen and the ISCOM matrix particle (Kersten et al., 1991; Barr & Mitchell 
1996). 
3.1.2 ISCOMs containing non-amphipathic molecules 
While amphipathic membrane proteins readily integrate into ISCOM matrices, the 
efficiency of incorporation of soluble hydrophilic proteins or very hydrophobic proteins is 
low (Fohlman et al., 1990; Morein et al., 1990; Reid 1992; Kersten & Crommelin 1995; 
Konnings et al., 2002). This is in contrast to liposomes that are able to entrap hydrophilic 
proteins in the aqueous, closed core of the vesicle (Knight 1981; New 1990; Kersten & 
Crommelin 2003). ISCOMs, because of their open structure are unable to incorporate 





A number of methods have therefore been investigated to expose or introduce hydrophobic 
regions into hydrophilic proteins so that these molecules can be linked to ISCOMs (Morein 
et al., 1990; Reid 1992; Sjolander et al., 1997a; Konnings et al., 2002). Whether these 
molecules are inserted into ISCOMs in the same manner as truly amphipathic molecules or 
merely associated with the ISCOM matrix remains to be determined but probably varies 
depending on the protein and method of association. 
Ovalbumin is often utilized as a model protein or antigen (Morein et al., 1990; Sjolander et 
al., 1997a; Ekstrom et al., 1999; Johansson & Lovgren-Bengtsson 1999; Mowat et al., 
1999; Konnings et al., 2002). Because of its hydrophilic nature it is not possible to 
incorporate ovalbumin into ISCOM matrices unless it is modified (Hoglund et al., 1989; 
Morein et al., 1990; Akerblom et al., 1993). In order to modify this hydrophilic protein 
with the aim of incorporating it into various colloidal particles containing Quil A, it is 
important to review the methods that have been used to modify antigen to produce 
amphipathic antigens. These methods are described below. 
3.1.2.1 Acid treatment of proteins 
Proteins that have no hydrophobic region(s) accessible under physiological conditions may 
still expose hydrophobic domains when exposed to non-physiological conditions such as a 
low or high pH (Pyle et al., 1989; Heeg et al., 1991). One of the earliest attempts to expose 
the hydrophobic moieties of proteins for incorporation into ISCOMs has been the use of 
acid (Morein et al., 1990). Using, bovine serum albumin (BSA) as a non-amphipathic 
model protein, an acidic aqueous solution (pH 2.5) was prepared by dissolving BSA in 
phosphate buffer saline (Morein et al., 1990). The BSA solution was added to a mixture 
containing Quil A, cholesterol and phospholipid dissolved in MEGA-10. The micellar 
solution was dialysed for two days to remove MEGA-10 resulting in the formation of 
ISCOMs. After separation of unincorporated BSA by ultracentrifugation in a sucrose 
gradient, the pelleted ISCOM band was isolated and protein incorporated into the colloidal 
structure was quantified by using a modified Bradford assay (Bradford 1976) for 




compared to 0% in the ISCOMs prepared using untreated BSA. From these results, it was 
concluded that acid treated BSA was able to be integrated into ISCOMs because the acidic 
medium exposed the otherwise inaccessible hydrophobic domains of BSA (Morein et al., 
1990). 
Similarly, another hydrophilic protein (gp 120 coat protein of the human immunodeficiency 
virus HIV-1) was reported to be incorporated into ISCOMs with 15% efficiency only after 
acid treatment (Pyle et al., 1989). Extremely high incorporation in the range of 15 - 80 % 
has been claimed to be achieved using purified rabbit or mouse immunoglobulin after acid 
exposure (Morein et al., 1990). Heeg et al also claimed good incorporation of ovalbumin 
into ISCOMs after acid treatment of the protein (Heeg et al., 1991). In contrast, recent 
study reported that exposing ovalbumin to acidic conditions did not result in the 
incorporation of the protein into ISCOMs (Joachim 2001, Copland 2003). In these studies, 
fluorescently labeled ovalbumin was used as a model antigen. The protein was dissolved 
into an isotonic sodium chloride solution adjusted to pH 2.5 with acetic acid. The resulting 
solution was mixed with Quil A, cholesterol and phosphatidylcholine dissolved in 
octylglucoside in a similar manner as described above for the preparation of ISCOMs by 
the dialysis method. Fluorescence spectroscopy of the bands isolated following 
ultracentrifugation through sucrose gradients showed no incorporation of fluorescently 
labeled protein regardless of whether the protein was exposed to an acidic solution or not. 
From these results, it was concluded that pretreatment of ovalbumin with acid failed to 
enable its incorporation into the ISCOM structure. 
The conflicting reports described above imply that there is no general agreement on the use 
of acidification to modify hydrophilic antigens so that they can be integrated into ISCOM 
structure. Apart from these contradicting studies, the use of acid buffer is not generally 
desirable when using proteins or antigens as it may affect the polarity or antigenicity of the 
bioactive (Pyle et al., 1989; Barr & Mitchell 1996; Matthews & van Bolde 1996; 
Defelippis & Akers 2000). It has been reported that since it was necessary to partly 
denature BSA to provoke the exposure of hydrophobic regions to enable ISCOM 
integration, it is likely that some antigenic determinants (epitopes) may be changed or 
100 
/ 
destroyed (Morein et al., 1990). In contrast, ISCOMs which contained the partially 
denatured BSA and HIV proteins still stimulated better antibody responses in mice and 
monkeys than the protein alone (Morein et al., 1990). The antiserum raised against the 
gp 120 coat protein was also functionally active in (limited) testing for in vitro HIV-1 viral 
neutralization (Pyle et al., 1989). Heeg et al also showed high levels of MHC class I-
restricted CTL in the draining lymph nodes of mice injected with ISCOMs containing 
ovalbumin that were not present in the lymph nodes of mice receiving ovalbumin alone 
(Heeg et al., 1991). 
3.1.2.2 Organic solute or solvent treatment of proteins 
Partial denaturation of hydrophilic proteins using agents such as urea and mercaptoethanol 
have been used in an attempt to uncover some of the hydrophobic regions within the 
protein (Akerblom et al., 1993). Treatment of recombinant HN proteins, including a gag 
fusion protein denoted as p24-p15 and PBl (the carboxy-terminal portion of gp 120), 
allowed incorporation of approximately 20% of the starting material for each of the 
proteins into ISCOMs after denaturation with 8 mol/1 urea and 15 mmol/1 mercaptoethanol 
solutions. However, this incorporation rate was far lower than the 80% incorporation of 
another recombinant HN protein gp 160 which has a native transmembrane anchor and did 
not require partial denaturation (Akerblom et al., 1993). 
In a recent study, the use of organic solvents to modify soluble protein to enable 
incorporation into ISCOMs was tested (Joachim 2001; Copland 2003). In this study, 
fluorescently labeled ovalbumin as a model antigen was dispersed in chloroform and 
agitated for 5 minutes in an attempt to partially denature the protein. Chloroform was 
evaporated under a stream of nitrogen gas, and the treated protein was mixed with Quil A, 
cholesterol and phosphatidylcholine in the presence of octylglucoside for the preparation of 
ISCOMs by the dialysis method. The incorporation of solvent treated protein was also 
tested for ISCOMs prepared by the hydration method. Following sucrose gradient 
ultracentrifugation, the pelleted bands consisting of ISCOMs were isolated and analysed for 
ovalbumin. Fluorescence spectroscopy showed no incorporation of fluorescently labeled 
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protein into ISCOMs. The failure to incorporate FITC labeled ovalbumin into the ISCOM 
structure was independent of the method used to prepare ISCOMs ( dialysis or hydration) 
(Joachim 2001; Copland 2003). These results are in contrast to earlier studies (Akerblom et 
al., 1993) and therefore imply that the use of organic solvents in an attempt to modify 
hydrophilic proteins into amphipathic molecules for incorporation into ISCOMs is variable 
and still requires further investigations. However, the importance of using organic solvents 
to modify proteins will remain questionable due to their well known damaging effects on 
proteins (Guagliardi et al., 1989; Haensler 1995; Barr & Mitchell 1996; Matthews & van 
Holde 1996; Easterbrook et al., 2001). 
3.1.2.3 Conjugation of proteins to preformed ISCOMs or ISCOM matrix 
Another method that can be used to associate hydrophilic molecules to ISCOMs is to use an 
amphipathic coupling protein that links antigens to preformed ISCOM matrices or ISCOMs 
(Lovgren et al., 1987; Sjolander et al., 1991; Larsson et al., 1993; Morein et al., 1995). 
Potentially this technique makes it possible to attain multiple antigens to the same ISCOM 
particle and immune responses have been generated not only to the coupled antigens but 
also to the influenza envelope protein to which it was linked (Sjolander et al., 1991). 
In a study of Lovgren et al, two different peptides were investigated, luteinizing hormone-
releasing hormone (LHRH) and a peptide of amino acid sequence 144-159 of foot-and-
mouth disease virus (FMDV) for their ability to be incorporated into ISCOMs following 
coupling of these peptides to preformed ISCOMs containing influenza virus envelope 
protein (carrier proteins) (Lovgren et al., 1987). In addition, small immunogenic molecules 
such as biotin (N-hydroxysuccinimidobiotin) were also investigated for their incorporation 
into ISCOMs using this coupling method. When coupling is performed via influenza 
envelope proteins, conventional coupling agents such as glutaraldehyde and 
heterobifunctional reagents can be used. The pre-formed influenza virus containing 
ISCOMs were activated by the addition of glutaraldehyde. This mixture was extensively 
dialysed followed by the addition of radiolabelled peptides. The coupling was initiated by 
the addition of carbonate buffer, pH 9.5 and the reaction was stopped by the addition of 
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glycine. The amount of peptides incorporated into the preformed ISCOMs was quantified 
following purification of peptides by gel filtration. The coupling of biotin molecules to 
preformed influenza virus ISCOMs was performed in the similar manner to that of peptides 
(Lovgren et al., 1987). 
Although incorporation of modified peptides into ISCOMs could be demonstrated, it was 
found that the incorporation of two or three peptides per protein caused polymerization of 
either the ISCOM carrier or the peptide (Lovgren et al., 1987). This finding demonstrates 
that the type of peptides that can be incorporated into ISCOMs using this conjugation 
method is limited. In an attempt to explore optimal conditions for the conjugation of 
synthetic peptides to preformed influenza virus containing ISCOMs without causing 
polymerization of ISCOM carrier or peptides, another study was conducted in which 
maleimidohexanoyl-N-hydroxy-succinimide ester (MHS) was used as a coupling agent 
(Lovgren & Larsson 1994). The peptide used in this study comprised the amino acids 122-
138 of porcine growth hormone (pGH). The study was partly successful as the aggregation 
behavior of the peptide-ISCOM conjugates was minimized by using a small amount of 
excess peptide compared to protein in the ISCOM resulting in moderately immunogenic 
soluble conjugates (Lovgren & Larsson 1994). Similar problems with aggregation and low 
solubility of the peptide-ISCOM conjugates were also reported by others (Peeters et al., 
1989) during conjugation of angiotensin to tetanus toxoid using MHS as a coupling agent. 
Biotins which are relatively small molecules were found to be incorporated into ISCOMs 
without aggregation and solubility problems (Lovgren et al., 1987). Conjugation of three 
to ten biotin molecules per viral protein in the ISCOMs was reported. It was also found 
that at least three biotin molecules per viral protein were required for good immunogenicity 
with 10 biotin molecules per viral protein leading to the optimal epitope density (Lovgren 
et al., 1987). Theoretically, coupling to ISCOM matrix alone can also be achieved by 
replacing phosphatidylcholine with phosphatidylethanolamine and using the amino group 
for covalent linking (Morein et al., 1995). This suggestion however, has not been tested 
experimentally. 
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Other coupling agents have been used to associate influenza nucleoprotein with ISCOMs. 
Chemical coupling by the periodate oxidation method was used to link influenza 
nucleoprotein to the liposaccharides of Escherichia coli (Weis et al., 1990). This allowed 
association of 10 - 20% of the nucleoprotein with ISCOMs. Immunization of mice with 
these ISCOMs gave partial protection from challenge with the same influenza strain and a 
high antibody response, whereas BSA coupled to the liposaccharides in the same manner in 
which ISCOMs were formed did not protect mice or induce influenza-specific antibody 
(Weis et al., 1990; Barr & Mitchell 1996). 
3.1.2.4 Conjugation of fatty acids or phospholipids to proteins 
One of the most common, simplest and universally useful methods to incorporate a 
hydrophilic peptide or protein into ISCOMs involves the addition of fatty acids such as 
palmitic acid (Mowat et al., 1991; Browning et al., 1992; Pedersen et al., 1992; Reid 1992; 
Kazanji et al., 1994; Konnings et al., 2002) or myriastic acid (Weijer et al., 1993) to the 
peptide or protein. There are two different approaches to the conjugation of fatty acid tails 
to proteins although both methods involve formation of an amide bond through covalent 
linking of a carboxylic group with an amino group. One approach is the linking of a 
carboxylic group of the fatty acid to the amino group of the protein (Huang et al., 1982; 
Shen et al., 1982; Konnings et al., 2002). The other approach is the linking of amino group 
of a phospholipid to a carboxylic group of the protein (Sjolander et al., 1997a; Ekstrom et 
al., 1999; Johansson & Lovgren-Bengtsson 1999). Both these methods are briefly 
described below. 
3.1.2.4.1 Fatty acids 
Palmitic acids are covalently coupled to proteins or antigens by using an activated ester, 
e.g. the N-hydroxysuccinimide ester of palmitic acid (NHSP) (Huang et al., 1983; Reid 










Figure 3.1 Schematic representation showing conjugation of fatty acid to protein by 
linking an amino group of the protein ( e.g ovalbumin) to the carboxylic group of a fatty 
acid (e.g palmitic acid as NHSP) (adapted from Huang et al., 1983). 
A simple method to attach palmitic acid to hydrophilic proteins has been described by Reid 
in 1992 (Reid 1992). Ovalbumin and cytochrome C were used as models. Aqueous 
solutions of these antigens were mixed with NHSP dissolved in dimethylsulfoxide. A 
surfactant such as sodium deoxycholate was necessary to help solubilise NHSP. Sodium 
deoxycholate was found to be a suitable reagent because in contrast to other dialyzable 
surfactants, it does not contain functional groups in its structure which will react with 
NHSP (Reid 1992). Other non-denaturing dialyzable surfactants such as octylglucoside 
that do not contain either primary or secondary amine groups may however, also be used in 
the reaction mixture. The disadvantage of the method described above is that like many 
protocols involving dialysis, the conjugation process may take several days and are usually 
labor intensive (Ollivon et al., 2000; Copland 2003; Demana et al., 2004e). In contrast to 
the unmodified ovalbumin and cytochrome the palmitified proteins were found to be 
incorporated into ISCOMs suggesting successful conjugation of fatty acids to proteins 
(Reid 1992). 
Recently, a much simpler and faster method of conjugation of fatty acids to protein has 
been reported (Konnings et al., 2002). In this method, the dialysis process was replaced by 
using a large ultrafiltration cell that reduces the time required to remove the surfactant. In 
the study, fluorescently labeled ovalbumin (FITC-OV A) was used as a model antigen. 
Palmitic acid was either attached to FITC-OV A or directly to ovalbumin that was then 
fluorescently labeled producing P-FITC-OVA and FITC-P-OVA respectively. 





OVA and FITC-P-OVA whereas hardly any fluorescence was obtained when FITC-OVA 
was used. Since only palmitified ovalbumin could be incorporated into ISCOMs, it was 
concluded that the conjugation process was successful although the extent of conjugation 
was not determined. 
3.1.2.4.2 Phospholipids 
Another conjugation strategy to the ones described above is the linking of the amino group 
of phospholipids to the carboxylic acid group of the protein (Sjolander et al., 1997a; 
Ekstrom et al., 1999; Johansson & Lovgren-Bengtsson 1999). In this method carbodiimide 
reagents are often used as the linking agents between the amino group of phospholipids and 
the carboxylic group of protein resulting in the formation of amide bonds (Figure 3 .2) . 
Protein + phospholipid ~ protein-phospholipid 
EDC+NHS conjugate 
RCOOH + R1NH2 ~ RCONHR1 
EDC+NHS 
Figure 3.2 Schematic representation showing conjugation of phospholipid to protein by 
linking the carboxylic group of a protein ( e.g ovalbumin) to the amino group of a 
phospholipid (e.g. phosphatidylethanolamine). The reagents used for linkage are 
carbodiimide (1-ethyl-3 1-(3-dimetylaminopropyl)carbodiimide hydrochloride (EDC)) 
and N-hydroxylsuccinimide (NHS) (Sjolander et al., 1997a). 
This method is universally useful because standard coupling methods using carbodiimides 
are considered effective (Starns et al., 1986), and in nearly all cases result in the successful 
formation of amide bonds (Sjolander et al., 1997a; Ekstrom et al., 1999; Johansson & 
Lovgren-Bengtsson 1999; Tropini et al., 2000). Phosphatidylethanolamine has been linked 
to ovalbumin by using carbodiimide hydrochloride (Sjolander et al., 1997a). In that study, 
an aqueous solution of ovalbumin was mixed with phosphatidylethanolamine dissolved in 
MEGA-10. N-hydroxysuccinimide was added to the mixture because it has been reported 
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to enhance the yields of the product (Starns et al., 1986). The conjugation of 
phosphatidylethanolamine to ovalbumin was initiated by the addition of carbodiimide 
hydrochloride. After incubation of at least 2 hours, cholesterol and a purified form of Quil 
A (ISCOPREP 703) were added to the reaction mixture followed by dialysis for at least 3 
days leading to the formation of ISCOMs containing ovalbumin that has been successfully 
linked to phosphatidylethanolamine (Sjolander et al., 1997a). 
The protein content in the ISCOMs was determined by amino acid analysis following 
sucrose gradient ultracentrifugation. The analysis revealed that 50 % of the conjugated 
ovalbumin was incorporated into ISCOMs (Sjolander et al., 1997a). Similar studies have 
also demonstrated successful linkage of the amino group of the phospholipid to ovalbumin 
with about 40 - 50 % entrapment into ISCOMs (Ekstrom et al., 1999; Johansson & 
Lovgren-Bengtsson 1999). Despite its relative simplicity, the disadvantage of this method 
is that it is still a time-consuming process since dialysis procedures are employed in the 
experimental protocol. With this in mind, in the current study it has been attempted to 
modify this method to reduce preparation time and to further simplify the method (see 
Section 3.3.4). 
Although the conjugation of fatty acids or phospholipids to proteins may potentially lead to 
loss of antigenic epitopes, most studies have demonstrated either similar or in some cases 
superior immunogenic properties of the conjugated protein compared to the untreated 
proteins (Mowat et al., 1991; Reid 1992; Barr & Mitchell 1996; Sjolander et al., 1997a; 
Ekstrom et al., 1999; Johansson & Lovgren-Bengtsson 1999). Weijer et al showed higher 
immunogenicity in cats and rabbits with peptides containing myriastic acid moeity (i.e. 
synthetic peptides derived from the feline leukemia virus) incorporated into ISCOMs than 
achieved by simply mixing the peptides with ISCOM matrix or by peptides adsorbed to 
aluminum hydroxide (Weijer et al., 1993). In the study of Ekstrom et al, it was 
demonstrated that after conjugation of phosphatidylethanolamine to ovalbumin which was 
incorporated into ISCOMs, ISCOMs induced high mucosal IgA response, whereas 
ovalbumin alone or co-administered with an ISCOM matrix produced low or no mucosal 




Besides ovalbumin and cytochrome C, several other proteins such as HN-I IIIB 
glycoprotein gp120, Tamm Horsfall glycoprotein, and haemogluttin proteins have been 
covalently attached to fatty acids resulting in the successful incorporation into ISCOMs 
(Weis et al., 1990; Mowat et al., 1991; Browning et al., 1992; Pedersen et al., 1992; 
Kazanji et al., 1994). The limitation with these studies however, is that the extent of 
conjugation is often not determined. Incorporation into ISCOMs could be maximized by 
controlling the extent of conjugation since strongly hydrophobically modified proteins tend 
to aggregate into micelles resulting in a lower incorporation rate (Pohlman et al., 1990; 
Kersten & Crommelin 1995; Morein et al., 1995; Barr & Mitchell 1996). 
Although peptides from 10 - 40 amino acids have been successfully modified with lipid 
tails and incorporated into ISCOMs (Barr & Mitchell 1996), it is possible that there may be 
some size limitations on particular peptide sequences. Furthermore, poorly-charged 
peptides may be too hydrophobic and therefore difficult to insert into ISCOMs (Kersten & 
Crommelin 1995; Morein et al., 1995; Barr et al., 1998). Very large proteins might also 
incorporate poorly due to steric hindrance (Kersten & Crommelin 1995). 
3.1.2.5 Modification of protein by genetic engineering 
Subunit vaccine development and recombinant strategies are dominating in vaccination 
programs (Stahl & Nygren 1997; Liljeqvist et al., 1999). Gene fusion is common to 
improve the production of antigens with desired characteristics (Stahl & Nygren 1997), and 
a variety of fusion partners are available that can be used for different purposes, including 
efficient incorporation into particulate carriers (Hajishengallis et al., 1995; Sjolander et al., 
1997b; Andersson et al., 1999). With regard to ISCOMs, Rimmelzwaan et al were the first 
to use this approach by re-engineering a protein to contain a transmembrane sequence 
(Rimmelzwaan et al., 1994). In this study, the env gene of feline immunodeficiency virus 
was modified by removing a cleavage site that resulted in the expression of a 150 kDa 
protein with an intact transmembrane domain. The 150 kDa protein, when incorporated 
into ISCOMs induced higher antibody titres in cats than the native 130 kDa alone or when 
combined with Quil A. 
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Recently, using genetic engineering, another strategy for the production of immunogens 
which can be efficiently incorporated into ISCOMs has been described (Andersson et al., 
2000). In this system, the target immunogen is produced with an N-terminal affinity tag 
suitable for affinity purification, and a C-terminal hydrophobic tag, which should enable 
association through hydrophobic interactions of the immunogen with ISCOMs. Two 
different hydrophobic tags were evaluated, a tag denoted M, derived from the membrane-
spanning region of Staphylococcus aureus protein A (SpA), and a tag denoted MI 
consisting of the transmembrane region of the haemogglutin from influenza A virus. 
Furthermore two alternative affinity tags were evaluated, the serum albumin-binding 
protein ABP, derived from streptococcal protein G, and the divalent IO-binding ZZ-
domains derived from SpA. A malaria peptide M5, derived from the central repeat region 
of the Plasmodium falciparum blood-stage antigen Pf155/RESA, served as model 
immunogen in the study. Four different fusion proteins, ABP-M5-M, ABP-M5-MI, ZZ-
M5-M and ZZ-M5-MI, were thus produced and evaluated for incorporation into ISCOMs. 
All of the fusion proteins were found in the ISCOM fractions after analytical sucrose 
gradient ultracentrifugation, indicating ISCOM incorporation. This was further supported 
by electron microscopy showing that ISCOMs were formed. In addition, these ISCOM 
preparations induced MS-specific antibody responses upon immunization of mice, 
confirming the successful incorporation into ISCOMs. The authors concluded that 
hydrophobic tagging of recombinant immunogens of hydrophilic nature should constitute 
an efficient strategy to improve incorporation levels of immunogens into ISCOMs by 
means of hydrophobic interactions. Therefore any hydrophilic antigen can thus in principle 
by expression of the desired characteristics using the described system, and after affinity 
purification be incorporated into ISCOMs (Andersson et al., 2000). 
In general, of all the methods described above, the commonly used method to modify 
hydrophilic proteins into amphipathic antigens for incorporation into ISCOM structure is 
the conjugation of fatty acids or phospholipids to proteins (Reid 1992; Barr & Mitchell 
1996; Sjolander et al., 1997a; Ekstrom et al., 1999; Konnings et al., 2002; Copland 2003). 
Although modification of such proteins by genetic engineering appears to be a promising 
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method, these techniques may be costly requiring specialist equipment and personnel. Fatty 
acids and phospholipids are readily available making it easy and feasible to produce 
amphipathic antigens in large quantities. 
3.2 Chapter aim 
Not much is known about the incorporation of antigens into ISCOMs and related colloidal 
structures prepared by the hydration method. Of colloidal particles containing Quil A, and 
prepared by the dialysis method, only ISCOMs have been investigated with respect to the 
incorporation of various proteins. Moreover, the impact of incorporation of antigen on the 
morphology of these various colloidal structures, and hence on the pseudo-ternary diagrams 
described in Chapter 2 has not been investigated. The objectives of this study therefore 
were: 
1. to modify ovalbumin by two different approaches to render the model antigen 
amphipathic with the aim of investigating which modified protein is better able to 
incorporate into the various colloidal particles formed by hydration of dried lipid 
films with an aqueous solution of Quil A 
2. to investigate which of the various colloidal particles prepared by the hydration 
method are capable of incorporating the modified protein and to rank the various 
types of colloidal particles in terms of their ability to incorporate modified protein 
3. to assess the impact of incorporation of modified protein on morphology, size and 
prevalence of the various colloidal structures 
4. to compare the incorporation of antigen into particles prepared by the hydration 
method and those prepared by the dialysis method. 
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3.3 Materials and methods 
3.3.1 Materials 
Quil A was obtained from Superfos Biosector, Denmark. Cholesterol (purity approx. 
95%), L-cx-phosphatidylethanolamine from bovine brain (purity approx. 98%), ovalbumin 
(Grade V, purity approx. 98%), fluorescein isothiocynate (purity approx. 90%), N-
(palmitoyloxy) succinimide (purity approx. 98%), 1-ethyl-3'-(3-
dimethylaminopropyl)carbodiimide hydrochloride (purity approx. 99 %), octylglucoside 
(purity approx. 98%), triton-X 100 (purity approx. 99 %), sucrose (purity approx. 99 %), 
sodium chloride (purity approx. 99%), and N-hydroxysuccinimide (purity approx. 98 %), 
were purchased from Sigma-Aldrich Pty Ltd, Missouri, USA. Sodium deoxycholate 
(purity approx. 90%) was purchased from Koch-Light Laboratories, England. Tris 
(hydroxymethyl) methylamine (purity approx. 98%), sodium carbonate (purity approx. 
99%), and sodium hydrogen carbonate (purity approx. 99%) were purchased from BDH 
Laboratories Supplies, Pool, England. A 1,000 Da molecular weight cut-off dialysis 
membrane (Regenerated Cellulose Tubing) was purchased from Spectrum Laboratories 
Inc., California, USA. Distilled deionised water having a conductivity of less than 0.1 µ,S 
(Milli-Q Water system, Millipore Corporation, Massachusetts, USA) was used throughout 
the study. All other chemicals and solvents were of at least analytical grade. 
3.3.2 Conjugation of fluorescein isothiocyanate (FITC) to ovalbumin (OVA) 
The conjugation of FITC to OVA was performed as described previously (Konnings et al., 
2002). Briefly, 20 mg FITC was dissolved in 10 ml of carbonate buffer (220 mM, pH 9.5) 
and 100 mg OVA was added. The mixture was gently stirred in the dark at 4 °C for 18 h. 
Buffer salts and unbound FITC were removed by repeated dilution with water and 
ultrafiltration using a 10,000-molecular weigh cut-off membrane and a 50 ml filtration cell 
(Amicon, Beverly, Massachusetts, USA) pressurized to 200 kPa. The resulting FITC-OV A 
solution was freeze-dried for 24 h (Freezone 6, Model 79340, Labconco, Missouri, USA) at 
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a condenser temperature of -82 °C and pressure of less than 10-1 mbar and subsequently 
stored protected from light at 4 °C. Yield, determined gravimetrically, of FITC-OV A was 
>90%. 
3.3.3 Conjugation of palmitic acid to FITC-OV A 
The conjugation of palmitic acid to FITC-OV A was performed as described previously 
(Konnings et al., 2002). Briefly, 30 mg FITC-OV A was dissolved in 30 ml of carbonate 
buffer (50 mM, pH 9) containing 30 mg sodium deoxycholate. 470 µl of a solution of 5 mg 
N-(palmitoyloxy) succinimide (NPS) in 500 µl dimethylsulfoxide was added. The mixture 
was protected from light and gently stirred for 15 h at 37 °C. Sodium deoxycholate and 
unbound NPS were then removed by washing and ultrafiltration as described above. The 
resulting solution was centrifuged at 30,000 g for 30 min (Beckman Ultracentrifuge, SW41 
Ti rotor, California, USA) and the clear supernatant was freeze-dried as described above. 
Yield, determined gravimetrically, of P-FITC-OVA was> 95%. 
3.3.4 Conjugation of phosphatidylethanolamine (PE) to FITC-OV A 
The conjugation of PE to FITC-OV A was performed according to the method described by 
Sjolander et al (Sjolander et al., 1997a), modified for the ISCOM preparation by the 
hydration method. 1-Ethyl-3'-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) 
was used to link the amino group of PE to the carboxyl groups in FITC-OV A. 100 mg 
FITC-OV A dissolved in 10 ml of water was mixed with 100 mg PE dissolved in 20 ml of 
10% w/v octylglucoside solution. 100 mg of N-hydroxysuccinimide was added to the 
mixture. The conjugation was initiated by addition of 2 g of EDC, and the total volume 
was adjusted to 80 ml with water. The mixture was protected from light and gently stirred 
for 30 h at 4 °C. After this incubation period, the PE-FITC-OVA formed was purified by 
repeated washing and ultrafiltration as described above. The resulting solution was freeze-




3.3.5 Mass spectroscopy 
Molecular weight determinations of ovalbumin and derivatives were carried out using 
matrix-assisted laser desorption ionization, time-of-flight mass spectrometry (MALDI-
TOF-MS) as described by Hubbard and McHugh (Hubbard & McHugh 1996). Briefly, 
samples were mixed with a saturated solution of the matrix sinapinic acid (3,5-dimethoxy-
4-hydroxycinnamic acid) at a concentration of 10 mg/ml in acetonitrile containing 0.1 % 
trifluoroacetic acid (1:1). Mass spectra were collected using a DePro mass spectrometer 
(PerSeptive Biosystems, Inc., Massachusetts, USA) fitted with a nebulization assisted 
atmospheric pressure ionization source. The nitrogen laser of the spectrometer operates at a 
wavelength of 337 nm, and the laser intensity was between 2400-2600 units in the 
instrument setting used in the current study. Spectra were acquired in positive ion linear 
mode with accelerating voltage 25,000, grid voltage 93%, 0.2% guide wire voltage and 
delay time 750 nsec. Masses were calibrated with respect to the expected molecular weight 
of ovalbumin of 42,700 Da (Nisbet et al., 1981). All samples were injected into the 
spectrometer using a fused silica capillary tube (i.d. 60 µm), at a rate of 5 µ1/min using a 
syringe pump (Harvard Apparatus, model 24000001, Massachusetts, USA). A coaxial 
spray of nitrogen at 0.9 1 per minute assisted nebulization of the liquid sample. 
3.3.6 Preparation of colloidal dispersions 
An overview of the formulations investigated is shown in Table 3.1. The formulations 
were chosen as representative samples of the different regions of the pseudo-ternary 
diagram (Figure 3.3). The pseudo-ternary diagram shown in Figure 3.3 was constructed in 
this study from aqueous lipid mixtures of Quil A, cholesterol and 
phosphatidylethanolamine as described in Chapter 2. 
3.3.6.1 Hydration method 
The hydration method was carried out as described in Section 2.3.2.1. Briefly, various 
amounts of PE and cholesterol were dissolved in 0.5 ml chloroform and evaporated to 
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dryness at 45°C for 1 h (Rotavapor Rl 10, BUchi, Switzerland). The resulting lipid films 
were hydrated for 5 h at room temperature with 3 ml Tris buffer (140 mM, pH 7.4) 
containing various amounts of Quil A and 3 mg of protein. The total polar lipid 
concentration in each sample (Quil A, cholesterol and PE) was 6.7 mg/ml. The samples 
were subsequently freeze-dried for 24 h (Freezone 6, Model 79340, Labconco, Missouri, 
USA) at a condenser temperature of -82 °C and pressure of less than 10-1 mbar. The 
freeze-dried samples were rehydrated with 3 ml of water and stirred using a magnetic stirrer 
for 5 h. All samples were prepared in triplicate and equilibrated for one week at 4 °C 
before analysis. 
3.3.6.2 Dialysis method 
The dialysis method was carried out as described in Section 2.3.2.2. Briefly, various 
amounts of PE and cholesterol were dissolved in 0.5 ml chloroform and evaporated at 45°C 
for 1 h (Rotavapor RllO, Blichi, Switzerland). Different amounts of Quil A in Tris buffer 
(140 mM, pH 7.4) was added to the dried lipid film so that the total polar lipid 
concentration in each sample (Quil A, cholesterol and PE) was 6.7 mg/ml. The surfactant 
octylglucoside at a concentration of 40 mg/ml was added to solubilise the polar lipids. 
Protein at a concentration of 1 mg/ml was added to the mixture. The micellar solution was 
stirred using a magnetic stirrer for 5 h at room temperature. The samples were dialyzed 
against 7 changes of 1 1 Tris buffer (140 mM, pH 7.4) at 4°C for 3 days to remove the 
octylglucoside. All samples were prepared in triplicate and equilibrated for one week at 4 
°C before analysis. 
3.3. 7 Characterization of colloidal dispersions 
3.3.7.1 Transmission electron microscopy (TEM) 
TEM investigation was performed as described in Section 2.3 .3 .1. In addition to colloidal 
dispersions, 1 mg/ml of aqueous solutions of protein ( ovalbumin and the derivatives, 
Section 3.3.2) were also negatively stained for TEM analysis. 
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3.3.7.2 Polarized light microscopy (PLM) 
PLM investigation was performed as described in Section 2.3.3.2. 
3.3.7.3 Sucrose density gradient ultracentrifugation 
All dispersions were purified from non-incorporated protein by analytical sucrose density 
gradient centrifugation (10-50% w/w, 18 h at 200,000 g, 10 °C) as previously described 
(Sjolander et al., 1997a; Ekstrom et al., 1999; Johansson & Lovgren-Bengtsson 1999; 
Konnings et al., 2002). Visible bands of colloids were isolated (Konnings et al., 2002; 
Demana et al., 2004b) and dispersed in 1 ml Tris buffer before fluorescence spectroscopy 
measurements. 
3.3. 7.4 Fluorescence spectroscopy 
The measurement of incorporated protein into the colloidal particles was carried out by 
fluorescence spectroscopy (Konnings et al., 2002). Colloidal structures were disrupted by 
addition of 50 µl of the dispersion to 750 µl Tris buffer (pH 6.6) containing 5% Triton X-
100. Fluorescence of the resulting solution was measured (Shimadzu FR 540, ex. 495 nm, 
em. 518 nm) and entrapment efficiency of protein into various colloidal particles was 
estimated as described below. Measurements were performed in quadruplicate. 
3.3.7.4.1 Preparation of calibration curves for FITC-OVA, P-FITC-OVA and 
PE-FITC-OV A 
Three replicate stock solutions of FITC-OVA, P-FITC-OV A and PE-FITC-OVA in Tris 
buffer, pH 6.6 containing 5% w/v Triton-X 100 were prepared (1 mg/ml for FITC-OVA, 1 
mg/ml for P-FITC-OV A and 0.8 mg/ml for PE-FITC-OV A). Each stock solution was 
diluted with buffer solution for final concentrations ranging from 0.8 to 35.0 µg/ml The 
diluted samples were analyzed by spectrofluorimetry (Shimadzu FR-540, Japan), at an 
excitation and emission wavelength of 495 nm and 518 nm respectively. Calibration curves 
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were constructed by plotting the fluorescence intensity against the concentration of 
modified protein. The slope, y-intercept and linearity of the calibration curve were 
determined by the use of linear least squares regression analysis (Minitab Inc., 
Pennsylvania, USA). 
Intra-day variability was determined by using either two or three diluted stock solutions. 
The concentrations chosen for validation were 2.0, 20.0 and 34 µg/ml (FITC-OVA), 2.0 
and 8 µg/ml (P-FITC-OVA), and 0.8, 2.4 and 4.0 µg/ml (PE-FITC-OVA). The solutions 
were prepared in triplicate. Replicate analyses (n = 5) of these solutions were undertaken 
for each concentration. For inter-day variability, three freshly prepared solutions of the 
same concentrations of each protein similar to those used for the validation of intra-day 
variability were prepared on each consecutive day. Replicate analyses (n = 5) of these 
solutions were also undertaken for each concentration. 
Limit of detection and quantitation were determined based on the standard deviation of the 
response and the slope of the calibration curve. 
The detection limit (DL) = 3.3cr/S 
The quantitation limit (QL) = lOcr/S 
Where cr = standard deviation of the response 
S = slope of the calibration curve 
The estimate of the standard deviation of response (cr) was carried out based on the 
standard deviation of the blank. The blank was repeatedly analyzed (n = 8) and the 
standard deviation of the response obtained was used in the equations above for 
calculations of DL and QL (Bass 1996). 
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3.3.7.4.2 Determination of entrapment efficiency 
From the calibration curves, the amount of protein incorporated into the colloidal particles 
was calculated and expressed as a percentage of the original amount of protein used per 
,u.mol of lipid as described by Allen (1983) and Kirby et al (Kirby & Gregoriadis 1983). 
The molecular weight of Quil A was assumed to be 2,000 (Barr et al., 1998), and the 
molecular weight of PE and cholesterol was 745 and 386.7 (Knight 1981; Windholz et al., 
1983) respectively. 
3.3.8 Statistical analysis 
A one-way analysis of variance (ANOVA) followed by Tukey's pairwise comparisons was 
used to assess statistical significance between the molecular weights obtained for the 
various proteins. The same tests were also used to assess statistical significance between 
the levels of protein incorporation into the various colloidal structures. P values of less 
than 0.05 were considered statistically significant. All statistical tests were run on Minitab® 












Table 3.1 Composition ofrepresentative samples of different regions of the 
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Figure 3.3 Pseudo-ternary diagram for aqueous mixtures of Quil A, cholesterol and 
phosphatidylethanolamine in Tris buffer (140 mM, 7.4) prepared by the hydration 









3.4.1 Characterization of protein by MALDI-TOF-MS 
Molecular weights of ovalbumin (OVA) and the OVA derivatives were determined by 
MALDI-TOF-MS to assess the extent of conjugation of fatty acids to FITC-OV A. The 
spectra were collected at voltages that gave signals for single protonated ions ([M + Ht) 
and double protonated ions ([M + 2H]2°\ Masses shown in Table 3.2 were calculated 
using the double protonated ions as these gave peaks that were better defined than the 
broader 1 + ions. The mass-charge ratio (m/z) obtained from the spectra of double 
protonated ions is therefore half that of the monovalent ion (Beavis & Chait 1990) and is 
calculated as follows: 
m/z = 0.5 x (molecular weight+ 2) 
The molecular weights of the various proteins were calculated from the four spectra for 
each of the compounds, and representative spectra are shown in Figures 3.3 - 3.7. 
Examples of m/z values used in the above equation to generate molecular weights of OVA 
and the OVA derivatives presented in Table 3.2 are also shown in the spectra (see arrows). 
Table 3.2 Molecular weight of proteins determined from MALDI-TOF-MS. 






Molecular weight (Da) 
43,683 ± 150 
45,256 ± 80 
46, 803 ± 92 
51,804 ±172 
Molecular weights of FITC and palmitic acid are 389.4 and 256.4 g/mol (Windholz et al., 
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Figure 3.7 MALDI-TOF-MS spectrum of PE-FITC-OVA 
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The average molecular weight of OVA determined by MALDI-TOF-MS was found to be 
close to the literature value of 42,700 Da (Beavis & Chait 1990) and was even closer to the 
value of 44,300 Da provided by the supplier (Sigma-Aldrich Pty Ltd). The molecular 
weight of FITC-OVA was on average more than 1500 g/mol higher than that of OVA 
suggesting that about 4 moles of FITC were bound to each mole of OVA. For P-FITC-
OV A and PE-FITC-OV A the molecular weights were also significantly higher than that of 
FITC-OVA (1547 g/mol and 6548 g/mol respectively) representing an average conjugation 
of approximately 6 moles of palmitic acid per mole FITC-OV A and approximately 9 moles 
of PE per mole FITC-OV A. These results confirm the successful conjugation of FITC to 
OVA and conjugation of P or PE to FITC-OVA. 
3.4.2 Characterization of protein by TEM 
Electron micrographs of aqueous concentrated solutions (1 mg/ml) of various proteins are 
shown in Figure 3.8. Aggregates of small particles (about 5 - 10 nm) could be observed in 
all micrographs but especially for P-FITC-OVA and PE-FITC-OVA solutions. These 
aggregates are possibly protein micelles formed due to hydrophobic interactions (Huang et 
al., 1982; Pohlman et al., 1990; Kersten & Crommelin 1995; Morein et al., 1995). When 
comparing various protein solutions, the aggregates appear to be increase in size and 
concentration in the following order: OVA = FITC-OVA < P-FITC-OVA < PE-FITC-
OVA. 
3.4.3 Characterization of colloidal formulations from the pseudo-ternary diagram of 
aqueous mixtures of Quil A, cholesterol and PE by TEM 
Initially, the pseudo-ternary diagram for aqueous mixtures of Quil A, cholesterol and PE in 
the absence of protein using the hydration method was constructed (Figure 3.3). 
Depending on the mass ratio of Quil A:cholesterol:PE, various types of colloidal particles 
were identified including ISCOM matrices, liposomes, ring-like micelles, lamellae 
(hexagonal array of ring-like micelles), worm-like micelles, and lipidic/layered structures. 




(Demana et al., 2004c). The whole area of lamellae structures presented in Figure 3.3 is 
very similar to the area of ring-like micelles found in the cholesterol rich systems described 
in Chapter 2. However, with PE-containing systems, the micelles aggregated resulting in a 
well formed hexagonal pattern (lamellae). Lamellae from PC-containing systems were 
generally not well formed as shown in Figure 2.17. 
Figures 3 .9 and 3 .10 show structures obtained for formulations A to F (Table 3 .1, Figure 
3.3) containing PE-FITC-OVA and without PE-FITC-OVA respectively. The appearance 
of the colloidal particles in the absence of PE-FITC-OVA is remarkably similar in 
morphology and size to the structures containing the protein. Similar results were obtained 
for systems containing P-FITC-OV A. 
In systems prepared by the dialysis method, the same colloidal structures as those prepared 
by the hydration method were obtained for Formulation A (liposomes), Formulation C 
(larnellae), and Formulation F (lipidic particles). However, in contrast to the hydration 
method, Formulations B, D and E, when prepared by the dialysis method produced 
predominantly a mixture of ISCOMs and liposomes, ISCOMs, and ring-like micelles. 








Figure 3.8 Electron micro graphs of aqueous solutions (1 mg/ml) of various proteins. A: 
OVA, B: FITC-OVA, C: P-FITC-OVA, D: PE-FITC-OVA 
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Figure 3.9 Electron micrographs of pseudo-binary and pseudo-ternary systems 
prepared by the hydration method. All systems contained a total lipid:PE-FITC-
OV A mass ratio of 6. 7: 1. A: PE:cholesterol, mass ratio of 1: 1 (liposomes ), B: 
Quil A:cholesterol:PE, mass ratio of 1: 1 :3 (ISCOMs), C: Quil A:cholesterol:PE, 
mass ratio of 1:3:1 (lamellae), D: Quil A:cholesterol:PE, mass ratio of 5:1:1 
(ring-like micelles), E: Quil A:cholesterol, mass ratio of 3: 1 (worm-like 
micelles), F: Quil A:PE, mass ratio of 1: 1 (lipidic/layered structures, arrow 






Figure 3.10 Electron micrographs of pseudo-binary and pseudo-ternary systems 
prepared by the hydration method in the absence of protein. All systems 
contained a total lipid mass of 6. 7 mg. A: PE:cholesterol, mass ratio of 1: 1 
(liposomes), B: Quil A:cholesterol:PE, mass ratio of 1:1:3 (ISCOMs), C: Quil 
A:cholesterol:PE, mass ratio of 1 :3: 1 (lamellae), D: Quil A:cholesterol:PE, mass 
ratio of 5: 1: 1 (ring-like micelles), E: Quil A:cholesterol, mass ratio of 3: 1 
(worm-like micelles), F: Quil A:PE, mass ratio of 1: 1 (lipidic/layered structures, 
arrow indicates particles as layered structures). 
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3.4.4 Characterization of colloidal dispersions by sucrose density gradient 
ultracentrifugation 
Figure 3 .11 shows the formation of bands following ultracentrifugation for 18 h at 10 °C in 
a sucrose gradient (10 - 50 % w/w, in which the top layer is a 10% sucrose solution). The 
bands formed were from various formulations (Table 3.1) prepared with PE-FITC-OVA. 
The position of the recovered bands for a specific colloidal structure did not vary in 
replicate experiments (n = 4), and was not influenced by the method of preparation 
(hydration or dialysis). On the other hand, different colloidal particles were isolated at 
different positions in the sucrose gradient. This is not unexpected, as the colloidal particles 
will show differences in their density due to differences in their composition. In the 
formulations A-F (Table 3.1, Figure 3.3), only one band was found for each of the 
formulations including formulation D that contained ring-like micelles and worm-like 
micelles. This may be due to almost similar densities of these two colloidal forms. 
ISCOMs were found in the layer between 20% and 30 % sucrose band, which is consistent 
with previous reports (Kersten et al., 1991; Sjolander et al., 1997a; Johansson & Lovgren-
Bengtsson 1999), (tube 4, typically about 30 mm from the bottom of the tube). The 
ISCOM band was found to be relatively thin and hence not that distinct (see arrow on tube 
4) compared to the bands in tubes 5 and 6. On the other hand, liposomes were found in the 
top fractions of the tube ( e.g. tube 5) which again is in agreement with other studies 
(Lovgren & Morein 1988; Konnings et al., 2002; Copland 2003). The band consisting of 
lipidic/layered structures (prepared with PE and Quil A) was isolated in the 20% sucrose 
layer (tube 6). Ring-like and worm-like micelles formed a thin, faint band that was found 
around the 30% sucrose layer which is also similar to the results reported by others for 
formulations containing a high amount of Quil A and small amounts of phospholipid and 
cholesterol (Konnings et al., 2002; Copland 2003) (tubes 2 and 3). The bands containing 
these type of micelles were very thin, and hence not distinct compared to any other 
formulations investigated in the current study. Lamellae sedimented to higher density 
sucrose solutions (40% sucrose, tube 1, about 15 mm from the bottom of the tube). 
Cholesterol crystals sedimented to the bottom of the tube along with unsolubilized PE-
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FITC-OV A. Unentrapped proteins, particularly FITC-OVA and P-FITC-OV A were found 
in the supernatant as expected (Lovgren & Morein 1988; Sjolander et al., 1997a). 
3.4.5 Incorporation of modified ovalbumin into various colloidal particles 
For the assessment of incorporation of modified ovalbumin into various colloidal particles, 
calibration curves for each protein (FITC-OV A, P-FITC-OV A and PE-FITC-OV A) were 
prepared as described in Section 3.3.7.4.1 and validated for linearity, reproducibility (intra-
day and inter-day variability), limit of detection and limit of quantitation. Linear regression 
analysis showed that the fluorescence intensity of each of the modified ovalbumins was a 
linear function of concentration with a slope significantly different from zero (r 2 > 0.992, p 
< 0.05) (Tables 3.3 - 3.5). The intra- and inter-day coefficient of variation of the 
fluorometric assay was< 5.5 % for each of the concentrations of modified ovalbumin tested 
(Table 3.6). The limit of detection and limit of quantitation were 0.041 µg/ml and 0.125 
µg/ml (FITC-OVA), 0.073 µg/ml and 0.221 µg/ml (P-FITC-OVA, and 0.077 µg/ml and 
0.233 µg/ml (PE-FITC-OV A) respectively. Figure 3.12 shows the entrapment efficiency 
of FITC-OVA, P-FITC-OVA and PE-FITC-OVA into the various colloidal particles. The 
encapsulation efficiency results demonstrate that all colloidal structures are capable of 





Figure 3.11 Sucrose density gradient ultracentrffugation showing formation of 
bands in layers of sucrose solutions (10 - 50% w/w, top layer 10% and bottom 
layer 50% sucrose solution). Tubes 1 to 6 contain formulation C (lamellae), D 
(ring-like micelles), E (worm-like micelles), B (ISCOMs), F (liposomes) and A 
(lipidic/layered structures) respectively. All formulations contained PE-FITC-
OV A and were prepared by the hydration method. 
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Table 3.3 Linear regression analysis of FITC-OVA calibration curve. 
StDev T p 
The regression equation is 
FI = 1.56 + 2.65 Cone of FITC-OV A 
Slope 2.65 0.02 159.73 0.000 
y intercept 1.56 0.25 6.31 0.000 
r2 0.999 
Analysis of Variance 
) 
Source df ss MS F 
Regression 1 18345 756.50 10672.81 
Residual error 22 16 0.07 
,, Total 23 18361 
Table 3.4 Linear regression analysis of P-FITC-OVA calibration curve. 
'( 
StDev T p 
The regression equation is 
FI= 0.39 + 1.60 Cone of P-FITC-OVA 
Slope 1.60 0.02 103.31 0.000 
y intercept 0.39 0.10 3.93 0.001 
r2 0.998 
Analysis of Variance 
Source Df ss MS F 
( 
Regression 1 756.50 756.50 10672.81 
Residual error 19 1.35 0.07 
Total 20 757.84 
:, 
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Table 3.5 Linear regression analysis of PE-FITC-OVA calibration curve. 
StDev T p 
The regression equation is 
FI= -0.330 + 1.42 Cone of PE-FITC-
OVA 
Slope 1.42 0.03 54.56 0.000 
y intercept -0.33 0.07 -4.65 0.000 
r2 0.993 
Analysis of Variance 
J 
Source df ss MS F 
Regression 1 116.17 116.17 2976.97 
i' Residual error 22 0.86 0.04 '·~ 
l Total 23 117.03 
Table 3.6 Intra-day and inter-day variation of the fluorometric assay. 
:1 
·j-·, Protein Concentration used Intra-day Inter-day 
(µg/ml) (CV%) (CV%) 
FITC-OVA 2 0.75 2.61 
20 0.54 1.43 
34 0.28 3.21 
P-FITC-OVA 2 3.22 5.42 
10 2.59 5.48 
PE-FITC-OVA 0.8 1.01 1.78 
2.4 1.67 3.34 
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Figure 3.12 Entrapment efficiency of protein in different colloidal dispersions (amount 
entrapped as a percentage of original amount of protein used per micromole lipid, type of 
colloidal dispersion described in Figure 3.10). Results are mean ± S.D., n = 4. The 
asterisks represent statistically significant differences between specified samples. Unless 








Systems prepared by the hydration method 
Although FITC-OVA, P-FITC-OVA and PE-FITC-OV A have been prepared in previous 
studies (Sjolander et al., 1997a; Ekstrom et al., 1999; Johansson & Lovgren-Bengtsson 
1999; Konnings et al., 2002), the extent of conjugation for these proteins was not known. 
It is however, important to determine the extent of conjugation because it is known that if 
an antigen is too hydrophilic it cannot be incorporated into ISCOM matrices (Morein et al., 
1990; Kersten et al., 1991; Rimmelzwaan & Osterhaus 1997; Barr et al., 1998), and if it is 
too lipophilic the protein tends to aggregate, thus also not allowing its incorporation 
(Kersten & Crommelin 1995; Morein et al., 1995). In previous studies it was only inferred 
that conjugation had occurred because P-FITC-OVA or PE-FITC-OVA could be 
incorporated into ISCOM matrices whereas FITC-OV A could not be incorporated into 
these colloids (Sjolander et al., 1997a; Ekstrom et al., 1999; Johansson & Lovgren-
Bengtsson 1999; Konnings et al., 2002). 
The relative hydrophobic nature of PE-FITC-OV A is highlighted in the TEM investigation 
where bigger aggregates of particles (possibly protein micelles, Figure 3.8) for PE-FITC-
OV A solution were observed in comparison with the other protein solutions. Similar 
results were obtained when comparing electron micrographs of FITC-OV A and P-FITC-
OV A solutions although the differences were less pronounced as between FITC-OV A and 
PE-FITC-OV A. The formation of protein micelles is known to be driven by hydrophobic 
interactions (Mazer et al., 1979; Shikata et al., 1990; Kersten & Crommelin 1995; 
Iampietro & Kaler 1999). 
Electron micrographs in Figure 3.9 showed that various types of colloidal particles were 
formed following aqueous dispersions of Quil A, cholesterol, PE and PE-FITC-OVA using 
the hydration method. In comparing the same formulations to those prepared without PE-
FITC-OV A (Figure 3.10), the remarkable similarity of the structures demonstrates that the 
protein incorporated into ISCOM matrices and other colloidal particles did not influence 




comparing the formulations prepared with or without P-FITC-OV A. This observation 
suggests that the nature of the protein investigated and the amount of protein incorporated 
into the various colloidal structures does not have a significance influence on the various 
regions of the pseudo-ternary diagram shown in Figure 3.3. Sucrose gradient 
ultracentrifugation also revealed that the nature and amount of protein incorporated did not 
significantly influence the sedimentation behavior of the various colloidal structures 
(Section 3.4.4). Similar results have also been previously reported by others in which 
regardless of molecular weight, level of glycosylation or tertiary structure of incorporated 
proteins, the sedimentation behavior of ISCOMs was the same (Lovgren & Morein 1988). 
As discussed in Section 3.1.1, this is surprising as the protein incorporated into ISCOMs 
should change the density of the particles. Other investigators have suggested that the 
partial entry of the protein molecule into ISCOMs and possibly also into other related 
colloids investigated in the current study or the actual low number of protein molecules 
incorporated into a colloidal particle may be the two factors causing similar sedimentation 
rate of ISCOMs regardless of the presence or absence of incorporated protein (Barr & 
Mitchell 1996) (see also Section 3.11 for further explanation). 
The incorporation efficiency results demonstrate that all colloidal structures are capable of 
incorporating both P-FITC-OVA and PE-FITC-OVA albeit to varying degrees (Figure 
3.12). Furthermore, the results demonstrate that incorporation of FITC-OVA into colloidal 
particles is only possible in the absence of Quil A i.e. when liposomes are present in the 
dispersion. This implies that non-modified, hydrophilic FITC-OV A could be encapsulated 
into the aqueous compartments of liposomes but could not be incorporated into non-
liposomal structures containing Quil A such as ISCOMs, lamellae, ring- and worm-like 
micelles. 
Incorporation of PE-FITC-OVA or P-FITC-OVA was possible with all colloidal structures 
investigated and was particularly evident when ISCOMs and lamellae were the 
predominant colloids with incorporation efficiencies reaching 20 %/µmol lipid or above for 
PE-FITC-OVA. The encapsulation efficiency of PE-FITC-OVA was significantly higher 
(p < 0.05) than that of P-FITC-OVA for all colloids except liposomes implying that PE-
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FITC-OVA was relatively more hydrophobic compared to P-FITC-OV A. This is because 
of the more lipophilic nature of PE having two fatty acids compared to palmitic acid having 
a single chain fatty acid. The higher lipophilicity of PE-FITC-OVA was confirmed by 
MALDI-TOF-MS analysis as approximately 9 moles of PE were conjugated per mole of 
FITC-OV A compared with about 6 moles of palmitic acid per mole of FITC-OV A. The 
higher lipophilicity of PE-FITC-OVA also resulted in a lower aqueous solubility of the 
compound compared to P-FITC-OVA which has been found to be freely soluble in water. 
In addition, upon sucrose gradient ultracentrifugation a precipitate of PE-FITC-OVA at the 
bottom of the centrifuge tube was frequently observed in contrast to samples containing P-
FITC-OV A or FITC-OV A where no sediment of modified protein was found. A 
precipitate is often observed with proteins due to aggregation of protein molecules as a 
result of increased hydrophobic interactions which may have been brought about by the 
conjugation of PE (Huang et al., 1982). 
All modified proteins (FITC-OVA, P-FITC-OVA and PE-FITC-OVA) could be 
incorporated into liposomes (Figure 3.12 A). However the lowest encapsulation efficiency 
was found with the hydrophilic FITC-OV A. Thus conjugation of fatty acids to FITC-OV A 
promotes incorporation even into liposomes that have an associated aqueous volume. The 
liposomes obtained by the preparation method used were observed to be multilamellar and 
hence the relative aqueous volume of these is small compared to other forms of liposomes 
such as unilamellar liposomes (Kirby & Gregoriadis 1984; New 1990). Hence lipid 
modification of the protein would have increased interaction with the lipid bilayers leading 
to a more efficient encapsulation of the modified protein within liposomes having a 
relatively low aqueous volume (Knight 1981; Kirby & Gregoriadis 1984; New 1990). 
The addition of Quil A to a binary mixture containing PE and cholesterol resulted in the 
formation of other colloidal structures, depending on the mass ratio of Quil 
A:cholesterol:PE (Figure 3.3 B-D (E and F are binary systems)). Formulations having a 
Quil A:cholesterol:PE mass ratio of 1: 1 :3 produced predominantly ISCOM matrices having 
a diameter of approximately 40 nm (Figure 3.9 B). The incorporation of modified protein 
into ISCOM matrices was higher than for liposomes especially with PE-FITC-OVA (Figure 
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3.12 B). FITC-OVA could not be incorporated into ISCOM matrices. ISCOMs have been 
characterized as "cage-like structures" and hence do not have a defined entrapped aqueous 
volume (Kersten et al., 1991). Hence, ISCOMs can only associate with proteins which 
have sufficiently amphipathic character that enables them to interact via hydrophobic 
interactions with the lipidic ISCOM matrix. This may also explain the higher incorporation 
of PE-FITC-OVA compared with P-FITC-OVA or FITC-OV A. Further, due to their open, 
cage-like structure, ISCOMs may provide a larger accessible surface area for the modified 
protein compared to liposomes, leading to a higher encapsulation efficiency of PE- and P-
FITC-OV A . 
When a high amount of cholesterol was used in the presence of comparatively small 
amounts of Quil A and PC to yield lamellae structures (Formulation C), incorporation of 
protein was even higher than for incorporation into ISCOM matrices for both P- and PE-
FITC-OV A (Figure 3.12 C). As described in Chapter 2, lamellae form as a result of the 
aggregation of the ring-like micelles formed at higher concentrations of cholesterol to yield 
an hexagonal pattern (Kersten & Crommelin 1995; Demana et al., 2004c). A high 
entrapment of the lipid-modified protein in this system probably arises due the increased 
lipophilicity of the lamellae compared to ISCOMs and liposomes as a result of the high 
ratio of cholesterol present in the lamellae. Both PE-FITC-OVA and P-FITC-OVA were 
incorporated into lamellae to a greater extent than into any other colloidal structure 
investigated in this study with the efficiency of entrapment again being greater for the more 
lipophilic PE conjugated protein. 
At high concentrations of Quil A, the predominant structures were ring-like micelles 
(Figure 3.3 D). An electron micrograph of a formulation with a Quil A:cholesterol:PE 
mass ratio of 5: 1: 1 shows these ring-like micelles, having a size of approximately 10 nm 
(Figure 3.9 D). These micelles were capable of incorporating both PE-FITC-OVA and P-
FITC-0 VA (Figure 3 .12 D). FITC-0 VA on the other hand was not incorporated into these 
ring-like micelles. The incorporation of PE-FITC-OVA or P-FITC-OVA was lower than 
into ISCOM matrices, lamellae or liposomes possibly because the ring-like micelles are 




concentration. Interestingly, the incorporation of the more lipophilic PE-FITC-OVA was 
still higher into the ring-like micelles than P-FITC-OVA. 
The mixture of Quil A and cholesterol in the absence of PE resulted in the formation of 
predominantly worm-like micelles. An electron micrograph of these worm-like structures 
is shown in Figure 3.9 E. Worm-like micelles were always observed together with 
cholesterol crystals, irrespective of the Quil A:cholesterol mass ratio used (Figure 3.3) 
suggesting that solubilisation of cholesterol by Quil A micelles in the absence of 
phospholipid is minimal in agreement with the results reported in Chapter 2 (Demana et al., 
2004c). Like ring-like micelles, worm-like micelles were capable of incorporating both 
PE-FITC-OVA and P-FITC-OVA but were not capable of incorporating FITC-OVA. This 
again would imply that they have accessible hydrophobic regions in their structures. The 
encapsulation efficiency of lipid-modified protein into these micelles, however was the 
lowest amongst the various colloidal particles investigated (Figure 3.12 E). The low 
incorporation is likely to be due to the comparatively low hydrophobicity of worm-like 
micelles which in tum is due to the high amount of Quil A present in these colloidal 
particles. 
A binary mixture of Quil A:PE at a mass ratio of 1: 1 prepared in the presence of protein 
produced predominantly lipidic particles (Figure 3.9 F). Morphology of the lipidic/layered 
structures reported in the current study is also consistent with the structures reported in 
Chapter 2 (Demana et al., 2004c) for similar systems of Quil A and phospholipid but 
without protein. Lipidic particles appeared again either as colloids that do not have a 
detectable bilayer structure when investigated by TEM or as layered structures in the form 
of stacks (Figure 3.9 F, arrow) having a layer thickness similar to that observed for 
liposomes (- 6 nm), suggesting that these layered structures might be bilayer fragments of 
vesicular structures (Demana et al., 2004c). Both PE-FITC-OVA and P-FITC-OVA could 
be incorporated into these lipidic particles, PE-FITC-OVA again to a larger extent than P-














compartments in their structures because FITC-OV A could not be incorporated into these 
colloids. 
Systems prepared by the dialysis method 
The incorporation of modified protein into the various colloidal particles prepared by the 
dialysis method using the same mass ratios of the polar lipids showed a similar pattern of 
encapsulation efficiency as for colloids prepared by the hydration method (Figure 3.12). 
Incorporation was essentially similar in samples prepared by dialysis compared to those 
prepared by the hydration method, provided the same structures were formed, i.e. in 
Formulation A (liposomes ), Formulation C (lamellae ), and Formulation F (lipidic 
particles). In the case where different colloidal structures were formed due to the method 
of preparation, differences in encapsulation efficiency were found (P < 0.05) (Figure 3.12). 
For example, using the dialysis method for the preparation of the sample comprising Quil 
A:cholesterol:PE mass ratio of 5:1:1 (Formulation D) produced mainly ISCOMs in 
agreement with the literature (Kersten et al., 1991; Ekstrom et al., 1999; Mowat et al., 
1999; Sjolander et al., 2001b) and also similar to the results reported in Chapter 2 (Demana 
et al., 2004e). In contrast, the same formulations prepared using the hydration method 
resulted in predominantly ring-like micelles, together with a few worm-like micelles. The 
reasons for the discrepancy between the two methods of preparation in some areas of the 
pseudo-ternary diagram are currently unclear but may be due to residual octylglucoside in 
the systems prepared by the dialysis method (Kersten & Crommelin 1995; Demana et al., 
2004e) or due to a very long equilibration time in the formulations prepared by the 
hydration method (Demana et al., 2004c). Since ISCOMs were formed when Formulation 
D was prepared by the dialysis method, encapsulation efficiencies of modified protein into 
this formulation resembled the encapsulation efficiencies observed for Formulation B 
which produced predominantly ISCOMs following both methods of preparation rather than 
the encapsulation efficiency noted when Formulation D was prepared by the hydration 
method yielding micelles. Similarly for Formulation E, where ring-like micelles were 
produced by the dialysis method as compared to worm-like micelles by the hydration 








closely resembled the results obtained for Formulation D prepared by the hydration method 







In this study palmitic acid and phosphatidylethanolamine were successfully conjugated to 
FITC-OVA resulting in the formation of P-FITC-OVA and PE-FITC-OVA respectively. 
Consequently, P-FITC-OVA and PE-FITC-OVA could be incorporated into various 
colloidal structures formed in systems containing Quil A, cholesterol and PE (ISCOM 
matrices, liposomes, ring-like and worm-like micelles, lamellae and lipidic/layered 
structures). The highest entrapment efficiency within all colloidal structures was found for 
PE-FITC-OV A, whereas FITC-OV A could only be incorporated into liposomes. The 
incorporated protein did not affect the size, morphology or the prevalence of the colloidal 
structures, and hence the appearance of the pseudo-ternary diagram. The degree of 
incorporation of protein as a function of the colloidal structure was in the order: worm-like 
micelles < ring-like micelles < lipidic/layered structures < liposomes < ISCOM matrices< 
lamellae. The incorporation of protein into various particles prepared by the hydration 
method was similar to those for samples prepared by the dialysis method provided the same 
structures were formed. However, in the case of different colloidal structures arising due to 
the preparation method, differences in encapsulation efficiency were found. This study has 
demonstrated that different types of colloids following the simple method of hydrating 
PE/cholesterol lipid film with aqueous solution of Quil A, are capable of incorporating an 
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As described in Chapter 1, ISCOMs have been developed to combine the multimeric 
delivery capacity of colloidal structures with an in-built adjuvant (Morein et al., 1984). 
From Chapter 2 and 3, it was demonstrated that ISCOMs and related colloidal particles 
could be prepared by the hydration method (Demana et al., 2004c) and are capable of 
incorporating an antigen with some amphiphilic character (Demana et al., 2004b ). 
ISCOMs have been shown to be a better adjuvant than Quil A on its own and have the 
additional benefit of reducing the side-effect profile of Quil A following its incorporation 
into the matrix (Hoglund et al., 1989; Kensil 1996). The adjuvant properties of ISCOMs 
have consequently been extensively studied in a range of animal models and with a large 
number of antigens (Kersten & Crommelin 1995; Barr & Mitchell 1996; Sjolander et al., 
1998). Recently human clinical trials with ISCOMs have been conducted (Barr et al., 
1998; Rimmelzwaan et al., 2000). Although the mechanism of the adjuvant effect of 
ISCOMs is not fully understood, it has been suggested that ISCOMs may act in several 
ways, including the formation of a depot after injection of an aqueous ISCOM dispersion 
from which the antigen is released slowly. Other possible mechanisms which have been 
proposed include the efficient targeting of antigen to lymphoid organs and antigen 
presenting cells and the modulation of the induced immune response (Barr et al., 1998; 
Morein & Bengtsson 1998; Ekstrom et al., 1999). The depot effect is considered 
potentially an important function of ISCOMs, as it traps the antigen at the site of 
administration and attracts various kinds of cells, including antigen-presenting cells. Other 
adjuvants, such as aluminium hydroxide, oil based adjuvants and polymeric microspheres 
are also believed to act in this manner (Morein & Bengtsson 1998). 
The depot effect of ISCOMs could possibly be enhanced by formulating implants from 
which ISCOMs containing antigen are slowly released. Indeed, sustained release lipid 
implants containing antigen and Quil A physically mixed have previously been studied and 
evaluated (Walduck et al., 1998). It was demonstrated by these authors that incorporation 









towards encapsulated antigen compared to that obtained from implants not containing the 
adjuvant. 
4.2 Chapter aim 
As described above, the results shown in Chapter 2 and 3 demonstrated that ISCOMs and 
related colloidal structures could be reproducibly formed when prepared by the simple 
hydration method (Demana et al., 2004b; Demana et al., 2004c). We have since noted that 
the incorporation of a freeze drying step following hydration of the lipid film improves the 
quality of the end product when redispersed in an aqueous medium (Demana et al., 2004c ). 
This presumably results from an improved mixing of the lipid components (Betageri & 
Makarla 1995). The freeze drying process also offers the opportunity to isolate lipid 
powder mixtures which spontaneously form different colloidal structures upon hydration 
(ISCOMs, liposomes, micelles, helices, and lipidic particles) (Demana et al., 2004c). 
The objectives of this study therefore were: 
1. to investigate whether lipid mixtures prepared by hydration and freeze drying and 
compressed into pellets would spontaneously form ISCOMs and other colloidal 
structures upon hydration 
2. to investigate whether the release rate of antigen-containing ISCOMs could be 




4.3 Materials and methods 
4.3.1 Materials 
Quil A was obtained from Superfos Biosector, Denmark. Cholesterol (purity approx. 
95%), L-a-phosphatidylcholine (PC) from egg yolk (purity approx. 98%), L-a-
phosphatidylethanolamine (PE) from bovine brain (purity approx. 98%), ovalbumin (OVA) 
(Grade V, purity approx. 98%), fluorescein isothiocynate (FITC) (purity approx. 90%), 
triton-X 100 (purity approx. 99 %), 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
hydrochloride (purity approx. 99 %), octylglucoside (purity approx. 98%), and N-
hydroxysuccinimide (purity approx. 98 %) were purchased from Sigma-Aldrich Pty Ltd, 
Missouri, USA Distilled deionised water having a conductivity of less than 0.1 µ,S (Milli-Q 
Water system, Millipore Corporation, Massachusetts, USA) was used throughout the study. 
All other chemicals and solvents were of at least analytical grade. 
4.3.2 Preparation of phosphatidylethanolamine conjugated, fluorescently labelled 
ovalbumin (PE-FITC-OV A). 
Preparation of PE-FITC-OVA was performed as described in Chapter 3 (Demana et al., 
2004b ). Briefly, ovalbumin (OVA) was firstly labelled with fluorescein isothiocyanate 
(FITC). This was performed by dissolving 20 mg FITC and 100 mg OVA in 10 ml 
carbonate buffer (220 mM, pH 9.5). The mixture was gently stirred in the dark at 4 °C for 
18 h. Buffer salts and unbound FITC were removed by repeated dilution with water and 
ultrafiltration using a 10,000-molecular weight cut-off membrane and a 50 ml filtration cell 
(Amicon, Massachusetts, USA) pressurized to 200kPa. The resulting FITC-OV A solution 
was freeze-dried. Secondly, phosphatidylethanolamine (PE) was conjugated to the FITC-
OV A. 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) was used to 
link the amino group of PE to the carboxyl groups in FITC-OV A. 100 mg FITC-OV A 
dissolved in 10 ml of water was mixed with 100 mg PE dissolved in 20 ml of a 10 % w/v 











conjugation was initiated by addition of 2 g of EDC, and the total volume was adjusted to 
80 ml with water. The mixture was protected from light and gently stirred for 30 hat 4 °C. 
After this incubation period, PE-FITC-OVA was purified by repeated dilution with water 
and ultrafiltration as described for the purification of FITC-OV A. The resulting solution 
was freeze-dried. Yield of PE-FITC-OVA as determined gravimetrically was> 90 % . 
4.3.3 Preparation of lipid powder mixtures 
Powders were prepared by either physical mixing of lipid powders or freeze drying an 
aqueous dispersion of the lipids prepared by hydrating a dried lipid film with an aqueous 
solution of Quil A. Table 4.1 summarizes the lipid compositions of the powders 
investigated. Binary systems of 7:3 mass ratio are approximated as 2:1 mixtures. 
Compositions were selected based on the pseudo-ternary diagram for Quil A, 
phosphatidylcholine (PC) and cholesterol in buffer (Demana et al., 2004c) (Figure 4.1). 
Based on the pseudo-ternary diagram, these mass ratios of lipids and corresponding 
formulations should yield lipidic/layered structures, worm-like micelles, ISCOMs and ring-
like micelles upon hydration (for Formulations A-D respectively). All formulations were 
prepared in triplicate. 
4.3.3.1 Preparation of lipid powder mixtures by physical mixing 
Physically mixed powders were prepared as described by Khan et al (Khan et al., 1991). 
Required amounts of Quil A, cholesterol and PC with and without PE-FITC-OVA were 
weighed (Sartorious Electronic Ultramicrqbalance, Model 4431MP8, Sartorious GmbH, 
Gottingen, Germany) and mixed thoroughly by light trituration for a total period of 3 min 
using a mortar and pestle. Solid PC was obtained by evaporation of chloroform to dryness 
overnight under vacuum (Speed Vac Concentrator, SVC-200H, Savant Instrument, Inc., 
USA). The amount of protein used was 1 mg and the total mass of polar lipids (Quil A, 







4.3.3.2 Preparation of lipid powder mixtures by freeze-drying of aqueous lipid 
dispersions 
Lipid powder mixtures were also prepared by freeze-drying aqueous lipid dispersions 
prepared by hydrating dried lipid films (PC and cholesterol) with an aqueous solution of 
Quil A based on the method for the preparation of ISCOMs and related colloidal structures 
by hydration described in Chapter 2 and 3 (Demana et al., 2004b; Demana et al., 2004c). 
Required amounts of PC and cholesterol were dissolved in 0.5 ml chloroform and 
evaporated to dryness at 45°C for 1 h (Rotavapor Rl 10, Buchi, Switzerland). The lipid 
films formed were hydrated for 2 h at room temperature with 3 ml phosphate buffered 
saline (PBS) (0.01M, pH 7.4) containing Quil A alone or together with PE-FITC-OV A. 
The amount of protein used was 1 mg and the total mass of lipids (Quil A, cholesterol and 
PC) was 6.7 mg. All samples were stored at 4 °C in a dessicator until required. Samples 
were subsequently freeze-dried for 48 h (Freezone 6, Model 79340, Labconco, Missouri, 
USA) at a condenser temperature of -82°C and pressure of less than 10·1 mbar. All samples 
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Figure 4.1 Pseudo-ternary diagram for mixtures of Quil A, cholesterol and 
phosphatidylcholine (PC) in Tris buffer (140 mM, 7.4) prepared by hydration. Total lipid 
concentration in the samples was 2% (w/w). All mixtures were characterized within 1 day 





4.3.4 Preparation of pellets 
Pellets were prepared as previously described by Khan et al (Khan et al., 1991), with minor 
modifications. Lipid powders prepared by physical mixing or freeze-drying of aqueous 
lipid dispersions in the absence of PE-FITC-OVA were compressed into small pellets 
having a weight of approximately 5.0 mg with a punch and die of 2 mm in diameter at a 
pressure of 0.2 tons using a Curver Laboratory Press (Model 3392, Fred S. Carver Inc., 
Wisconsin, USA). For entrapment studies, pellets were prepared from powder mixtures 
containing PE-FITC-OVA and lipid compositions of described by formulations C and D 
only (Table 1). The weight of pellets was again 5.0 mg, with each pellet containing 
approximately 0.65 mg of PE-FITC-OV A. 
For the release study, pellets were prepared from a powder mixture (Formulation C) 
containing PE-FITC-OVA prepared by physical mixing or freeze-drying. An intricate mix 
of lipids having this ratio of Quil A:cholesterol:PC (2: 1 :2) would be expected to lead to 
formation of ISCOM matrices upon hydration (Demana et al., 2004c ). Release studies 
were also conducted from pellets incorporating additional cholesterol as a strategy to 
decrease the rate of release of the model antigen (PE-FITC-OVA). These pellets were 
prepared by adding different masses of excess cholesterol powder to 5 mg of freeze-dried 
or physically mixed lipid powders. The amount of added cholesterol by weight ranged 
from 0% to 72% of the total weight of the mixed lipid powder. Cholesterol was mixed with 
the freeze-dried powders or physically mixed powders by light trituration with a mortar and 
pestle. The powders were then compressed into small pellets containing approximately 
0.65 mg of PE-FITC-OVA with a punch and die of 2 mm in diameter. All pellets were 
prepared in triplicate. Pellets without PE-FITC-OVA were prepared similarly and used as 
controls. 
4.3.5 Determination of entrapment efficiency 
To determine the amount of PE-FITC-OVA entrapped within colloidal structures formed 





system gently agitated for 2 h at room temperature using a magnetic stirrer. The resulting 
dispersions were then subjected to sucrose density gradient ultracentrifugation (10-60% 
w/w, 18 hat 200,000 g, 10 °C). This process allows for the separation of PE-FITC-OVA 
associated with colloidal structures from free protein (Sjolander et al., 1997a; Konnings et 
al., 2002; Demana et al., 2004b ). Visible bands containing colloids were collected and 
dispersed in 1 ml PBS (O.OlM, pH 7.4). Colloidal structures were subsequently disrupted 
by addition of 50 µ1 of the isolated colloidal dispersion to 750 µ1 PBS (O.OlM, pH 7.4) 
containing 5% Triton X-100. Fluorescence of the resulting solution was measured 
(Shimadzu FR 540, ex. 495 nm, em. 518 nm) and protein content estimated using a 
calibration curve for PE-FITC-OVA in 5% Triton X-100. The presence of lipid 
components was shown not to affect the fluorescence assay. The entrapment of protein 
incorporated into the colloidal particles was expressed as a percentage of the original 
amount of protein present in the pellet. 
4.3.6 Release studies 
The in vitro release of PE-FITC-OVA from compressed pellets was investigated over the 
course of 10 days. Pellets were placed in 2 ml PBS (0.01M, pH 7.4), incubated at 37 °C 
and gently agitated at 25 oscillations/min (Type SS40-2 Incubator, Grant Instruments Ltd, 
Cambridge, England). 150 µl of supernatant was withdrawn at various time points (0.5 to 
233 h) and the volume replaced by the same volume of fresh PBS. Samples were 
centrifuged (Eppendorf Centrifuge 5417C, Hamburg, Germany) at 14,000 g for 10 minutes 
at room temperature to remove any non-colloidal lipid fragments. The supernatants were 
diluted with PBS (O.OlM, pH 7.4) containing 5% Triton-X 100 as appropriate, and the 
amount of PE-FITC-OVA was quantified by fluorescence spectroscopy (Shimadzu FR 






4.3. 7 Characterization of lipid powders 
4.3. 7.1 X-ray powder diffraction (XRPD) 
A Phillips PW 1130/00 diffractometer equipped with a Phillips 1050 goniometer (Phillips, 
The Netherlands) was used to collect X-ray diffraction data for the powders. A copper tube 
coupled with a graphite monochromator was used as the anode material (CuKa, A = 
1.54 lA). Analysis was carried out at room temperature at an acceleration voltage of 40 kV 
and filament emission of 30 mA with 50 steps/degree and 1 second/step. Diffraction 
patterns were collected from 3 - 35 degrees 28 using an aluminium sample holder. The 
XRPD patterns were then graphed using Mac Diffversion 4.0.5 software (Petschick 1998). 
4.3.7.2 Differential scanning calorimetry (DSC) 
Thermograms were recorded using a Pyris 1 DSC (Perkin-Elmer, Connecticut, USA). The 
samples (1-5 mg) were placed in aluminium pans and crimped using a universal crimper 
(Perkin-Elmer, Connecticut, USA). The DSC was calibrated using Milli-Q grade water 
( onset melting temperature of O 0 C) and indium ( onset melting temperature of 156.6 °C) at a 
heating rate of 10 °C/minute. The sample holders were purged with a shield of dry nitrogen 
gas at a pressure of 35 psi. All thermograms were baseline corrected and recorded at the 
same heating rate as the calibration measurements. 
4.3.7.3 Scanning electron microscopy (SEM) 
Powder samples were sputter coated with gold/palladium (Bio-rad E5100, Microscience 
Division, UK). Coated samples were mounted onto specimen stubs with double-sided 
carbon tape and the stubs placed on the scanning electron microscope stage. Samples were 
viewed with a Cambridge S360 scanning electron microscope (Cambridge Instruments, 










4.3.7.4 Polarized light microscopy (PLM) 
Samples were examined using a phase contrast light microscope (Model 218502, Nikon, 
Japan) equipped with polarizer and analyzer (Optiphot, Nikon, Japan) to detect the presence 
of cholesterol crystals in lipid dispersions and powder mixtures. 
4.3.7.5 Transmission electron microscopy (TEM) 
Powder samples, pellets and the collected bands obtained from sucrose density gradient 
ultracentrifugation following entrapment and release studies were suspended in 1 ml of 
PBS (O.OlM, pH 7.4). Powder samples and pellets (with or without PE-FITC-OVA) were 
gently agitated for 2 h using magnetic stirrer before TEM analysis. The collected bands 
were gently vortexed for 10 seconds before TEM analysis. Carbon-coated copper grids 
were glow-discharged (Edwards E306A Vacuum Coater, England) and 10 µ1 of sample 
adsorbed onto these grids. The samples were negatively stained using 10 µ1 of filtered 2% 
phosphotungstic acid, pH 5.2 as a contrast agent. Samples were investigated using a 
Phillips CMlOO transmission electron microscope at an acceleration voltage of 100 kV and 
typically viewed at a magnification of 135,000x. The size of the colloidal structures was 
determined using AnalySIS® software (Soft Imaging Systems, Germany). 
4.3.8 Statistical analysis 
Analysis of variance (ANOVA) followed by Tukey's pairwise comparisons was used to 
assess statistical significance on the entrapment and release data of PE-FITC-OVA from 
various compressed pellets. P values of less than 0.05 were considered statistically 
significant. All statistical tests were run on Minitab® Statistical Software Release 12.1 





4.4.1 Characterization of lipid powder mixtures 
The XRPD diffractograms and DSC thermograms of the various powder mixtures are 
shown in Figure 4.2 and 4.3 respectively. The diffractogram for Quil A only shows a 
'halo', absent of sharp diffraction peaks indicating the material to be X-ray amorphous. 
The thermogram of Quil A does not show a melting peak again implying absence of any 
crystalline order. Diffractograms and thermograms of cholesterol are consistent with those 
of anhydrous cholesterol described in the literature (Garti et al., 1981; Runglertkriangkrai 
1997). The intensity of the diffraction peaks of cholesterol after freeze-drying was 
generally lower in agreement with earlier studies where it has been suggested that freeze-
drying cholesterol leads to a reduction in its crystallinity (Runglertkriangkrai 1997). The 
positions of the diffraction peaks however, did not change, implying that freeze-drying did 
not induce a polymorphic change from anhydrous cholesterol to the monohydrate form. 
The X-ray diffractograms and thermograms of PC are consistent with earlier studies 
(Chapman & Collin 1965; Small 1967; Ladbrooke et al., 1968; Runglertkriangkrai 1997). 
A sharp diffraction peak at about 7° 28 and a peak at approximately 17° 28 is often 
observed with phospholipids and are attributed to lateral spacings of the phospholipids in 
bilayers in the crystalline state (Chapman & Collin 1965; Ladbrooke et al., 1968). The 
thermogram of PC at temperatures below 80 °C shows a broad endotherm which following 
freeze-drying became more defined, again consistent with the literature (Chapman & Collin 
1965; Small 1967). The thermal events of phospholipids at higher temperatures (usually> 
120 °C) may be due to a polymorphic transition of phospholipids from one liquid 
crystalline state to another or to chemical degradation (Chapman & Collin 1965; Small 
1967). 
Lipid powder mixtures of Quil A and PC at a mass ratio of2:1 only show a 'halo' pattern in 
the X-ray diffractogram indicating that the mixtures are X-ray amorphous irrespective of 
the preparation method used to produce the powder mixtures (Figure 4.2, Formulation A). 





crystalline order and suggesting an interaction between Quil A and PC. It is also possible 
however, that the absence of peaks might have been due to trituration process or by dilution 
of PC with amorphous Quil A. Thermal analysis of the freeze-dried Quil A:PC powder 
mixture (Figure 4.3, A fd) did not show any noticeable melting peaks confirming lack of 
crystallinity and an interaction between the Quil A and cholesterol upon freeze-drying. 
However, in the physical mixture a small endotherm at 31 °C can still be observed and 
hence some crystalline PC must persist in the physically mixed powder (Figure 4.3, A pm). 
This suggests that there is less interaction between Quil A and PC when the two are 
physically mixed compared when aqueous dispersions of the two compounds are freeze-
dried. Nevertheless, as discussed above it is again possible that trituration may probably 
reduce crystallinity and dilution with an amorphous substance such as Quil A may further 
mask any peak. 
A close examination of the diffractograms of a 2: 1 mixture of Quil A and cholesterol 
prepared by physical mixing shows few signals of weak intensity attributable to some 
crystalline cholesterol (Figure 4.2, B pm). Thermal analysis of this sample shows a small 
endotherm at 143 °C also attributable to crystalline cholesterol (Figure 4.3, B pm). On the 
other hand, powder mixtures containing Quil A and cholesterol prepared by freeze-drying 
yielded diffractograms having no apparent diffraction peaks (Figure 4.2, B fd) and 
thermograms that did not show a melting peak (Figure 4.3, B fd). This may suggest that a 
stronger interaction occurs between Quil A and cholesterol when aqueous dispersions of the 
two compounds are freeze-dried compared to when the powdered compounds are simply 
physically mixed by trituration. It can however not be excluded that the absence of melting 
peak could have resulted from a reduced crystallinity of cholesterol itself as a result of the 
freeze-drying process, although this peak did persist following freeze drying of cholesterol 
powder (see above). 
For mixtures containing Quil A, cholesterol and PC, similar results as for the binary 
mixtures described above were obtained. Diffractograms for these mixtures are shown in 
Figure 4.2 (C and D). Lipid powder mixtures prepared by freeze-drying showed a reduced 







DSC investigations confirmed these results. The thermograms of freeze-dried powder 
mixtures showed either weak or no melting peaks implying a lower degree of crystallinity 
of cholesterol in these systems (Figure 4.3, C and D). 
SEM micrographs of powder mixtures containing Quil A, cholesterol and PC in a ratio of 
2: 1 :2 (Formulation C) are shown in Figure 4.4. Individual particles are clearly visible in 
the lipid powder mixture prepared by physical mixing. On the other hand, only smaller 
particles were observed in the powder mixtures prepared by freeze-drying. Observation by 
PLM showed less birefringence in the freeze-dried powder compared to mixtures prepared 
by physical mixing, again confirming a reduced crystallinity in the freeze-dried 
formulations. Similar SEM and PLM observations were made for all other formulations 
(i.e. Formulations A, B and D) (Appendix II). The surface appearance of the compressed 
pellets prepared from freeze-dried lipid mixtures was relatively smooth compared to that of 
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Figure 4.2 Diffractograms of Quil A, cholesterol and phosphatidylcholine 
(PC) and Quil A-lipid powder mixtures. A: Quil A:PC, mass ratio 2:1, B: 
Quil A:cholesterol, mass ratio 2: 1, C: Quil A:cholesterol:PC, mass ratio 2: 1 :2, 
D: Quil A:cholesterol:PC, mass ratio 3:6: 1. fd: freeze-drying, pm: physical 
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Figure 4.3 Thermograms of Quil A, cholesterol and phosphatidylcholine 
(PC) and Quil A-lipid powder mixtures. A: Quil A:PC, mass ratio 2: 1, 
B: Quil A:cholesterol, mass ratio 2: 1, C: Quil A:cholesterol:PC, mass 
ratio 2: 1 :2, D: Quil A:cholesterol:PC, mass ratio 3 :6: 1. fd: freeze-







Figure 4.4 SEM micrographs of ternary lipid powder mixtures and the 
respective compressed pellets (Formulation C with Quil A:cholesterol:PC mass 
ratio 2: 1 :2). Pellets were prepared by compressing either lipid powder mixtures 








4.4.2 Characterization of aqueous colloidal dispersions 
Hydration of compressed pellets prepared from freeze-dried powders composed of Quil A 
and PC (Formulation A) lead to the formation of lipidic particles as evidenced by TEM 
(Figure 4.5A, fd). These lipidic particles appeared to have a layered structure (arrow) as 
previously reported (Demana et al., 2004c ). For · compressed pellets prepared from 
physically mixed powders, larger lipidic particles were observed having a less apparent 
layered morphology (Figure 4.5A, pm). 
Pellets composed of Quil A and cholesterol (Formulation B) prepared by compression of 
freeze-dried powders yielded worm-like micelles upon hydration (Figure 4.5B, fd) again in 
agreement with previous observations reported in Chapter 2 and 3 (Demana et al., 2004b; 
Demana et al., 2004e; Demana et al., 2004c). In contrast, hydration of pellets prepared by 
compression of physical mixtures did not result in the formation of such micelles as 
expected from the pseudo-ternary diagram of the three components (Figure 1 ). An electron 
micrograph of the particles formed when pellets of physically mixed Quil A and cholesterol 
are hydrated is shown in Figure 4.5B (pm). Without freeze-drying, few worm-like micelles 
were observed, and instead predominantly Quil A micelles and cholesterol crystals were 
found in the system. 
Spontaneous formation of ISCOM matrices occurred when pellets compressed from the 
freeze-dried powder mixture consisting of Quil A, cholesterol and PC (Formulation C) 
were hydrated (Figure 4.5C, fd). Together with these colloidal structures, individual ring-
like micelles were also observed as a minor colloidal structure (< 5 % of particles). 
ISCOMs were not evident when pellets having the same composition but prepared by 
physically mixing the components were hydrated. Instead of ISCOM matrices, worm-like 
and ring-like micelles were observed (Figure 4.5C, pm). Analysis of these samples by 
PLM revealed the presence of cholesterol crystals which were not evident in dispersions 
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Results for Formulation D containing Quil A, PC and a higher proportion of cholesterol 
(60% w/w) compared to Formulation C is shown in Figure 4.5D. For pellets prepared from 
the freeze-dried powder, lamellae structures having a hexagonal pattern were observed to 
form spontaneously, resulting from the aggregation of ring-like micelles (Kersten et al., 
1991; Demana et al., 2004e; Demana et al., 2004c). No spontaneous formation of lamellae 
was observed from the pellets prepared from powders of the physical mixture, rather a 
mixture of worm-like and ring-like micelles was again observed. PLM revealed a relatively 
high abundance of crystalline cholesterol crystals in these systems which was not evident in 
systems produced from the freeze-dried powders. 
4.4.3 Entrapment and release of PE-FITC-OV A 
Aqueous dispersion of compressed pellets made from either freeze-dried or physically 
mixed lipid powders containing PE-FITC-OVA, formed the same colloidal structures as 
those for protein free systems and shown in Figure 4.5 (refer to Appendix III for other 
micrographs). This is in agreement with previous findings reported in Chapter 3 where 
incorporation of protein into various colloidal particles from different regions of the 
pseudo-ternary diagram (Figure 4.1) did not change the morphology or size of the colloids 
(Demana et al., 2004b ). 
Figure 4.6 shows the entrapment efficiency of PE-FITC-OVA into colloidal structures 
formed upon dispersion of the compressed pellets (Formulation C and D) in PBS. For all 
pellets investigated (i.e. Formulation C and D), entrapment efficiency of PE-FITC-OVA 
was higher in colloids formed from hydrating pellets compressed from freeze-dried 
powders than from those prepared from physically mixed powders (P < 0.05). Formulation 
E has the same composition as Formulation C except prepared by physically mixing the 
freeze-dried lipid powder with PE-FITC-OVA i.e. the PE-FITC-OVA was not incorporated 
prior to the freeze-drying step. Entrapment efficiency of PE-FITC-OVA into Formulation 











Figure 4.7 shows the release of PE-FITC-OVA from pellets (Formulation C) made by 
compression of physically mixed powders (Figure 4.7a), and freeze-dried powders (Figure 
4.7b). Varying amounts of cholesterol were physically mixed with these lipid powder 
mixtures prior to compression. The results demonstrate that adding cholesterol to the 
powder mixtures slowed down the rate of PE-FITC-OVA release. Regardless of the 
amount of cholesterol added however, about 50% or more of PE-FITC-OVA was released 
within the first 48 h from pellets prepared from the compression of powders produced by 
physical mixing (Figure 4.7a). For pellets prepared from freeze-dried powders, only those 
containing 5 and 15 % cholesterol released more than 50 % of their protein load within the 
first 24 hours. Thus, it is apparent that cholesterol is better able to control the release of 
protein from lipid matrices prepared from freeze-dried powders than powders prepared by 












Figure 4.5 TEM micrographs of aqueous dispersions of compressed pellets: A: 
Quil A:PC, mass ratio 2: 1 (lipidic particles, arrows indicate layered morphology), 
B: Quil A:cholesterol mass ratio 2: 1 (worm-like micelles, fd). All pellets were 
prepared by compressing either lipid powder mixtures produced by physical 







Figure 4.5 (Continued) TEM micrographs of aqueous dispersions of compressed 
pellets. C: Quil A:cholesterol:PC, mass ratio 2: 1 :2, worm-like micelles (pm), 
and ISCOMs (fd), D: Quil A:cholesterol:PC, mass ratio 3:6:1, worm-like 
micelles (pm), and lamellae (fd). All pellets were prepared by compressing 
either lipid powder mixtures produced by physical mixing (pm) or lipid powder 































E (matrix (fd) + protein) 
Entrapment efficiency of PE-FITC-OVA within colloidal 
structures formed upon dispersion of compressed pellets in PBS (O.OlM, pH 
7.4) (entrapment as a percentage of original amount of protein in the 
formulations). All formulations were composed of a total lipid:protein mass 
ratio of 6.7: 1. The composition of Formulation Eis similar to Formulation C 
except that in Formulation E, PE-FITC-OVA was physically mixed with the 
freeze-dried lipids. All pellets were prepared by compressing either lipid 
powder mixtures produced by physical mixing (pm) or lipid powder 
mixtures produced by freeze-drying (fd). Results are mean ± S.D. (n = 4). 
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Figure 4.7 Release of PE-FITC-OVA from compressed pellets (Formulation C 
with a total lipid:protein mass ratio of 6.7:1). Pellets were prepared by 
compressing either lipid powder mixtures produced by physical mixing (a) or 
freeze-drying (b ). The amount of additional cholesterol added to the lipid 
powder mixtures is given as a percentage of the total weight of the powder 













In general, the physical properties of the powder mixtures investigated using XRPD, DSC, 
SEM and PLM clearly demonstrated differences between samples prepared by physical 
mixing and those prepared by freeze-drying. The significance of these differences on the 
spontaneous formation of ISCOM matrices and other, related colloidal structures upon 
hydration was investigated by negative staining TEM. 
From the results of TEM shown in Figure 4.5, it would appear that compression of the 
freeze-dried lipid powders into pellets does not affect the ability of these systems to form 
the colloidal structures expected from the pseudo-ternary diagram of the three components 
(Demana et al., 2004c). It is also apparent that simply physically mixing the three 
components as powders and compressing this into pellets yields systems which behave 
differently from freeze-dried systems. Pellets produced by physically mixing the three 
components produce worm-like micelles as the predominant colloidal structure. The type 
of colloid formed appears to be independent of the ratio of the three components used for 
the preparation of the pellets. The relatively high amount of crystalline cholesterol in such 
powder mixtures is probably the reason for this, as it would appear that this is not available 
for immediate incorporation into the colloidal structures. 
The entrapment efficiency of PE-FITC-OVA into colloidal structures within the pellets is 
shown in Figure 4.6 ( only Formulations C and D were investigated in this study). 
Formulations C and D prepared from freeze-dried powders spontaneously form ISCOMs 
and lamellae structures respectively upon hydration. ISCOMs are known to entrap a 
variety of amphiphatic antigens (Barr et al., 1998; Konnings et al., 2002; Demana et al., 
2004b) and we have also demonstrated that amphipathic proteins are efficiently 
incorporated into lamellae (Chapter 3 (Demana et al., 2004b ). In contrast, Formulations C 
and D prepared by physical mixing produce predominantly worm-like micelles upon 
hydration. In Chapter 3, it was also shown that worm-like micelles do not incorporate 






The results shown in Figure 4.6 also demonstrate that entrapment of PE-FITC-OVA into 
lamellae structures (Formulation D) was greater than into ISCOMs. The higher amount of 
cholesterol present in the lamellae structures and hence increased lipophilicity (Kersten et 
al., 1991; Demana et al., 2004e; Demana et al., 2004c) is probably not only the reason for 
the aggregation of ring-like micelles into lamellae but also the reason for the higher 
encapsulation efficiency for PE-FITC-OVA found with these structures (Demana et al., 
2004b). 
Figure 4.6 also shows the entrapment of PE-FITC-OVA in a formulation (E) which has the 
same compositions as Formulation C except prepared by physically mixing the freeze-
dried lipid powder with PE-FITC-OVA i.e. the PE-FITC-OVA was not incorporated prior 
to the freeze drying step. It can be seen that entrapment of protein is much less if the 
protein is not freeze-dried together with the lipid components. Some association is 
however observed suggesting that antigen can be incorporated into pre-formed ISCOMs. 
The increased adjuvanticity of empty ISCOMs when mixed with antigen (Windon et al., 
2001) may thus, at least in part, be attributed to the incorporation of antigen into pre-
formed ISCOM matrices (Kersten & Crommelin 2003). 
Most of the pellets prepared from the compression of physically mixed powders were 
observed to swell and fragment within 48 h upon in contact with the dissolution medium. 
Both Quil A and the PE-FITC-OVA are water-soluble and hence upon contact of the pellet 
with water it is likely that these two components, which constitutes 30 % of the pellet, 
dissolve forming channels throughout the compressed matrix. A physical mix of 
formulation C yields ring- and worm-like micelles upon dispersion of the pellet in water 
(Figure 4.5, C). Thus, the Quil must dissolve with some lipid to produce these micelles but 
a large proportion of cholesterol and phospholipids remains as solid particles. The channels 
produced lead to the fragmentation of the pellets exposing a greater surface area from 
which the protein is released. In contrast, compressed pellets prepared from powders 
produced by freeze-drying were visually intact for at least 72 h when in contact with the 
dissolution medium, especially those containing > 15 % of additional cholesterol. Pellets 
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prepared from freeze-dried powders of formulation C produce ISCOMs upon hydration 
(Figure 4.5, C fd) suggesting that most of the Quil A is bound and hence released within 
ISCOMs. It is also likely that much of the protein is associated with ISCOMs following 
freeze-drying as evidenced by the data of Figure 4.6. Hence, these water-soluble 
components are not available for immediate dissolution and release as they are in pellets 
prepared from physical mixtures. Consequently, channels do not form as readily within 
pellets produced from freeze-dried powders and the matrices remain intact for longer 
resulting in a more sustained release of the protein. To investigate whether PE-FITC-OV A 
released from the pellets was actually incorporated into ISCOMs, samples of the release 
medium were taken at various times and investigated by TEM following sucrose density 
gradient ultracentrifugation. The fluorescent band obtained at a density of approximately 
30 % w/w sucrose upon ultracentrifugation suggested that the protein was indeed associated 
with ISCOMs (Kersten et al., 1991; Sjolander et al., 1997a; Johansson & Lovgren-
Bengtsson 1999; Demana et al., 2004b). The supernatant was observed to be non-
fluorescent implying that most of the protein (if not all) was released entrapped into 
ISCOM structures. The presence of ISCOMs in the 30% w/w sucrose band was confirmed 
by TEM. Hence, protein was released from these pellets prepared using freeze-dried 
powders in the form of ISCOMs and this did not appear to be influenced by the presence of 
additional cholesterol within the pellets. 
Using Quil A incorporated into phospholipid and cholesterol implants prepared from the 
physically mixed powders, poor immune response compared to two times antigen solution 
injections has been demonstrated (Walduck et al., 1998). This was possibly because the 
antigen was released quickly from the implants prepared from the physically mixed 
powders, and also because the antigen was not released incorporated within the ISCOM 
structure. However, in the current study, at longer sampling times, some ISCOMs were 
observed in the dispersion medium of pellets produced by compression of physically mixed 
powders suggesting that upon extended equilibration times ISCOMs form in the presence 






This study shows that simple physical mixing of Quil A, cholesterol and phospholipid with 
or without antigen in ratios known to form ISCOMs or related colloidal structures upon 
hydration does not lead to spontaneous formation of the expected colloids. In contrast, 
freeze-drying of aqueous dispersion of the polar lipids was a better mixing technique to 
produce solid mixtures that spontaneously formed the expected colloids upon hydration. 
The study also demonstrates that compression of the freeze-dried powders into pellets did 
not adversely affect the ability of the mixtures to spontaneously form the expected colloidal 
structures upon hydration. Incorporation of an amphipathic protein (PE-FITC-OVA) in the 
aqueous lipid dispersion before freeze-drying resulted in a large percentage of the protein 
being released from compressed pellets in the form of ISCOMs. This was not observed if 
the protein is simply physically mixed with the lipid components. Further, it was 
demonstrated that it is possible to control the release rate of ISCOMs containing protein 
from compressed pellets by incorporating additional cholesterol, physically mixed with the 
freeze dried powder. These sustained release matrices of ISCOMs based on freeze-dried 
powders of Quil A, cholesterol, phospholipids (ratio 2: 1 :2) and amphipathic protein are 
expected to be better delivery systems for sub-unit antigens than previously studied 
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It is now well recognised that antigen taken up within particles is presented to the immune 
system more effectively by antigen presenting cells (APCs) than antigen taken up from 
solution (Hoglund et al., 1989; Morein et al., 1990). Much interest in the uptake of antigen 
by the APCs is currently focused on lipid-based nanostructures such as ISCOMs (Bungener 
et al., 2002; Kersten & Crommelin 2003) because it has been demonstrated that colloidal 
particles rather than microparticulate systems are generally better taken up by the APCs and 
hence often induce a relatively strong immunological response (Morein & Bengtsson 1998; 
Sjolander et al., 1998; Jenkins 1999; Bungener et al., 2002). It is thought that the colloidal 
size of the delivery systems mimics the submicroscopic particulate nature of a pathogen 
(Hoglund et al., 1989; Morein & Bengtsson 1998; Sjolander et al., 1998). Most studies 
investigating the uptake of particulate antigen systems by APCs have used macrophages 
(Schafer et al., 1992; Chavany et al., 1994; Roser et al., 1998; Torche et al., 1999; Whyte 
et al., 2000; Thiele et al., 2001; Ahsan et al., 2002). Macrophages have an inherent 
phagocytic role, removing particulate matter including microorganisms and dead cells from 
the body (Raitt et al., 1998; Shen & Louie 1999). However, despite having a role in 
inducing and regulating the immune response, macrophages, unlike the dendritic cells (DC) 
(Chapter 1), are incapable of stimulating na'ive T cells (Inaba et al., 1990; Thiele et al., 
2001). 
DC are currently considered to be the most potent APCs (Bhardwaj 2001; Robson et al., 
2003b; Wang et al., 2003), essential for the initiation of the immune response with 
extraordinary capacity for inducing differentiation of na'ive CD4+ or CDS+ cells into helper 
and cytotoxic T cells respectively in both primary and secondary T cell responses (Bell et 
al., 1999; Thiele et al., 2001). DC are present in low numbers throughout the body in 
lymphoid and non-lymphoid tissues (Bell et al., 1999). As described in Chapter 1, they are 
derived from myeloid cells in the bone marrow and circulate in the blood stream as 
'precursor DC'. When they extravasate, particularly to tissues which interface with the 
external environment and which are frequently insulted by microorganisms, they develop 





Bhardwaj 2001). Immature DC are well equipped to acquire both particulate and soluble 
antigen by phagocytosis, receptor-mediated endocytosis and macropinocytosis (Bell et al., 
1999; Banchereau et al., 2000; Bowers 2001). Uptake of antigen and exposure to 
inflammatory cytokines induces maturation of the cell (Figure 5 .1) (Banchereau et al., 
2000), characterized by downregulation of antigen uptake and processing, migration to the 
local draining lymphoid tissue and the concurrent upregulation of antigen presenting 
function. The maturation process itself is associated with several coordinated events such 
as loss of endocytic/phagocytic receptors, increased expression of class II MHC molecules, 
upregulation of costimulatory molecules expressed on the surface such as CD40, CD58, 
CD80 and CD86, and changes in morphology (Banchereau et al., 2000). The CD40, CD86 
and MHC class II molecules are commonly used as indicators of the activation of DC 
(Maloy et al., 1995a; Swain et al., 1999; Banchereau et al., 2000; Beacock-Sharp et al., 
2003; Robson et al., 2003c), and hence were therefore used in the investigations reported in 
this chapter relating to the activation of DC by different particulate antigen delivery 
systems. 
The DCs are important for presenting the antigen to the T cells. Following presentation of 
antigen to the T-cells, certain molecules are expressed indicating activation or proliferation 
of the T cells (Kapsenberg et al., 1998; Bell et al., 1999; Banchereau et al., 2000). One of 
the popular molecule used for investigation of T-cell activation and proliferation is CD25, 
which is the IL-2 receptor a-chain (Banchereau et al., 2000; Cavani et al., 2003; Cozzo et 
al., 2003) (Chapter 1). Therefore, this molecule was used in this study for investigation of 
the effect of different particulate antigen delivery systems on the activation and 
proliferation of T-cells following uptake of antigen by the DC. 
Owing to the increasingly recognised importance of DC in the induction of the immune 
system, the uptake of particulate antigen delivery systems has been investigated both in 
vivo (Alpar et al., 1989; Lefevre et al., 1989; Jani et al., 1990), and in vitro using cell 
cultures or cell lines (Scheicher et al., 1992; Reece et al., 2001; Thiele et al., 2001; Robson 
et al., 2003b ). Using cell cultures/cell lines of DC often allows better and more ready 






the biological environment and reduces the cost and ethical implications of the in vivo 
investigations (Copland et al., 2003; Pitaksuteepong 2003). However, to ensure that data of 
in vitro cell cultures/cell lines can be extrapolated back to the in vivo situation, the selection 
of the cell culture model for investigating particulate uptake must be appropriate 
(Pitaksuteepong 2003). 
ANTIGEN PRESENTATION 
Figure 5.1 Schematic representation of a life circle of DC (adapted from 
Banchereau et al., 2000). At the site of inflammation, immature DC capture 
antigen to process it and then migrate to lymph nodes where they undergo a 
process of various changes including expression of surface molecules. In the 
lymph node, the mature DC selectively activate lymphocytes that are specific 
for the antigen presented on the surface of the DC. These lymphocytes 
subsequently enter the blood stream as effector cells, attacking the antigen 
they are directed against. 
The in vitro uptake of antigen-loaded nanoparticles such as ISCOMs by DCs has recently 
also received some attention (Le et al., 2001; Bungener et al., 2002; Robson et al., 2003c). 
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DC cultures suitable for assessmg particle uptake can be obtained by culturing and 
differentiating cells isolated from human (e.g. peripheral-blood mononuclear cells) (Reece 
et al., 2001; Thiele et al., 2001) or animals (e.g. bone-marrow derived DC) (Scheicher et 
al., 1992; Denis-Mize et al., 2000; Mendoza et al., 2002; Nesbum et al., 2002; Robson et 
al., 2003b; Vassiliou et al., 2003). In the current study, murine bone-marrow derived DCs 
were chosen as appropriate cells for investigation of delivery of antigen to DCs. 
When investigating the interaction of cell cultures with particulate antigen delivery carriers, 
it is important to consider the cytotoxicity of such systems to the cells (Kensil 1996; Barr et 
al., 1998; Pitaksuteepong 2003). Otherwise, interpretation of results obtained on the uptake 
of antigen, activation of APCs, and T-cell proliferation may become difficult and 
meaningless. This is because in such circumstances, the toxicity may somewhat be 
artificial and not indicative of the biocompatibility of the delivery system in a "whole" 
biological system (Pitaksuteepong 2003). This becomes even more important in cell 
cultures where the local concentration of the degradation products can become quite high in 
the absence of systems to eliminate these. Therefore, a preliminary experiment was 
conducted in this study to investigate the viability of DC following exposure to different 
particulate antigen delivery systems. 
5.2 Chapter aim 
As discussed above, the delivery of antigen to the APCs (particularly DC) in form of 
particles is often superior to the delivery of the same antigen in solution. Although 
ISCOMs and liposomes have been characterized previously as antigen delivery systems or 
as adjuvants (Kersten & Crommelin 2003), there is however, little information in the 
literature on the delivery and immunological properties of ISCOMs and other related 
colloidal particles prepared by the hydration method, which contain the built-in adjuvant 
Quil A in their structure, such as the ring-like micelles (Demana et al., 2004c) (Chapter 2). 
From the results in Chapter 3 and 4 (Demana et al., 2004b; Demana et al., 2004d), it was 
demonstrated that different particulate systems were capable of incorporating a model 








method as antigen carriers, chosen from the different regions of the pseudo-ternary 
diagram, the objectives of this study were: 
1. to investigate the in vitro delivery of a model antigen formulated in three different 
lipidic particles (liposomes, ISCOMs and ring-like micelles) to murine bone-
marrow derived DC 
2. to investigate whether the three different particulate antigen delivery systems are 
able to prime receptor-transgenic T-cells directed against an epitope within a model 
antigen and hence show some characteristics of activation or proliferation of these 






5.3 Materials and methods 
5.3.1 Materials 
Phycoerythrin conjugated antibodies to mouse cell surface markers (CD40, CD86, and 
MHC-II), allophycocyanin (APC) labelled anti mouse CD25, APC labelled anti mouse 
CDl lc, 2.402 antibody, streptavidin-PerCP, streptavidin-PE, and propidium iodide were 
obtained from PharMingen, Becton Dickinson, California, USA. Carboxyfluorescein 
diacetate succinimidyl diester (CFSE) was purchased from Molecular Probes, Oregon, 
USA. Iscove's modified Dulbecco's medium (IMDM), foetal calf serum, 2-
mercaptoethanol, a solution of 10,000 IU/ml penicillin G sodium, 10000 µg/ml 
streptomycin sulfate in 0.85% saline, glutamax, and biotin were purchased from GIBCO 
BRL, Life Technologies Limited, Melbourne, Australia. Recombinant macrophage colony 
stimulating factor (rGM-CSF) was kindly supplied by Dr G. Buchan, University of Otago. 
Sodium azide was obtained from BDH Laboratories Supplies, Poole, England. Trypan blue 
solution, ovalbumin (OVA), and fluorescein isothiocynate (FITC) were obtained from 
Sigma-Aldrich Pty Ltd, Missouri, USA. Fluorescein isothiocynate labelled ovalbumin 
conjugated to phosphatidylethanolamine (PE-FITC-OVA) was synthesized as described in 
Chapter 3. All other chemicals and solvents were of at least analytical grade. 
5.3.2 Mice 
Male and female C57B 1/6J mice serving as source for bone marrow stem cells to grow 
bone marrow derived dendritic cells were bred and maintained in micro-isolators under 
specific pathogen-free conditions at the Hercus Tairei Resource Unit (HTRU), University 
of Otago. Male and female OT-1 transgenic mice supplying the need for antigen-specific 
splenocytes/T-cells (experimental antigen used was ovalbumin) were also obtained from 




5.3.3 Preparation of formulations 
All formulations were prepared by the hydration method described in Chapters 2 and 3. 
Formulations containing antigen (PE-FITC-OVA) with a total lipid:PE-FITC-OVA 
mass ratio of 6. 7: 1 were prepared by the same method as described in Chapter 3 
(Demana et al., 2004b). Formulations without antigen were also prepared and used as 
controls. Briefly, dried thin lipid films of required amounts of 
phosphatidylethanolamine and cholesterol at a constant mass ratio of 3: 1 were hydrated 
with aqueous solution of Quil A (with or without antigen), resulting in 0%, 20% and 
70% of Quil A in the final formulations, and 1 mg/ml PE-FITC-OVA for antigen 
containing formulations . Formulations were chosen to represent colloidal structures 
found in the different regions of the pseudo-ternary diagram as described in Chapter 2 
(Demana et al. , 2004e). The pseudo-ternary diagram showing the position of the final 
preparations chosen for investigation in this study, is shown in Figure 5.2. All 











• ISCOM matrices 
• ring-like micelles 
• worm-like micelles 
lipidic/layered structures 
1 liposomes 
• Quil A micelles 
'=' cholesterol crystals 
1 lamellae 
100 
60 50 40 30 20 10 0 
Cholesterol 
Figure 5.2 Pseudo-ternary diagram of aqueous mixtures of Quil A, 
cholesterol and phosphatidylethanolamine (Demana et al., 2004e) showing the 
position of the liposome (A), ISCOMs (B) and ring-like micelles (C) 






5.3.4 Characterization of colloidal particles and antigen incorporation 
The morphology and size of different colloidal particles following sucrose density gradient 
ultracentrifugation (Section 3.3.7.3) was determined by negative staining transmission 
electron microscopy (TEM) as described in Chapter 2. Quantification of the antigen 
incorporated into the different particles was determined fluorimetrically as described in 
Chapter 3 (Demana et al., 2004b ). 
After measuring the relative antigen incorporation rates, the amounts of empty (i.e. no 
antigen) and antigen containing formulations were adjusted to give preparations containing 
equal amounts of PE-FITC-OVA and total lipid in order to compare various formulations 
for their immunological effects on the cultured cells. 
5.3.5 General cell culture conditions 
All cells were grown in IMDM + 5% foetal calf serum (FCS) + 1 % glutamax + 1 % 
antibiotics (penicillin + streptomycin) + 0.1 % of 2-mercapto-ethanol, referred to as 
cIMDM or complete medium. Cells were cultured in an incubator, keeping temperature 
and CO2 content constant at 37 °C and 5%, respectively. In some cases, 20 or 10 ng/ml of 
rGM-CSF was added to either differentiate stem cells from the dendritic cells or to keep the 
latter ones alive (Scheicher et al., 1992). All cultures were microscopically checked for 
contamination on a daily basis. 
5.3.6 Generation and activation of bone-marrow derived dendritic cells (BMDC) 
BMDC were generated by culturing bone marrow derived stem cells from C57Bl/6J mice 
in cIMDM with 20 ng/ml recombinant granulocyte/macrophage colony stimulating factor 
(clone kindly supplied by Dr G. Buchan, University of Otago) for 6 days at 37 °C, 5% CO2• 






BMDC viability after the 48 hour pulse was assessed by trypan blue exclusion and the 
percent live cells were calculated. Uptake of the formulations by CD 11 c +ve cells was 
measured by flow cytometry (FACScalibur, Becton Dickinson, USA) 48 hours after the 
addition of the various formulations. Cells were stained with antibodies and propidium 
iodide according to the manufacturer's instructions. Data was analysed using CellQuest 
Pro (Becton Dickinson, USA) and the fold increase in FITC positive CD 1 lc +ve cells 
calculated by dividing the % CD 11 c +ve cells fitc positive after incubation with the 
formulations by the% CDl lc+ve cells fitc positive in the negative control (no formulation). 
The fold increase in mean fluorescence intensity (MFI) was similarly calculated by dividing 
the MFI of CD 11 c +ve cells after incubation with the formulations by the MFI of CD 11 c +ve 
cells in the negative control (no formulation). Activation of BMDC was measured by flow 
cytometric analysis of the activation markers CD86 and CD40 on propidium iodide -ve, 
CD 11 c +ve cells 48 hours after the addition of the various formulations. The fold increase in 
CD86hi or CD40hi BMDC was calculated by dividing the% CD86hi or CD40hi' propidium 
iodide -ve, CDl lc+ve cells activated by each formulation by the % CD86hi or CD40hi' 
propidium iodide -ve, CD 11 c +ve cells in the negative control. 
5.3. 7 T cell prolif era ti on and activation 
To examme the ability of the formulations to stimulate antigen specific lymphocyte 
proliferation and activation, BMDC pulsed with the various formulations for 48 hours were 
washed to remove excess formulation and incubated with OT-I splenocytes stained with 
carboxyfluorescein succinimidyl ester (CFSE) for 72 hours. CFSE couples covalently with 
various intracellular proteins and is partitioned equally between daughter cells as initially 
stained cells proliferate (Parish 1999). A brief illustration of mechanism of CFSE staining 
is shown in Figure 5 .3. 
CFSE staining and CD25 expression on OT-1 transgenic T cells were measured by flow 
cytometry. Data was analysed using CellQuest Pro. The fold increase in proliferation was 







formulation-pulsed-BMDC by the % proliferated OT-1 transgenic T cells in the negative 
control (T cells incubated with BMDC not pulsed with any formulation). 
The rather lipophilic and non-
fluorescent CFSE( or CFDA-
SE) can easily diffuse into the 
cytosol, where esterases 
irreversibly hydrolyse the two 
ester-bonds to entrap the now 
fluorescent molecule. Very 
stable non-diffusing 
conjugates (CFR) are formed 
when the highly reactive 
succinimidyl moiety is 
attacked by free amino groups 
resulting in an amide bond to 
intracellular peptides (Parish 
1999) 
Cell exterior slow 
Cell membrane 
Figure 5.3 Schematic representation of a mechanism of CFSE-staining 
(adapted from Parish 1999). 
5.3.8 Statistical analysis 
A one-way analysis of variance (ANOVA) was used to assess statistical significance on the 
incorporation of PE-FITC-OVA in various formulations. The same tests were also used to 
assess statistical significance between the levels of expression of cell surface markers for 





ofless than 0.01 or 0.001 were considered statistically significant. All statistical tests were 





5.4.1 Characterization of colloidal particles 
Preparation of three formulations i.e. liposomes (0% Quil A), ISCOMs (20% Quil A) and 
ring-like micelles (70% Quil A) by the hydration method was successful as seen by TEM 
(Figure 5.4). The phospholipid and cholesterol formulation (i.e. 0% Quil A) formed 
liposomes with the characteristic bilayer wall enclosing an aqueous core. The addition of 
20% Quil A disrupted the bilayers and regular spherical cage-like structure of about 40 nm 
was formed. The size and morphology of these particles are characteristics of ISCOMs 
(Chapters 2, 3 and 4) (Kersten & Crommelin 1995; Sjolander et al., 2001a; Demana et al., 
2004c ). With the addition of 70% Quil A the liposome structures were broken down 
further and small ring-like micelles of 10 nm in diameter were formed. All these structures 
were similar to those found in Chapter 3 (Demana et al., 2004b) and hence again 
suggesting that the nature and the amount of antigen incorporated into these particles does 
not affect the morphology, size or prevalence of the structures formed. 
5.4.2 Incorporation of antigen into the formulations 
Of key importance to any particulate delivery system is the amount of antigen that can be 
loaded into or onto the particles. This is important for the efficacy of the product in vivo 
but is also an important practical consideration as formulations with low antigen 
incorporation will be expensive to produce. As discussed in Chapter 1, an advantage of 
liposomes is the wide variety of antigens that can be incorporated into them. Hydrophilic 
antigens can be loaded into the aqueous core while lipophilic antigens can be incorporated 
into the lipid bilayer. However as the addition of Quil A to liposomes destroys the lipid 
bilayer there is no longer an enclosed aqueous core in which to load hydrophilic antigens. 
Therefore in order for an antigen to be incorporated into Quil A containing formulations, 
the antigen must have a lipophilic domain in its chemical structure. For this reason the 
model antigen used was OVA conjugated to PE. A fluorescent tag (FITC) was also added 




less than 30% (Figure 5.5). Antigen incorporation decreased significantly with the addition 
of Quil A (26% incorporation with 0% Quil A down to 18% incorporation with 20% Quil 
A). The amount of Quil A added also had an affect on incorporation with PE-FITC-OVA 
incorporation decreasing with increasing Quil A concentration (18% incorporation with 
20% Quil A down to 7% incorporation with 70% Quil A). 
In contrast to the results described in Chapter 3, the incorporation of PE-FITC-OVA into 
ISCOMs is less compared to that in liposomes. The reason for this is possibly due to 
physical instability of liposomes as it is well known that upon storage these structures do 







Figure 5.4 Electron micrographs of formulations. A: 0 
% Quil A (liposomes), B: 20 % Quil A (ISCOMs), C: 
70 % Quil A (ring-like micelles). The total lipid:protein 
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Figure 5.5 Incorporation of PE-FITC-OVA into formulations containing 
0 %, 20 % and 70% Quil A (amount incorporated as a percentage of 
original amount of protein). Results are mean ± S.D., n = 3. The 
asterisks represent statistically significant differences between specified 
samples. 
5.4.3 Uptake of formulations by BMDC 
As shown in Figure 5.5, incorporation of antigen into the formulation was not the same for 
all formulations. However, for the studies examining uptake and activation it is required 
that the same amount of lipid and PE-FITC-OV A was delivered to the cells. In order to do 
this, two preparations of each formulation were made, one containing PE-FITC-OVA and 
one without antigen. Using the incorporation data the preparations were mixed to give a 
stock formulation containing 100 µg/ml of lipid and 1 µg/ml PE-FITC-OV A. The uptake 
of antigen by BMDC could then be directly compared (Figure 5.6). As expected, the 
number of cells taking up PE-FITC-OV A increased with the addition of increasing amounts 
of formulation (Figure 5.6 A). The formulation containing no Quil A was taken up by 
significantly more CD 11 c +ve cells than the Quil A containing formulations. This was even 
more impressive considering over half of the 0% Quil A formulation contained no antigen. 
Examination of uptake of the Quil A containing formulations showed that increasing the 







formulation. The amount of antigen taken up by CDllc+ve cells was examined by 
measuring the increase in mean fluorescence intensity (MFI) of FITC+ve cells. Again it was 
the 0% Quil A containing formulation that had the highest uptake (Figure 5.6 B). 
Interestingly, with the 20% Quil A containing formulation, although there was a 25 fold 
increase in the number of BMDC taking up antigen (Figure 5.6 A), the BMDC took up 
significantly lower amounts of 20% Quil A containing formulation as compared with the 
0% Quil A containing formulation. This data shows that the number of cells taking up 
antigen and the amount of antigen taken up by the cells can vary considerably in response 
to the composition of the formulation. 
5.4.4 Viability of BMDC 
As described in the introduction section of this chapter, a viability study was necessary in 
order to explain the results obtained for the uptake of antigen by DC, activation of DC, and 
T-cell proliferation as it is well recognised that cytotoxicity of DC should be taken into 
consideration in using cell cultures in order to investigate interaction between delivery 
systems and the cells (Kensil 1996; Barr et al., 1998; Pitaksuteepong 2003). This was also 
important because the adjuvant Quil A has been reported to be haemolytic both in vitro and 
in vivo (Kersten & Crommelin 1995; Kensil 1996; Barr et al., 1998). The haemolytic 
activity of Quil A however, is reduced upon incorporation of the adjuvant into colloidal 
particles (Kersten et al., 1991; Barr et al., 1998; Sjolander et al., 1998). 
The viability of cells in culture after 48 hours incubation with the various formulations was 
examined (Figure 5.7). The viability of cells cultured for 48 hours without antigen was 
greater than 90%. Addition of the 0% Quil A formulation at concentrations ranging from 1 
- 50 µg/ml resulted in a modest decrease in viability (greater than 80% viable cells at 50 
µg/ml) indicating that cholesterol and PE were not themselves toxic. However the addition 
of Quil A to the liposomes resulted in a significant concentration dependent decrease in 
viability. At lipid concentrations of 50 µg/ml the viability of cells pulsed with the 20% 
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Quil A formulation was only 30%. Increasing the Quil A concentration from 20% to 70% 
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Figure 5.6 Uptake of PE-FITC-OVA colloidal formulations by BMDC. 
Formulations containing the same amount of PE-FITC-OVA, but either 0% (+), 
20% (•) or 70% (t:.) Quil A were incubated with BMDC for 48 hours. FITC 
fluorescence of CDl lc positive cells was measured by flow cytometry. The fold 
increase in FITC+ve CDl lc cells (A) and the fold increase in mean fluorescence 
intensity (MFI) in the FITC+ve cells (B) is shown. Results are mean± S.D., n = 
3. t p < 0.01 vs cells pulsed with 20% Quil A containing formulations. t p < 
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Figure 5. 7 Viability of BMDC following incubation with colloidal 
formulations containing Quil A. Formulations containing the same 
amount of PE-FITC-OVA, but either 0% (+), 20% (II) or 70% (6) 
Quil A were incubated with BMDC for 48 hours. Viability of BMDC 
was determined by staining cells with Trypan Blue. Results are mean 
± S.D., n = 3. t p < 0.01 vs cells pulsed with 20% Quil A containing 





5.4.5 Activation of BMDC 
As shown above, incubation of BMDC with Quil A containing formulations resulted in 
substantial cell death. Therefore analysis of DC activation was carried out on live cells 
only, using propidium iodide staining to exclude dead and dying cells. Analysis of the 
expression of two DC activation markers, CD86 and CD40, showed that incubation of 
BMDC with the 0% Quil A formulation resulted in only a slight increase in the number of 
CDl lc cells staining positive for CD40 (Figure 5.8 B) with no increase in the number of 
CD86+ve cells (Figure 5.8 A). Incubation of DC with formulation containing 20% Quil A 
resulted in increases in the number of CD86+ve and CD40+ve CD 11 c cells. Increasing 
adjuvant levels up to 70% did not further increase activation and instead produced lower 
numbers of CD86+ve and CD40+ve CD 11 c cells than did formulations containing 20% Quil 
A. 
5.4.6 Activation and proliferation of T cells 
Splenocytes from OT-I transgenic cells were incubated with DC pulsed with formulations 
containing 0%, 20% or 70% Quil A. Splenocytes were stained with CFSE and antigen 
specific proliferation was assessed by flow cytometry. Incubation of OVA transgenic T 
cells with DC pulsed with formulations containing no Quil A did not result in any antigen 
specific proliferation (Figure 5.9 A). Similarly there was no increase in the number of 
transgenic T cells expressing CD25 (Figure 5.9 B). However, incubation of transgenic T 
cells with DC pulsed with formulations containing either 20 or 70% Quil A did result in 
both T cell proliferation and increased CD25 expression . 
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Figure 5.8 BMDC activation following incubation with colloidal 
formulations containing either 0% (+), 20% (•) or 70% (.6) Quil 
A. The fold increase in live CD 11 c positive cells expressing the 
activation markers CD86 (A) and CD40 (B) following incubation of 
the BMDC with formulations for 48 hours is shown. Results are 
mean± S.D., n = 3. t p < 0.05 vs cells pulsed with 0% Quil A 
containing formulations. t p < 0.01 vs cells pulsed with 0% or 70% 





























~ t t .s 2 
~ t t • 
~ 0-+---'---~-~--~--I 








Figure 5.9 T cell proliferation and activation following incubation with 
colloidal formulations containing either 0% (+), 20% (•) or 70% (6.) Quil 
A. BMDC pulsed with the various formulations for 48 hours were washed 
and then incubated with CFSE stained OT-I splenocytes for 72 hours. 
Proliferation and CD25 expression was measured by flow cytometry. A. 
Fold increase in proliferation of CFSE stained OT-I T cells. B. Fold 
increase in CD25hi OT-IT cells. Results are mean± S.D., n = 3. t p < 0.05 
vs cells pulsed with 20% Quil A containing formulations. t p < 0.05 vs cells 









The aim of this chapter was to investigate the antigen-delivering and immunostimulating 
activities of three different lipidic formulations prepared by the hydration method 
(liposomes, ISCOMs and ring-like micelles containing PE-FITC-OVA as a model antigen). 
It was also interesting to specifically find out if increasing the amount of the adjuvant Quil 
A incorporated in the formulation from 20 to 70% would further boost immune 
responsiveness. These concentrations of Quil A were chosen based on the pseudo-ternary 
diagram established for phospholipids, cholesterol and Quil A reported in Chapter 2 
(Demana et al., 2004c ). The addition of 20% Quil A to phospholipid and cholesterol (ratio 
3: 1) causes the formation of predominantly IS CO Ms. Quil A disrupts the enclosed bilayer 
of the liposome forming regular cage-like structures of approximately 40 nm in diameter. 
When the Quil A content is increased to 70% ISCOM structures are replaced by small 
(about 10 nm) ring-like micelles. It has previously been shown that increasing Quil A 
increases the hydrophilicity of the colloidal structures (Konnings et al., 2002). Therefore in 
formulations containing 70% Quil A, ring-like micelles do not aggregate to form ISCOM 
structures or lamellae (hexagonal array of ring-like micelles) but instead disperse in the 
aqueous phase as individual particles (Kersten et al., 1991; Demana et al., 2004b; Demana 
et al., 2004e; Demana et al., 2004c). 
Next, the effect of the increase m percentage Quil A in the formulation on antigen 
incorporation was investigated. A key feature on any delivery system is antigen 
incorporation. Peptide and protein antigens are commonly expensive to produce therefore 
it is important antigen incorporation is efficient and does not affect the immunogenicity of 
the antigen. For mass manufacturing, formation of the particles and antigen incorporation 
should be simple. Formation of the Quil A containing liposomes using the hydration 
method is indeed a simple process. However antigen incorporation becomes more difficult 
with the inclusion of Quil A in the liposomes as there is no longer an enclosed aqueous core 
in which hydrophilic protein and peptide antigens can be entrapped and therefore 
incorporation rates of proteins are low (Demana et al., 2004b ). Antigens which have a 





proteins or any antigen that is naturally expressed on the surface of a cell, will fulfill these 
requirements and can be easily incorporated into ISCOMs or ISCOM-like particles 
(Hoglund et al., 1989; Barr & Mitchell 1996). 
As discussed in Chapter 3, the simplest way to incorporate proteins or peptide antigens is to 
attach a lipid tail to the antigen (Reid 1992; Sjolander et al., 1997a; Konnings et al., 2002). 
In this study PE was attached to OVA by a conjugation reaction and antigen incorporation 
was investigated using FITC as a fluorescent tag also linked to the OVA. The antigen 
incorporation rate for all particles was less than 30%. The addition of Quil A to the 
liposomes decreased incorporation, as did increasing the amount of Quil A from 20% to 
70%. The decrease in incorporation in ISCOMs as compared to liposomes can be 
attributed at least partially to the loss of the enclosed aqueous core. The further decrease in 
incorporation with the increase in Quil A from 20% to 70% can be attributed to the 
increased hydrophilicity of the ring like micelles. This will decrease the incorporation of 
the amphiphilic PE-FITC-OVA in agreement with results reported in Chapter 3 (Demana et 
al., 2004b ). The morphology of PE-FITC-OV A did not change the morphology or size of 
the colloidal particles in agreement with previous results (Demana et al., 2004b ). 
The ability of murine BMDC to take up the different particles was then examined. 
Parameters examined were the percentage of cells taking up antigen, the amount of antigen 
taken up and the ability of BMDC to take up the different types of particles. To allow for 
the different amount of antigen in the particles and corresponding differences in 
fluorescence, cells were given a mixture of formulations containing antigen and empty 
formulations was given. This meant the BMDC were all pulsed with the same amount of 
antigen and lipid. Uptake of the particles varied considerably with liposomes having the 
highest uptake and ring-like micelles having the lowest uptake. Again this most likely 
reflects changes in the lipid composition of the particles which lead to increased 
hydrophilicity and increasingly negative zeta potential upon increasing Quil A 
concentration (Kersten et al., 1991). The liposomes are the least hydrophilic particles and 
can interact intimately with the cellular membrane whereas with increasing Quil A 







2004c) and may not interact so well with the cell membranes. Liposomes also have a 
neutral charge but with increasing Quil A concentration as stated above, the colloidal 
particles will develop a stronger negative charge due to presence of glucuronic acid in the 
Quil A molecule (Higuchi & Komori 1987; Kersten et al., 1991) and may hence not be so 
easily taken up by the cells that also have a negative surface charge. Analysis of the 
fluorescence intensity of cells that had taken up antigen showed that incubation of BMDC 
with liposomes results in the highest amounts of antigen being taken up into cells. This is 
consistent with the large size of the liposomes and the higher antigen incorporation, and 
demonstrates one of the advantages of using a delivery system with a larger particle size 
instead of smaller particles such as micelles that would need to be taken up at a much 
higher rate to load the same amount of antigen into a cell. 
Saponins as well as having adjuvant activity are also haemolytic. Therefore it was 
important to determine what effect increasing the amount of Quil A in the particles had on 
cell viability as well as on the ability to stimulate an immune response. Not unexpectedly, 
it was found that particles containing Quil A were more toxic to BMDC in cell culture than 
were particles containing only phospholipid and cholesterol. However, increasing the 
amount of Quil A from 20% to 70% did not result in a further decrease in cell viability. In 
fact the 70% Quil A containing particles were, if anything less, toxic than the 20% Quil A 
containing particles. This difference may be at least partially explained by the decreased 
uptake of the 70% Quil A containing particles. 
Next the immune stimulatory ability of the particles was investigated by examining the 
ability of the particles to activate BMDC and the subsequent capacity of the formulation 
pulsed BMDC to induce the proliferation and activation of transgenic CD8 T cells. In order 
to stimulate a protective acquired immune response the vaccine (antigen plus delivery 
system) must be able to activate the antigen presenting cell but as well as doing this, 
antigen must be presented on MHC molecules in sufficient quantities to activate T cells. 
Dendritic cell activation without antigen presentation will not stimulate immune responses 
and indeed may induce autoimmunity and antigen presentation without dendritic cell 








Therefore it is important for safety as well as efficacy that the vaccine is able to activate the 
antigen-presenting cell and introduce sufficient antigen into the cell in such a way that it is 
targeted to the appropriate antigen processing and presentation pathway. In this 
experimental system it was chosen to look at MHC class I antigen presentation and the 
activation of CD8 T cells. This type of response is more difficult to stimulate than the 
MHC class II, CD4 T cell mediated immune response as exogenous antigen delivered in a 
non-living delivery system is generally targeted to the MHC class II antigen processing and 
presentation pathway. However other researchers have demonstrated that Quil A 
containing particles can in fact access the MHC class I presentation pathway and activate 
CD8 T cells (Robson et al., 2003a). 
In this study, the ability of Quil A containing particles to induce the upregulation of the 
costimulatory molecules CD86 and CD40 was firstly examined. The addition of Quil A to 
the delivery system resulted in an increase in the number of BMDC expressing both of 
these molecules. The particles containing 20% Quil A induced higher levels of activation 
than did the particles containing 70% Quil A. This reduced activation by the particles 
containing 70% Quil A is most likely due to the reduced uptake of the formulations by the 
dendritic cells. The 0% Quil A containing particles did not induce any BMDC activation 
even with high levels of uptake as liposomes are not inherently immunostimulatory. As the 
model antigen used in this study was OVA, the ability of the particles to induce a T cell 
response using transgenic OT-I CD8 T cells was investigated. The results of these 
experiments were striking in that the formulations containing 0% Quil A were completely 
unable to stimulate T cell proliferation or the upregulation of the IL-2 receptor a-chain 
(CD25). However, both of the Quil A containing formulations were able to induce 
substantial antigen specific T cell proliferation and the upregulation of CD25. The 20% 
Quil A containing formulation again performed best, probably reflecting the differences in 
uptake. Neither of the formulations had titrated out to background levels of proliferation 
indicating it may be appropriate to decrease the amount of formulation used even further, 
which would further reduce the cytotoxicity of the formulation and would reduce the 






It has been shown that while liposomes are an excellent delivery system for delivery of 
large amounts of antigen to antigen presenting cells without harming the cell they are not 
highly immunogenic and would benefit from the addition of an adjuvant. The adjuvant 
examined in this thesis was the saponin Quil A. The addition of 20% and 70% of this 
hydrophilic adjuvant had profound effects on the structure of the particles, decreasing the 
size of the particles and disrupting the lipid bilayer. The more Quil A was added the 
smaller the particles became and the less antigen could be incorporated. The increased 
hydrophilicity of the small negatively charged particles containing high amounts of Quil A 
also had a negative effect on uptake. The inclusion of the adjuvant Quil A (both 20% and 
70%) did however, greatly increased the ability of the particles to activate BMDC and T 
cell in vitro. Analysis of all the data leads to the conclusion that the addition of Quil A is 
highly desirable in terms of immunogenicity, even though it makes antigen loading more 
difficult. Increasing the amount of Quil A from 20% to 70% is of no advantage as there is 
no corresponding increase in immunogenicity. This is most likely due to the low uptake 
caused by the increased hydrophilicity and increased negative charge on the particles. 
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6.1 General Discussion 
As discussed in Chapter 1, there is a growing trend to use purified antigen (subunit 
vaccines) instead of whole pathogens for vaccination in order to overcome many of the 
negative side effects associated with the use of whole microorganisms. However, the use 
of subunit vaccines generally results in poor immunogenicity (Kersten et al., 1988a; Morein 
et al., 1990; Bungener et al., 2002). In order to enhance the immunogenicity of subunit 
vaccines, colloidal lipid particles such as liposomes or protein micelles have been used as 
particulate carriers of antigens, which are present in multimeric form in these particles 
(Kersten & Crommelin 1995; Kensil 1996). However, additional adjuvants usually have to 
be added because the immunogenicity of antigens presented in these colloidal particles is 
often not sufficient (Hoglund et al., 1989; Kersten & Crommelin 2003). The use of 
additional adjuvants which are often added in high concentrations so that a sufficiently 
strong immune response may be elicited can, however, result in unwanted side effects 
(Hoglund et al., 1989; Kersten & Crommelin 1995). As such, lipidic colloidal particles 
known as ISCOMs were developed in order to overcome many of the problems associated 
with the use of purified subunit vaccines and particulate antigen delivery systems (Morein 
et al., 1984; Morein & Bengtsson 1998). 
ISCOMs distinguish themselves from other lipid-based colloidal particles because of a 
built-in adjuvant (Quil A) in their structure and hence have recently received much 
attention in the immunological field (Mowat et al., 1991; Morein et al., 1995; Barr & 
Mitchell 1996; Sjolander et al., 1998; Kersten & Crommelin 2003). Due to the presence of 
Quil A in their structure, ISCOMs have been reported to be about ten times more 
immunogenic than other colloidal particulate delivery systems such as liposomes or protein 
micelles (Kersten & Crommelin 1995; Barr & Mitchell 1996; Sundquist et al., 1996; 
Osterhaus & Rimmelzwaan 1998). ISCOMs are able to boost both humoral and cellular 
responses (Barr et al., 1998; Morein & Bengtsson 1999; Sjolander et al., 2001b; Kersten & 
Crommelin 2003). Further, in addition to their use in parenteral immunization, ISCOMs 
have been used for both oral and mucosa! delivery of antigens (Rimmelzwaan & Osterhaus 




2001b; Kersten & Crommelin 2003). The applicability of ISCOMs in vaccine delivery is 
therefore diverse. 
To date, most studies on ISCOMs have utilized the dialysis method to prepare ISCOMs 
(Barr & Mitchell 1996; Ekstrom et al., 1999; Johansson & Lovgren-Bengtsson 1999; 
Mowat et al., 1999; Sjolander et al., 2001b; Kersten & Crommelin 2003). However, the 
recent development of a relatively simple method called the hydration or lipid film 
hydration method (Copland et al., 2000; Konnings et al., 2002; Demana et al., 2004c) 
appears to be a promising alternative method to prepare ISCOMs and ISCOM matrices. 
Therefore, the aim of this study was to use the hydration method to investigate mass 
combinations of Quil A, cholesterol and phospholipids that not only form ISCOM matrices 
but can also form other types of colloidal lipid-based particles containing Quil A that may 
be useful for antigen delivery or as adjuvants. In Chapter 2, pseudo-ternary diagrams of the 
aqueous mixtures of the polar lipids Quil A, cholesterol and phospholipid were investigated 
in terms of the types of particulate structures formed therein (Demana et al., 2004e; 
Demana et al., 2004c). Depending on the mass ratio of Quil A, cholesterol and 
phospholipid in the systems, various colloidal particles including ISCOM matrices, 
liposomes, lipidic/layered structures, ring-like micelles and worm-like micelles were 
observed. Other colloidal particles were also observed as minor structures in the presence 
of these predominant colloids including helices and lamellae (hexagonal pattern of ring-like 
micelles). As discussed in Chapter 2, the effect of buffer salts, equilibration time and type 
of phospholipid were chosen for investigation in the present study since these factors may 
affect the phase behaviour of phospholipids and aggregation of the surfactants into micelles 
(Gulik-Krzywicki et al., 1969; Mazer et al., 1979; Hauser 1984; New 1990). 
Pseudo-ternary diagrams were established for lipid mixtures hydrated in water and in Tris 
buffer (pH 7.4) (Demana et al., 2004e; Demana et al., 2004c). The effect of equilibration 
time was investigated by comparing pseudo-ternary diagrams of aqueous mixtures of the 
polar lipids characterized within 1 day of preparation with those equilibrated for one or two 
months at 4 °C. The area of the pseudo-ternary diagrams associated with systems 





period < hydrated in buffer/short equilibration period < hydrated in water or Tris 
buffer/prolonged equilibration period. ISCOM matrices appeared to form over time from 
samples which initially contained a high concentration of ring-like micelles and liposomes 
suggesting that these colloidal structures may be precursors to ISCOM matrix formation. 
Helices were also frequently found in samples containing ISCOM matrices as a minor 
colloidal structure. Equilibration time and presence of buffer salts also promoted the 
formation of liposomes in systems not containing Quil A. These parameters however, did 
not appear to significantly affect the occurrence and predominance of other structures 
present in the pseudo-binary systems containing Quil A. 
Differences were observed between pseudo-ternary diagrams prepared usmg either 
phosphatidylethanolamine or phosphatidylcholine as phospholipids. ISCOM-like 
structures (i.e. morphologically less defined ISCOM matrices) were observed more 
frequently m pseudo-ternary systems containing phosphatidylcholine than m 
phosphatidylethanolamine containing systems. Furthermore, the hexagonal pattern of ring-
like micelles in the cholesterol rich samples (lamellae structures) were well formed and 
more frequently observed in phosphatidylethanolamine containing pseudo-ternary systems 
than in the respective phosphatidylcholine containing systems. The type of phospholipid 
investigated did not significantly affect the morphology of other colloidal structures such as 
lipidic/layered particles, worm-like micelles, and ring-like micelles that were observed at 
high Quil A:cholesterol:phospholipid mass ratios. 
There are no studies in the literature of pseudo-ternary diagrams of aqueous mixtures of 
Quil A, cholesterol and phospholipid prepared by the dialysis method. Whether the other 
types of colloids containing Quil A prepared by the hydration method and identified in the 
different regions of the pseudo-ternary diagram would appear at the same mass 
combinations if prepared by the dialysis method is unknown. Therefore, in Chapter 2 
various formulations were also prepared by the dialysis method for comparison (Demana et 
al., 2004e). The results reveal that depending on the mass ratio of Quil A, cholesterol and 
phospholipid, predominant colloidal particles including ISCOM matrices, liposomes and 








In contrast, worm-like micelles were only observed in systems prepared by the hydration 
method. The existence of worm-like micelles in systems containing only Quil A and 
cholesterol prepared by the hydration method which were not found in samples prepared by 
the dialysis method implies that in the absence of an additional surfactant, Quil A 
solubilised cholesterol to an extent insufficient to allow the formation of ring-like micelles 
(Demana et al., 2004e). 
Interestingly, the regions of the pseudo-ternary diagrams in which ISCOM matrices were 
observed differ between the two methods of preparation (Demana et al., 2004e). For 
samples prepared by the dialysis method, ISCOM matrices are predominantly found near 
the Quil A apex of the pseudo-ternary diagram (> 50% Quil A). For samples prepared by 
the hydration method, ISCOM matrices are predominantly found near the phospholipid 
apex of the pseudo-ternary diagram (> 50% phospholipid). The difference is attributed to 
residual surfactant (octylglucoside) that may be left with formulations during dialysis. As 
previously suggested for pseudo-binary Quil A/cholesterol systems, if residual surfactant 
plays ( at least partly) the role of phospholipids and thereby promotes IS COM formation in 
pseudo-binary systems (Kersten et al., 1991; Kersten & Crommelin 1995), then it is equally 
likely that octylglucoside can play the role of phospholipids in pseudo-ternary systems and 
hence result in a shift of the region in the pseudo-ternary diagram in which ISCOMs are 
observed into areas of lower phospholipid concentration, ie towards the Quil A apex. 
Alternatively, the difference noted between the two methods of preparation may also result 
from the loss of Quil A during dialysis. Quil A is a heterogeneous mixture containing 
saponins of different molecular weights (Barr et al., 1998). It may be possible that 
saponins with a low molecular weight can pass through the 1,000 molecular weight cut-off 
membrane and be lost as a partner to form ISCOM matrices. Consequently, this would lead 
to an insufficient effective concentration of Quil A, especially in formulations with a low 
weight percentage of the saponin mixture. A low concentration of Quil A would result in 
the formation of colloidal structures other than the ISCOM matrices such as liposomes. 
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The widespread distribution of ISCOM matrices in samples prepared by the hydration 
method after an extended equilibration period not only implies that the equilibration period 
is important to prepare ISCOM matrices by this method but also that ISCOM matrices 
appear to be the thermodynamically stable colloidal form for the majority of pseudo-ternary 
aqueous systems of Quil A, cholesterol and phospholipid. 
The unexpected observation of ISCOM matrices as mmor colloidal structures in the 
pseudo-binary systems of Quil A and cholesterol prepared by the dialysis method that were 
not observed in these systems prepared by the hydration method is interesting. These 
findings are again attributed to the possible presence of residual surfactant ( e.g. 
octylglucoside) that may be left with the formulations during dialysis. This study has 
demonstrated that the formation of ISCOM matrices requires the presence of all three 
components (Quil A, cholesterol and phosphatidylcholine or phosphatidylethanolamine) as 
ISCOM matrices were not observed in the pseudo-binary systems prepared by the hydration 
method which does not require the use of an additional surfactant (Demana et al., 2004e ). 
From the results presented in Chapter 2, it is possible to propose a mechanism for the 
formation of ISCOM matrices by the hydration method. The results indicate that there are 
possibly two different pathways in which ISCOM matrices could be formed (Demana et al., 
2004e): one is from the association and aggregation of ring-like micelles into ISCOM 
matrices possibly due to micelle-micelle hydrophobic interactions; the other mechanism is 
from liposomes because ISCOM matrices appear to bud off from the phospholipid bilayers 
(the detailed mechanism of this phenomenon is discussed in Chapter 2). This latter 
pathway is frequently observed in ternary systems with high concentrations of 
phospholipids upon increasing the Quil A concentration. On the other hand, the formation 
of ISCOM matrices by the dialysis method involves a different mechanism from that in 
which ISCOMs are formed by lipid film hydration. With dialysis, the pathway for the 
formation of ISCOMs is from mixed micelles involving additional surfactant ( often 







As discussed in Section 1.3.6.3, the benefits ofISCOMs as adjuvants and in the delivery of 
antigens appears greatest if the antigen or protein can be incorporated into the ISCOM 
matrix (Barr & Mitchell 1996; Ekstrom et al., 1999). For incorporation into ISCOMs, it is 
desirable that the antigen has an amphiphilic character (Kersten & Crommelin 1995; Barr 
& Mitchell 1996). If the antigen is hydrophilic there is no driving force for its 
incorporation into the lipid matrix (Morein et al., 1990; Kersten et al., 1991; Rimmelzwaan 
& Osterhaus 1997; Barr et al., 1998), while if it is too lipophilic the protein tends to 
aggregate, thus preventing its incorporation into a colloidal structure (Kersten & 
Crommelin 1995; Morein et al., 1995). However, little is known about the incorporation of 
antigen or protein in ISCOM matrices and related colloidal particles containing Quil A 
prepared by the lipid film hydration method. Moreover, the impact of incorporation of 
antigen on the type of colloidal particles produced by aqueous mixtures of Quil A, 
cholesterol and phospholipid in the pseudo-ternary diagram is not known. Therefore, 
investigations reported in Chapter 3 (Demana et al., 2004b) were conducted in order to 
evaluate which type of model antigen is better able to incorporate into various colloidal 
particles formed by hydration of dried lipid films with an aqueous solution of Quil A. 
Further objectives were to investigate which of the various colloidal particles prepared by 
the hydration method are capable of incorporating the model antigen and to rank the 
various types of colloidal particles in terms of their ability to incorporate a model antigen, 
to assess the impact of incorporation of protein on morphology, size and prevalence of the 
various colloidal structures, and to compare the incorporation of antigen into particles 
prepared by the hydration method and particles prepared by the classical dialysis method. 
The model antigen used was fluorescently labeled ovalbumin (FITC-OV A), which was 
modified with palmitic acid and phosphatidylethanolamine to produce P-FITC-OVA and 
PE-FITC-OVA respectively. The results demonstrate that the various colloidal particles 
formed as a result of hydrating phospholipid/cholesterol lipid films with different amounts 
of Quil A are capable of incorporating an antigen, provided it is amphipathic. The more 
lipophilic the protein (i.e. PE-FITC-OVA), the better the incorporation into all colloidal 
structures possibly due to increased hydrophobic interactions. If a hydrophilic protein such 




























contained Quil A were found to incorporate the protein. On the other hand, liposomes, 
which do not contain Quil A, could incorporate FITC-OV A. The degree of incorporation 
of protein is in the following order: worm-like micelles < ring-like micelles < 
lipidic/layered structures < liposomes < ISCOMs < lamellae (Demana et al., 2004b ). The 
incorporation of protein into the various particles prepared by the hydration method is 
similar to those for colloidal particles prepared by the dialysis method (provided both 
methods lead to the formation of the same colloidal structures). In the case of different 
colloidal structures arising due to the preparation method, differences in encapsulation 
efficiency were found for formulations with the same polar lipid composition (Demana et 
al., 2004b ). 
Since ISCOMs are always administered as solutions (Barr et al., 1998; Rimmelzwaan et al., 
2000), and the depot effect is considered an important function of ISCOMs (Morein & 
Bengtsson 1998), it is potentially advantageous to prepare solid lipid mixtures that are able 
to deliver the antigen in colloidal ISCOM structures as a controlled delivery implant from 
the site of injection. However, no such studies have been previously performed using 
phospholipids, cholesterol and Quil A in a ratio suitable for the formation of ISCOM 
matrices. Since the results in Chapter 3 show that not only ISCOMs are capable of 
incorporating an amphipathic protein, but also other related colloidal particles containing 
Quil A, investigations were conducted in Chapter 4 for the preparation of solid Quil A-lipid 
particles (as powders or compressed pellets) with the objectives of evaluating spontaneous 
formation of various colloids and the release of model antigen from the pellets (Demana et 
al., 2004d; Demana et al., 2004a). All powder mixtures were prepared by physical mixing 
using pestle and mortar or by freeze-drying of an aqueous dispersion of these components 
in ratios that allow for the spontaneous formation of ISCOMs and other colloidal structures. 
The effect of addition of excess cholesterol on the release of model antigen ( ovalbumin) 
from the pellets was also investigated. 
The results reveal that solid lipid powder mixtures prepared by physical mixing have to 
only a low tendency to form ISCOM matrices and related colloidal structures such as 








structures upon hydration. These results are attributed to a high degree of crystallinity of 
cholesterol as demonstrated by XRPD, DSC, SEM and PLM. In contrast, spontaneous 
formation of the expected colloids upon hydration of solid freeze-dried lipid powder 
mixtures was demonstrated. The compression of lipid mixtures into small pellets was 
found not to alter the nature of the colloidal structures found upon hydration, and the 
addition of excess cholesterol physically mixed to the freeze-dried polar lipid samples 
slowed down the release of antigen from the compressed pellets. The investigations reveal 
that the antigen is released from the compressed pellets incorporated into ISCOMs 
especially from the pellets made using freeze-dried lipid powder mixtures. The findings 
obtained in Chapter 4 (Demana et al., 2004d; Demana et al., 2004a) are important in 
formulating solid Quil A containing lipid particles as controlled particulate adjuvant 
containing antigen delivery systems. 
The ultimate goal of any adjuvant or antigen particulate delivery system is to evaluate if an 
immune response can be induced. Although the results in Chapter 3 demonstrate that 
ISCOMs and related colloidal structures prepared by the hydration method are capable of 
incorporating an antigen (Demana et al., 2004b ), and that these colloids may be used as a 
sustained antigen delivery system (Chapter 4) (Demana et al., 2004d; Demana et al., 
2004a), little is known about the capability of these systems (particularly colloids with 
built-in adjuvant Quil A in their structures) to deliver antigen to antigen presenting cells 
such as DCs. Therefore, studies reported in Chapter 5 (Demana et al., 2004£) were 
conducted using colloidal particles chosen from different regions of the pseudo-ternary 
diagram with the aims of investigating the ex vivo delivery of a model antigen formulated 
in three different lipidic particles (ISCOMs, liposomes and ring-like micelles) to murine 
bone-marrow derived dendritic cells (BM-DC), and also to investigate whether the three 
different particulate antigen delivery systems are able to prime receptor-transgenic T-cells 
directed against an epitope within a model antigen and hence show some characteristics of 
activation or proliferation of these cells. The model antigen chosen was PE-FITC-OVA 
because it was demonstrated in Chapter 3 to be incorporated with a higher encapsulation 












The results obtained not only demonstrate that different lipidic particles prepared by the 
hydration method following a simple aqueous mixture of Quil A, cholesterol and 
phospholipid with a model antigen can deliver the protein to the dendritic cells, but have an 
ability to induce T-cell immunological response in vitro (Demana et al., 2004±). Their 
capability to deliver and prime T-cell proliferation was found to be dependent on the nature 
(morphology) of their structures, i.e. whether they are liposomes, ISCOMs or ring-like 
micelles. Liposomes were found to deliver more antigens to BMDC than the ISCOMs, 
which in tum gave greater delivery than the ring-like micelles. Despite greatest uptake of 
liposomes by BMDC, these colloids were found to be the least capable of activating 
BMDC. The CD86- and CD40-expression patterns as cell surface markers for the 
activation of BMDC were higher for ISCOMs, which in tum were greater than for the ring-
like micelles. With respect to the results of T-cell priming, ISCOMs were found to be 
superior to ring-like micelles which in tum were superior to liposomes despite the fact that 
both ISCOMs and ring-like micelles showed some cytotoxicity towards BMDC attributed 
to the presence of Quil A (Demana et al., 2004f). The findings obtained in the current 
study may also be applicable to other vaccine particulate systems containing Quil A such as 
worm-like micelles, lamellae and lipidic/layered structures found in the different regions of 
the pseudo-ternary diagram as investigated in Chapter 2 . 
6.2 Future Research 
The research presented in this thesis has revealed that, depending on the various mass ratios 
of Quil A, cholesterol and phospholipid in aqueous media, different colloidal particles 
including ISCOM matrices, ring-like and worm-like micelles, lamellae and lipidic/layered 
structures can be formed. However, the actual chemical composition of the colloidal 
particles was not investigated in the present study. The differences observed in the type 
and prevalence of colloidal structures formed by the hydration method with those prepared 
by the standard dialysis method were mainly attributed to the use of additional surfactant in 
the dialysis, which is not required in the hydration method. Therefore, future work needs 











more especially for the dialysis method, to investigate the role of additional surfactants in 
the formation process of these important sub-unit vaccine delivery systems. 
In order to further understand the morphology of the colloidal structures presented in this 
study, future studies should include other sensitive microscopic techniques such as cryo-
TEM. The use of small angle X-ray diffractometry may be particularly useful in the 
analysis of the layered morphology of the lipidic particles formed through an interaction of 
phospholipid and Quil A. 
Most samples containing Quil A, cholesterol and phospholipid formed predominantly 
ISCOM structures after prolonged storage especially formulations prepared by the 
hydration method. It is not known if chemical degradation of polar lipids influences the 
formation of ISCOM matrices upon storage. Future research must therefore investigate the 
chemical stability of these lipid mixtures using advanced analytical techniques such as high 
performance liquid chromatography (HLPC). 
Quil A is a semi-purified mixture of many structurally related bidesmosidic triterpenoid 
glycosides (Kensil et al., 1991 b ). The development of advanced analytical techniques have 
led to more purified forms of Quil A such as QS-21 (Kensil 1996), QA-3, QA-17, QA-20, 
QA-22 and QA-23 (Stittelaar et al., 2000). ISCOPREP 703® is a mixture consisting of 
QA-3 for ISCOM formation and QA-23 for maximum adjuvant activity (Barr et al., 1998). 
Purification of Quil A is therefore important for future studies using it as adjuvant or in 
particulate vaccine delivery systems as this will not only be advantageous in reducing 
toxicity associated with the less purified Quil A, but it would be much easier to interpret the 
data generated from using the purified forms. Although the ability of purified forms of 
Quil A such as QA-3 to form ISCOMs have been demonstrated (Stittelaar et al., 2000), it 
remains to be investigated whether these and other purified Quil A molecules would be able 
to form ISCOMs and the other related colloidal particles prepared by the hydration method 
as described throughout this thesis. Future investigations should, therefore, not only 
evaluate their capability to form ISCOMs and related colloidal particles, but also evaluate 







immune response and to investigate their toxicity. This is particularly important as it has 
been reported that the more hydrophobic purified forms of Quil A are very potent adjuvants 
with respect to inducing cellular immunity (Stittelaar et al., 2000). 
Investigations in Chapter 3 concerning incorporation of antigen into ISCOMs and related 
colloidal particles demonstrate that the conjugation of ovalbumin with fatty acids (i.e. 
palmitic acid) or phospholipids (e.g. phosphatidylethanolamine) lead to better incorporation 
than using unmodified ovalbumin (Demana et al., 2004b ). However, it is not known 
whether the modification of ovalbumin as described in Chapter 3 would lead to alteration in 
the immunogenicity of the antigen. Similarly, the effects of freeze-drying and 
ultracentrifugation used in this study on the immunogenicity of the antigen were not 
investigated. Therefore, future work should investigate whether conformation and 
immunogenicity of the antigen is affected by the chemical modification of antigen, or the 
use of ultracentrifugation and freeze-drying using techniques such as infrared spectroscopy, 
sodium dodecyl sulfate-polyacrylamide gel elcetrophoresis (SDS-PAGE), circular 
dichroism and enzymic activity assays using enzymes as model antigens. 
Delivery of antigen to dendritic cells, and the immunological characteristics of the antigen 
such as uptake, activation and T-cell proliferation was also investigated in vitro using 
ISCOMs, liposomes and ring-like micelles. Whether data similar to that obtained in the 
current investigation will be found using other related colloidal systems such as lamellae, 
lipidic/layered structures and possibly even helices remains to be investigated. Therefore, 
future investigations should be conducted regarding the ability of these other lipid systems 
containing Quil A to deliver antigen to dendritic cells, and to evaluate their 
immunestimulating effects. 
Excess cholesterol was found to slow down the release of antigen from the pellets (Demana 
et al., 2004a). It would be interesting to investigate the release of antigen from pellets 
incorporating other molecules such as biodegradable polymers ( e.g. polylactide-glycolide ). 
The investigations conducted in this thesis were all in-vitro studies. It would therefore be 





in-vivo in order to establish if the data generated in this study can be correlated with that 
generated in a relevant biological system akin to the human body. 
In conclusion, the research conducted in this thesis has provided new insights into lipid-
based colloidal systems containing the adjuvant Quil A produced by the simple method of 
lipid film hydration for application in vaccination or immunology as particulate 









ACHARYA, D. P., KUNIEDA, H. (2003) Formation of viscoelastic wormlike micellar 
solutions in mixed nonionic surfactant systems. Journal of Physical Chemistry B 
107: 10168-10175 
ADAMINA, M., SCHUMACHER, R., BOLLI, M., ZURBRIGGEN, R., MARTI, W., 0ERTLI, D., 
SPAGNOLI, G., HEBERER, M. (2003) Virosomes are powerful adjuvants in the 
induction of cytotoxic T cell responses against human tumor associated antigens. 
Journal of the American College of Surgeons 197: S84-S85 
AHSAN, F. L., RIVAS, I. P., KHAN, M. A., SUAREZ, A. I. T. (2002) Targeting to 
macrophages: role of physicochemical properties of particulate carriers-liposomes 
and microspheres-on the phagocytosis by macrophages. Journal of Controlled 
Release 79: 29-40 
AKERBLOM, L., NARA, P., N., D., PUTNEY, S., MOREIN, B. (1993) HIV experimental 
vaccines based on the ISCOM technology using envelope and gag gene products. 
Biotechnology Therapy 4: 145-161 
ALLEN, T. M. (1983) Removal of detergent and solvent traces from liposomes. In: 
Gregoriadis, G. (ed.) Liposome Technology. CRC Press, Inc., Florida, pp 109-122 
ALLISON, A. C., BYARS, N. E. (1990) Adjuvants for a new generation of vaccines. In: 
Woodrow, G. C., Levine, M. M. (eds) New Generation Vaccines. Marcel Dekker, 
Inc., New York, pp 129-140 
ALMGREN, M. (2000) Mixed micelles and other structures in the solubilization of bilayer 
lipid membranes by surfactants. Biochimica et Biophysica Acta 1508: 146-163 
ALPAR, H. 0., FIELD, W. N., LEWIS, D. A. (1989) The transport of microspheres from the 
gastrointestinal-tract to inflammatory air pouches in the rat. Journal of Pharmacy 
and Pharmacology 41: 194-196 
ALVINO, C. A. (1991) Liposomes as earners of antigens and adjuvants. Journal of 
Immunological Methods 140: 1-13 
ANDERSSON, C., SANDBERG, L., MURBY, M., SJOLANDER, A., LOVGREN-BENGTSSON, K., 






tagged immunogens for direct 1scom incorporation. Journal of Immunological 
Methods 222: 171-182 
ANDERSSON, C., SANDBERG, L., WERNERUS, H., JOHANSSON, M., LOVGREN-BENGTSSON, 
K., STAHL, S. (2000) Improved systems for hydrophobic tagging of recombinant 
immunogens for efficient iscom incorporation. Journal of Immunological Methods 
238: 181-193 
AUDIBERT, F. M., LISE, L. D. (1993) Adjuvants - Current status, clinical perspectives and 
future-prospects. Immunology Today 14: 281-284 
BABIUK, S., BACA-ESTRADA, M., BABIUK, L. A., EWEN, C., FOLDVARI, M. (2000) 
Cutaneous vaccination: the skin as an immunologically active tissue and the 
challenge of antigen delivery. Journal of Controlled Release 66: 199-214 
BACHMANN, M. F., ZINKERNAGEL, R. M. (1997) Neutralizing antiviral B cell responses. 
Annual Review oflmmunology 15: 235-270 
BANCHEREAU, J., STEINMAN, R. M. (1998) Dendritic cells and the control of immunity. 
Nature 392: 245-252 
BANCHEREAU, J., BRIERE, F., CAUX, C., DA YOUST, J., LEBECQUE, S., LIU, Y. T., 
PULENDRAN, B., PALUCKA, K. (2000) Immunobiology of dendritic cells. Annual 
Review oflmmunology 18: 767-+ 
BANGHAM, A. D., HORNE, R. W. (1962) Action of saponin on biological cell membranes. 
Nature 196: 952-953 
BANGHAM, A. D., HORNE, R. W. (1964) Negative staining of phospholipids and their 
structural modification by surface-active agents as observed in the electron 
microscope. Journal of Molecular Biology 8: 660-668 
BANGHAM, A. D., STANDISH, M. M., WATKINS, J. C. (1965) Diffusion of univalent ions 
across the lamellae of swollen phospholipids. Journal of Molecular Biology 13: 
238-262 
BARR, I. G., MITCHELL, G. F. (1996) ISCOMs (immunostimulating complexes): The first 
decade. Immunology and Cell Biology 74: 8-25 
BARR, I. G., SJOLANDER, A., Cox, J.C. (1998) ISCOMs and other saponin based adjuvants. 








BASS, R. (1996) Validation of Analtical Procedures: Methodology (CPMP/ICH/281/95), 
The European Agency for the Evaluation of Medicinal Products (EMEA),, London, 
pp 1-9 
BEACOCK-SHARP, H., DONACHIE, A. M., ROBSON, N. c., MOWAT, A. M. (2003) A role for 
dendritic cells in the priming of antigen-specific CD4( +) and CD8( +) T 
lymphocytes by immune-stimulating complexes in vivo. International Immunology 
15: 711-720 
BEAVIS, R. C., CHAIT, B. T. (1990) Rapid, sensitive analysis of protein mixtures by mass-
spectrometry. Proceedings of the National Academy of Sciences of the United 
States of America 87: 6873-6877 
BECK, R., GRADZIELSKI, M., HORBASCHEK, K., SHAH, S. S., HOFFMANN, H., STRUNZ, P. 
(2000) Phase behaviour and physical properties of the cationic quaternary system 
tetradecyldimethylamine oxide hydrochloric acid 1-hexanol water. Colloid and 
Polymer Science 278: 137-142 
BEHBOUDI, s., MOREIN, B., RONNBERG, B. (1995) Isolation and quantification of Quillaja 
saponaria Molina saponins and lipids in iscom-matrix and iscoms. Vaccine 13: 
1690-1696 
BELL, D., YOUNG, J. W., BANCHEREAU, J. (1999) Dendritic cells Advances in Immunology, 
Vol. 72. Academic Press Inc, San Diego, pp 255-324 
BELL, S. J. (2002) Calcium phosphate nanoparticle adjuvant and delivery vehicle - safer 
2nd generation vaccine products. Proceedings of Immunopotentiators in Modem 
Vaccines. Radisson SAS Hotel, Praque, Czech Republic 
BERGER, N., SACHSE, A., BENDER, J., SCHUBERT, R., BRANDL, M. (2001) Filter extrusion 
of liposomes using different devices: comparison of liposome size, encapsulation 
efficiency, and process characteristics. International Journal of Pharmaceutics 223: 
55-68 
BETAGERI, G. V., MAKARLA, K. R. (1995) Enhancement of dissolution of glyburide by 
solid dispersion and lyophilization techniques. International Journal of 
Pharmaceutics 126: 155-160 
BHARDWAJ, N. (2001) Processing and presentation of antigens by dendritic cells: 




BIRCHALL, J. c., KELLAWAY, I. W., MILLS, s. N. (1999) Physico-chemical characterisation 
and transfection efficiency of lipid-based gene delivery complexes. International 
Journal of Pharmaceutics 183: 195-207 
BLOMQVIST, G. A. M., LOVGREN-BENGTSSON, K., MOREIN, B. (2003) Influence of 
maternal immunity on antibody and T-cell response in mice. Vaccine 21: 2022-2031 
BOMFORD, R. (1989) Aluminium salts: perspectives in their use as adjuvants. In: 
Gregoriadis, G., Allison, A. C., Paste, G. (eds) Immunlogical Adjuvants and 
Vaccines. Plenum Press, New York, pp 35-41 
BOURGES, M., SMALL, D. M., DERVICHIAN, D. G. (1967) Biophysics of lipidic associations. 
II. The ternary systems cholesterol-lecithin-water. Biochimica et Biophysica Acta 
137: 157-167 
BOWERS, W. (2001) Cells involved in immune responses. Online. Accessed 8 February 
2002. Available from Department of Microbiology and Immunology, University of 
South Carolina. http://www.med.sc.edu:85/bowers/immune%20cells.htm 
BRADFORD, M. M. (1976) A rapid and sensitive method for the quantitation of microgram 
quantities of protein utilising the principles of protein-dye binding. Analytical 
Biochemistry 72: 248-254 
BROWNING, M., REID, G., OSBORNE, R., JARRETT, 0. (1992) Incorporation of soluble-
antigens into ISCOMs - Hiv Gp120 ISCOMs induce virus neutralizing antibodies. 
Vaccine 10: 585-590 
BUNGENER, L., HUCK.RIEDE, A., WILSCHUT, J., DAEMEN, T. (2002) Delivery of protein 
antigens to the immune system by fusion- active virosomes: A comparison with 
liposomes and ISCOMs. Bioscience Reports 22: 323-338 
BUSQUETS, M. A., ALSINA, M. A., HARO, I. (2003) Peptides and liposomes: from 
biophysical to immunogenic studies. Current Drug Targets 4: 633-642 
BUWALDA, R. T., JONKER, J. M., ENGBERTS, J. (1999) Aggregation of azo dyes with 
cationic amphiphiles at low concentrations in aqueous solution. Langmuir 15: 1083-
1089 
CAVANI, A., NASORRI, F., 0TTAVIANI, C., SEBASTIAN!, S., DE PITA, 0., GIROLOMONI, G. 
(2003) Human CD25(+) regulatory T cells maintain immune tolerance to nickel in 







CELLA, M., SALLUSTO, F., LANZAVECCHIA, A. (1997) Origin, maturation and antigen 
presenting function of dendritic cells. Current Opinion in Immunology 9: 10-16 
CEVC, G. (1996) Transfersomes, liposomes and other lipid suspensions on the skin: 
Permeation enhancement, vesicle penetration, and transdermal drug delivery. 
Critical Reviews in Therapeutic Drug Carrier Systems 13: 257-388 
CEVC, G. (2003) Transidermal drug delivery of insulin with ultradeformable earners. 
Clinical Pharmacokinetics 42: 461-474 
CEVC, G., SCHATZLEIN, A., BLUME, G. (1995) Transdermal drug carriers - basic properties, 
optimization and transfer efficiency in the case of epicutaneously applied peptides. 
Journal of Controlled Release 36: 3-16 
CHANG, M. F., SHI, Y., NAIL, S. L., HOGENESCH, H., ADAMS, S. B., WHITE, J. L., HEM, S. 
L. (2001) Degree of antigen adsorption in the vaccine or interstitial fluid and its 
effect on the antibody response in rabbits. Vaccine 19: 2884-2889 
CHAPMAN, D., COLLIN, D. T. (1965) Differential thermal analysis of phospholipids. Nature 
206: 189 
CHA VANY, C., SAISONBEHMOARAS, T., LEDOAN, T., PUISIEUX, F., COUVREUR, P., HELENE, 
C. (1994) Adsorption of oligonucleotides onto polyisohexylcyanoacrylate 
nanoparticles protects them against nucleases and increases their cellular uptake. 
Pharmaceutical Research 11: 1370-1378 
CHEETHAM, J. J., WACHTEL, E., BACH, D., EPAND, R. M. (1989) Role of the 
stereochemistry of the hydroxyl group of cholesterol and the formation of 
nonbilayer structures in phosphatidylethanolamines. Biochemistry 28: 8928-8934 
CHUNG, D. S., BENEDEK, G. B., KONIKOFF, F. M., DONOVAN, J. M. (1993) Elastic free 
energy of anisotropic helical ribbons as metastable intermediates in the 
crystallization of cholesterol. Proceedings of the National Academy of Science, 
USA 90: 11341-11345 
CLAASSEN, E., DELEEUW, W., DEGREEVE, P., HENDRIKSEN, C., BOERSMA, W. (1992) 
Freund complete adjuvant - an effective but disagreeable formula. Research in 
Immunology 143: 4 78-483 
CLAASSEN, I., OSTERHAUS, A. (1992) The ISCOM structure as an Immune-enhancing 





CLELAND, J. L., K.ENSIL, C. R., LIM, A., JACOBSEN, N. E., BASA, L., SPELLMAN, M., 
WHEELER, D. A., Wu, J. Y., POWELL, M. F. (1996) Isomerization and formulation 
stability of the vaccine adjuvant QS-21. Journal of Pharmaceutical Sciences 85: 22-
28 
COLLINS, J. J., PHILLIPS, M. C. (1982) The stability and structure of cholesterol-rich 
codispersions of cholesterol and phosphatidylcholine. Journal of Lipid Research 23: 
291-298 
CONLAN, J. W., KRISHNAN, L., WILLICK, G. E., PATEL, G. B., SPROTT, G. D. (2001) 
Immunization of mice with lipopeptide antigens encapsulated in novel liposomes 
prepared from the polar lipids of various Archaeobacteria elicits rapid and 
prolonged specific protective immunity against infection with the facultative 
intracellular pathogen, Listeria monocytogenes. Vaccine 19: 3509-3517 
COPLAND, M. J. (2003) Colloidal Systems for Delivery to DC. School of Pharmacy, 
University of Otago, Dunedin, New Zealand, PhD Thesis 
COPLAND, M. J., RADES, T., DA VIES, N. M. (2000) Hydration of lipid films with an 
aqueous solution of Quil A: a simple method for the preparation of immune-
stimulating complexes. International Journal of Pharmaceutics 196: 135-139 
COPLAND, M. J., BAIRD, M. A., RADES, T., MCKENZIE, J. L., BECKER, B., RECK, F., TYLER, 
P. C., DA VIES, N. M. (2003) Liposomal delivery of antigen to human dendritic cells. 
Vaccine 21: 883-890 
COSTANZO, R., DEPAOLI, T., IHLO, J. E., HAGER, A. A., FARACH, H. A., POOLE, C. P., 
KNIGHT, J. M. (1994) Esr study of order and dynamics in lecithin liposomes with 
high cholesterol content. Spectrochimica Acta Part a-Molecular and Biomolecular 
Spectroscopy 50: 203-208 
Cox, J. C., COULTER, A. R. (1997) Adjuvants - a classification and review of their modes 
of action. Vaccine 15: 248-256 
Cozzo, C., LARKIN, J., CATON, A. J. (2003) Cutting edge: Self-peptides drive the 
peripheral expansion of CD4( + )CD25 ( +) regulatory T cells. Journal of Immunology 
171: 5678-5682 
CULLIS, P.R., DE KRUIJFF, B. (1979) Lipid polymorphism and the functional roles oflipids 





DA FONSECA, D., FRERICHS, J., SINGH, M., SNIPPE, H., VERHEUL, A. F. M. (2000) Induction 
of antibody and T-cell responses by immunization with ISCOMs containing the 38-
kilodalton protein ofMycobacterium tuberculosis. Vaccine 19: 122-131 
DE VRIES, P., VA WEZEL, A. L., BEUVERY, E. C. (1990) Process for preparing immunogenic 
complexes and pharmaceutical composition containing these complexes,. USA 
Patent 4900549 
DE VRIES, P., VANBINNENDIJK, R. s., VANDERMAREL, P., VANWEZEL, A. L., VooRMA, H. 
0., SUNDQUIST, B., UYTDEHAAG, F., OSTERHAUS, A. (1988) measles-virus fusion 
protein presented in an immune-stimulating complex (ISCOM) induces hemolysis-
inhibiting and fusion-inhibiting antibodies, virus-specific T-cells and protection in 
mice. Journal of General Virology 69: 549-559 
DEFELIPPIS, M. R., AKERS, M. (2000) Peptides and proteins as parental suspensions: an 
overview of design, development, and manufacturing considerations. In: Frokjaer, 
S., Hovgaard, L. (eds) Pharmaceutical Formulation: Development of Peptides and 
Protein. Taylor & francis Ltd, London, pp 113-145 
DEMANA, P. H., DAVIES, N. M., RAD ES, T. (2004a) Release of a model antigen from pellets 
prepared by compression of Quil A-cholesterol-phospholipid powder mixtures 
forming ISCOMs upon hydration. Proceedings of the Controlled Release Society 
31st Annual Meeting. Honolulu, Hawaii, U.S.A. 
DEMANA, P. H., DAVIES, N. M., BERGER, B., RADES, T. (2004b) Incorporation of 
ovalbumin into ISCOMs and related colloidal particles prepared by the lipid film 
hydration method. International Journal of Pharmaceutics. 278: 263-274 
DEMANA, P.H., DAVIES, N. M., VOSGERAU, U., RADES, T. (2004c) Pseudo-ternary phase 
diagrams of aqueous mixtures of Quil A, cholesterol and phospholipid prepared by 
the lipid-film hydration method. International Journal of Pharmaceutics 270: 229-
239 
DEMANA, P. H., DAVIES, N. M., HOOK, S., RADES, T. (2004d) Quil A-lipid powder 
formulations releasing ISCOMs and related colloidal structures upon hydration. 
Journal of Controlled Release (Submitted) 
DEMANA, P. H., DAVIES, N. M., BERGER, B., VOSGERAU, U., RADES, T. (2004e) A 







and phospholipid prepared by lipid film hydration and dialysis. Journal of Pharmacy 
and Pharmacology. 56: 573-580 
DEMANA, P. H., FEHSKE, c., WHITE, K., RA.DES, T., HOOK, s. (2004£) Effect of 
incorporation of the adjuvant Quil A on structure and immune stimulatory capacity 
ofliposomes. Immunology and Cell Biology (In Press) 
DENIS-MIZE, K. S., DUPUIS, M., MACK!CHAN, M. L., SINGH, M., DOE, B., O'HAGAN, D., 
ULMER, J. B., DONNELLY, J. J., McDONALD, D. M., OTT, G. (2000) Plasmid DNA 
adsorbed onto cationic microparticles mediates target gene expression and antigen 
presentation by dendritic cells. Gene Therapy 7: 2105-2112 
DONG, P., BRUNN, C., Ho, R. J. Y. (1995) Cytokines as vaccine adjuvants: current status 
and potential applications. In: Powell, M. F., Newman, M. J. (eds) Vaccine Design: 
The Subunit and Adjuvant Approach. Plenum Press, New York, pp 625~643 
DOURMASHKIN, R.R., DOUGHERTY, R. M., HARRIS, R. J. C. (1962) Electron microscopy 
observations on rous sarcoma virus and cell membranes. Nature 194: 1116-1119 
EASTERBROOK, J., Lu, C., SAKAI, Y., LI, A. P. (2001) Effects of organic solvents on the 
activities of cytochrome P450 isoforms, UDP-dependent glucuronyl transferase, and 
phenol sulfotransferase in human hepatocytes. Drug Metabolism and Disposition 
29: 141-144 
EKSTROM, J., Hu, K. F.,. BENGTSSON, K. L., MOREIN, B. (1999) ISCOM and ISCOM-
matrix enhance by intranasal route the IgA responses to OVA and rCTB in local and 
remote mucosa! secretions. Vaccine 17: 2690-2701 
EPAND, R. M., BACH, D., EPAND, R. F., BOROCHOV, N., WACHTEL, E. (2001) A new high-
temperature transition of crystalline cholesterol in mixtures with phosphatidylserine. 
Biophysical Journal 81: 1511-1520 
POHLMAN, J., ILBACK, N. G., FRIMAN, G., MOREIN, B. (1990) Vaccination of Balb/C Mice 
against Enteroviral Mediated Myocarditis. Vaccine 8: 381-384 
FREEMAN, R., FINEAN, J. B. (1975) Cholesterol:lecithin association at molecular ratios of 
up to 2: 1. Chemistry and Physics of Lipids 14: 313-320 
GAINS, H., HAUSER, H. (1983) Formation of unilamellar liposomes by pH adjustment. In: 
Gregoriadis, G. (ed.) Liposome Technology, Preparation of Liposomes. CRC Press, 






GARTI, N., ASERIN, A. (1996) Pharmaceutical emulsions, double emulsions, and 
microemulsions. In: Benita, S. (ed.) Microencapsulation: Methods and Industrial 
applications. Marcel Dekker, New York, pp 411-534 
GARTI, N., KARPUJ, L., SARIO, S. (1981) Correlation between crystal habit and the 
composition of solvated and nonsolvated cholesterol crystals. Journal of Lipid 
Research 22: 785-791 
GLAUERT, A. M., DINGLE, J. T., LUCY, J. A. (1962) Action of saponin on biological cell 
membranes. Nature 196: 953-955 
GLUCK, R. (1999) Adjuvant activity of immunopotentiating reconstituted influenza 
virosomes (IRIV s ). Vaccine 17: 1782-1787 
GLUCK, R., WEGMANN, A. (1997) Virosomes, a new liposome-like vaccme delivery 
system. In: Gander, B., Merkle, H.P., Corradin, G. (eds) Antigen Delivery Systems. 
Harwood Academic Publishers, Amsterdam, Netherlands, pp 101-122 
GOULD-FOGERITE, S., KHEIRI, M. T., ZHANG, F., WANG, Z., SCOLPINO, A. J., FEKETEOVA, 
E., CANKI, M., MANNINO, R. J. (1998) Targeting immune response induction with 
cochleate and liposome-based vaccines. Advanced Drug Delivery Reviews 32: 273-
287 
GUAGLIARDI, A., MANCO, G., ROSSI, M., BARTOLUCCI, s. (1989) Stability and activity of a 
thermostable malic enzyme in denaturants and water-miscible organic-solvents. 
European Journal of Biochemistry 183: 25-30 
GULIK-KRzYWICKI, T., TARDIEU, A., LUZZATI, V. (1969) Smectic phase of lipid-water 
systems: properties related to the nature of the lipid to the presence of net electrical 
charges. Molecular Crystals and Liquid Crystals 8: 285-291 
GUPTA, R. K., SIBER, G. R. (1995) Adjuvants for human vaccines - current status, problems 
and future-prospects. Vaccine 13: 1263-1276 
GUPTA, R. K., ROST, B. E., RELYVELD, E., SIBER, G. R. (1995) Adjuvant properties of 
aluminium and calcium compounds. In: Powell, M. F., Newman, M. J. (eds) 






GUPTA, R. K., R.ELYVELD, E. H., LINDBLAD, E. B., BIZZINI, B., BENEFRAIM, S., GUPTA, C. 
K. (1993) Adjuvants - a balance between toxicity and adjuvanticity. Vaccine 11: 
293-306 
HAENSLER, J. (1995) Vaccine delivery systems. Veterinary Research 26: 226-231 
HAJISHENGALLIS, G., HOLLINGSHEAD, s. K., KOGA, T., RUSSELL, M. w. (1995) Mucosa! 
immunization with a bacterial protein antigen genetically coupled to cholera-toxin 
A2/B Subunits. Journal oflmmunology 154: 4322-4332 
HARDING, C. v., COLLINS, D. s., KANAGAWA, 0., UNANUE, E. R. (1991) Liposome-
encapsulated antigens engender lysosomal processing for class-II MHC 
presentation and cytosolic processing for class-I presentation. Journal of 
Immunology 147: 2860-2863 
HAUSER, H. (1984) Some aspects of the phase behavior of charged lipids. Biochimica et 
Biophysica Acta 772: 37-50 
HEEG, K., KUON, W., WAGNER, H. (1991) Vaccination of class-I major histocompatibility 
complex (MHC)- restricted murine CDS+ cytotoxic lymphocytes-T towards 
soluble-antigens - immunostimulating-ovalbumin complexes enter the Class-I 
MHC-restricted antigen pathway and allow sensitization against the 
immunodominant peptide. European Journal oflmmunology 21: 1523-1527 
HEYMAN, B. (2000) Regulation of antibody responses via antibodies, complement, and Fe 
receptors. Annual Review oflmmunology 18: 709-738 
HIGUCHI, R., KOMORI, T. (1987) Structures of compounds derived from the acyl moieties 
of quillajasaponin. Phytochemistry 26: 2357-2360 
HOFER, c., GOBEL, R., DEERING, P., LEHMER, A., BREUL, J. (1999) Formulation of 
interleukin-2 and interferon-alpha containing ultradeformable carriers for potential 
transdermal application. Anticancer Research 19: 1505-1507 
HOGLUND, S., DALSGAARD, K., LOVGREN, K., SUNDQUIST, B., 0STERHAUS, A., MOREIN, B. 
(1989) ISCOMs and immunostimulation with viral antigens. In: Harris, J. R. (ed.) 
Subcellular Biochemistry. 1st edn. Plenum, New York, pp 39-68 
HUANG, A., TSAO, Y. s., KENNEL, s. J., HUANG, L. (1982) Characterization of antibody 








HUANG, J. Y., BUBOLTZ, J. T., FEIGENSON, G. W. (1999) Maximum solubility of 
cholesterol in phosphatidylcholine and phosphatidylethanolamine bilayers. 
Biochimica Et Biophysica Acta-Biomembranes 1417: 89-100 
HUANG, L., HUANG, A., KENNEL, S. J. (1983) Coupling of antibodies with liposomes. In: 
Gregoriadis, G. (ed.) Liposome Technology. CRC Press, Inc., Florida, pp 51-73 
HUBBARD, M. J., MCHUGH, N. J. (1996) Mitochondrial ATP synthase F-1-beta-subunit is a 
calcium- binding protein. Febs Letters 391: 323-329 
lAMPIETRO, D. J., KALER, E. W. (1999) Phase behavior and microstructure of aqueous 
mixtures of cetyltrimethylammonium bromide and sodium perfluorohexanoate. 
Langmuir 15: 8590-8601 
!MAE, T., KAMIYA, R., IKEDA, S. (1985) Formation of spherical and rod-like micelles of 
cetyltrimethylammonium bromide in aqueous NaBr solutions. Journal of Colloid 
and Interface Science: 215-225 
INABA, K., METLAY, J. P., CROWLEY, M. T., STEINMAN, R. M. (1990) Dendritic cells 
pulsed with protein antigens In-vitro. Can prime antigen-specific, MHC-restricted 
T-cells In situ. Journal of Experimental Medicine 172: 631-640 
IORIO, A. M., FRANCISCI, D., CAMILLONI, B., STAGNI, G., DE MARTINO, M., TONEATTO, 
D., BUGARIN!, R., NERI, M., PODDA, A. (2003) Antibody responses and HIV-1 viral 
load in HIV-1-seropositive subjects immunised with either the MF59-adjuvanted 
influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly 
active antiretroviral therapy. Vaccine 21: 3629-3637 
JACKSON, M. L., SCHMIDT, C. F., LICHTENBERG, D., BJ., L., ALBERT, A. D. (1982) 
solubilzation of phosphatidylcholine bilayers by octyl glucoside. Biochemistry 21: 
4576-4582 
JANI, P., HALBERT, G. W., LANGRIDGE, J., FLORENCE, A. T. (1990) Nanoparticle uptake by 
the rat gastrointestinal mucosa - quantitation and particle-size dependency. Journal 
of Pharmacy and Pharmacology 42: 821-826 
JENKINS, P. G. (1999) Mucosa! vaccine delivery. Expert Opinion on Therapeutic Patents 9: 
255-262 
JENNINGS, V. M. (1995) Review of selected adjuvants used in antibody production. ILAR 
Journal 37: 119-125 
220 
JIANG, W. P., SWIGGARD, W. J., HEUFLER, C., PENG, M., MIRZA, A., STEINMAN, R. M., 
NUSSENZWEIG, M. C. (1995) The Receptor Dec-205 expressed by dendritic cells 
and thymic epithelial-cells is involved in antigen-processing. Nature 375: 151-155 
JOACHIM, I. (2001) Investigation of entrapment of FITC-OVA into ISCOMs. School of 
Pharmacy, University of Otago, Dunedin, New Zealand, Postgraduate Diploma 
Thesis 
JOHANSSON, M., LOVGREN-BENGTSSON, K. (1999) ISCOMs with different quillaja saponin 
components differ in their immunomodulating activities. Vaccine 17: 2894-2900 
KAPLUN, A., TALMON, Y., KONIKOFF, F. M., RUBIN, M., EITAN, A., TADMOR, M., 
LITCHTENBERG, D. (1994) Direct visualization of lipid aggregates in native human 
bile by light and cryo-transmission electron microscopy. FEBS Letters 340: 78-82 
KAPSENBERG, M. L., HILKENS, C. M. U., WIERENGA, E. A., KALINSKI, P. (1998) The role 
of antigen-presenting cells in the regulation of allergen-specific T cell responses. 
Current Opinion in Immunology 10: 607-613 
KAZANJI, M., LAURENT, F., PERY, P. (1994) Immune-responses and protective effect in 
mice vaccinated orally with surface sporozoite protein of eimeria-falciformis in 
ISCOMs. Vaccine 12: 798-804 
KENSIL, C. R. (1996) Saponins as vaccine adjuvants. Critical Reviews in Therapeutic Drug 
Carrier Systems 13: 1-55 
KENSIL, C. R., PATEL, U., LENNICK, M., MARCIANI, D. (1991a) Separation and 
characterization of saponins with adjuvant activity from Quillaja saponaria Molina 
cortex. The Journal oflmmunology 146: 431-437 
KENSIL, C. R., PATEL, U., LENNICK, M., MARCIANI, D. (1991b) Separation and 
characterization of saponins with adjuvant activity from Quillaja-saponaria Molina 
cortex. Journal oflmmunology 146: 431-437 
KERN, F., ZANA, R., CANDAU, S. J. (1991) Rheological properties of semidilute and 
concentrated aqueous-solutions of cetyltrimethylammonium chloride m the 
presence of sodium-salicylate and sodium-chloride. Langmuir 7: 1344-1351 
KERSTEN, G. F. A. (1990) Aspects of ISCOMs. Analytical, pharmaceutical and adjuvant 






KERSTEN, G. F. A., CROMMELIN, D. J. A. (1995) Liposomes and ISCOMs as vaccine 
formulations. Biochimica Et Biophysica Acta-Reviews on Biomembranes 1241: 
117-138 
KERSTEN, G. F. A., CR.OMMELIN, D. J. A. (2003) Liposomes and ISCOMs. Vaccine 21: 
915-920 
KERSTEN, G. F. A., SPIEKSTRA, A., BEUVERY, E. C., CROMMELIN, D. J. A. (1991) On the 
structure of Immune-stimulating saponin-lipid complexes (ISCOMs). Biochimica Et 
Biophysica Acta 1062: 165-171 
KERSTEN, G. F. A., VANDEPUT, A. M., TEERLINK, T., BEUVERY, E. C., CROMMELIN, D. J. 
A. (1988a) Immunogenicity of Liposomes and ISCOMs containing the major outer-
membrane protein of neisseria-gonorrhoeae - influence of protein-content and 
liposomal bilayer composition. Infection and Immunity 56: 1661-1664 
KERSTEN, G. F. A., TEERLINK, T., DERKS, H., VERKLEIJ, A. J., VANWEZEL, T. L., 
CROMMELIN, D. J. A., BEUVERY, E. C. (1988b) Incorporation of the major outer-
membrane protein of neisseria-gonorrhoeae in saponin-lipid complexes (ISCOMs) -
chemical-analysis, some structural features, and companson of their 
immunogenicity with 3 other antigen delivery systems. Infection and Immunity 56: 
432-438 
KHAN, M. Z. I., TUCKER, I. G., 0PDEBEECK, J.P. (1991) Cholesterol and lecithin implants 
for sustained-release of antigen - release and erosion In-vitro, and antibody-
response in mice. International Journal of Pharmaceutics 76: 161-170 
KIRBY, C., GREGORIADIS, G. (1984) Dehydration-rehydration vesicles (DRV): a new 
method for high yield drug entrapment in liposomes. Biotechnology 2: 979-984 
KIRBY, C. J., GREGORIADIS, G. (1983) Incorporation of factor VIII into liposomes. In: 
Gregoriadis, G. (ed.) Liposome Technology. CRC Press, Florida 
KITSON, N., MONCK, M., WONG, K., THEWALT, J., CULLIS, P. (1992) The influence of 
cholesterol 3-sulfate on phase-behavior and hydrocarbon order in model membrane 
systems. Biochimica Et Biophysica Acta 1111: 127-13 3 
KNIGHT, C. G. (1981) Liposomes: from physical structure to therapeutic applications. 




KOMURA, S., ZHONG-CAN, 0. Y. (1998) High and low pitch helical structures of tilted 
chiral lipid bilayers. Physical Review Letters 81: 473-476 
KONIKOFF, F. M., COHEN, D. E., CAREY, M. C. (1994) Phospholipid molecular species 
influence crystal habits and transition sequences of metastable intermediates during 
cholesterol crystallization from bile-salt model systems. Journal of Lipid Research 
35: 60-70 
KONIKOFF, K. M., CHUNG, D.S., DONOVAN, J.M., SMALL, D. M., CAREY, M. C. (1992) 
Filamentous, helical, and tubular microstructures during crystallization from bile. 
Evidence that cholesterol does not nucleate classic monohydrate plate. Journal of 
Clinical Investment 90: 1155-1160 
KONNINGS, S., COPLAND, M. J., DA VIES, N. M., RADES, T. (2002) A method for the 
incorporation of ovalbumin into immune stimulating complexes prepared by the 
hydration method. International Journal of Pharmaceutics 241: 385-389 
KRlSHNAN, L., DICAIRE, C. J., PATEL, G. B., SPROTT, G. D. (2000) Archaeosome vaccine 
adjuvants induce strong humoral, cell-mediated, and memory responses: 
Comparison to conventional liposomes and alum. Infection and Immunity 68: 54-63 
KRlSHNAN, L., SAD, S., PATEL, G. B., SPROTT, G.D. (2001) The potent adjuvant activity of 
archaeosomes correlates to the recruitment and activation of macrophages and 
dendritic cells in vivo. Journal oflmmunology 166: 1885-1893 
KUNITAKE, T., 0KAHATA, Y., MASATSUGU, S., YASUNAMI, S., TAKARABE, K. (1981) 
Formation of stable bilayer assemblies in water from single-chain amphiphiles. 
Relationship between the amphiphile structure and the aggregate morphology. 
Journal of American Chemical Society 103: 5401-5143 
LADBROOKE, B. D., WILLIAMS, R. M., CHAPMAN, D. (1968) Studies on lecithin-
cholesterol-water interactions by differential scanmng calorimetry and x-ray 
diffraction. Biochimica et Biophysica Acta 150: 333-340 
LARSSON, M., LOVGREN, K., MOREIN, B. (1993) Immunopotentiation of synthetic 
oigopeptides by chemical conjugation to ISCOMs. Journal of Immunological 





LE MAIRE, M., CHAMPEIL, P., MOLLER, J. V. (2000) Interaction of membrane proteins and 
lipids with solubilizing detergents. Biochimica Et Biophysica Acta-Biomembranes 
1508: 86-111 
LE, T. T. T., DRANE, D., MALLIAROS, J., Cox, J. c., ROTHEL, L., PEARSE, M., 
WOODBERRY, T., GARDNER, J., SUHRBIER, A. (2001) Cytotoxic T cell polyepitope 
vaccines delivered by ISCOMs. Vaccine 19: 4669-4675 
LEE, H. J. (2002) Protein drug oral delivery: The recent progress. Archives of Pharmacal 
Research 25: 572-584 
LEFEVRE, M. E., BOCCIO, A. M., JOEL, D. D. (1989) Intestinal uptake of fluorescent 
microspheres in young and aged mice. Proceedings of the Society for Experimental 
Biology and Medicine 190: 23-27 
LEVINE, A. (1972) A predictive equation for the primary immune response of mice to 
adsorbed tetanus toxoid as a function of dose of antigen and dose of adjuvant. 
Journal oflmmunology 109: 1138-1142 
LICHTENBERG, D., 0PATOWSKI, E., KOZLOV, M. M. (2000) Phase boundaries in mixtures of 
membrane-forming amphiphiles and micelle-forming amphiphiles. Biochimica et 
Biophysica Acta 1508: 1-19 
LICHTENBERG, D., ZILBERMAN, Y., GREENZAID, P., ZAMIR, S. (1979) Structural and kinetic 
studies on the solubilization of lecithin by sodium deoxycholate. Biochemistry 18: 
3517-3525 
LILJEQVIST, S., CANO, F., NGUYEN, T. N., UHLEN, M., ROBERT, A., STAHL, S. (1999) 
Surface display of functional fibronectin-binding domains on Staphylococcus 
carnosus. Febs Letters 446: 299-304 
LIN, K., WEIS, R. M., MCCONNEL, H. M. (1982) Induction of helical liposomes by Cal -
mediated intermembrane binding. Nature 296: 164-165 
LIN, Z., CAI, J. J., SCRIVEN, L. E., DAVIS, H. T. (1994) Spherical-to-wormlike micelle 
transition in Ctab solutions. Journal of Physical Chemistry 98: 5984-5993 
LINDBLAD, E. B. (2000) Freund's adjuvants. In: O'Hagan, D. T. (ed.) Vaccine Adjuvants: 




LOVGREN, K., MOREIN, B. (1988) The requirement of lipids for the formation of 
Immunostimulating complexes (ISCOMs). Biotechnology and Applied 
Biochemistry 10: 161-172 
LOVGREN, K., LARSSON, M. (1994) Conjugation of synthetic peptides to carrier ISCOMs -
factors affecting the immunogenicity of the conjugate. Journal of Immunological 
Methods 173: 237-243 
LOVGREN, K., LINDMARK, J., PIPKORN, R., MOREIN, B. (1987) Antigenic presentation of 
small molecules and peptides conjugated to a preformed ISCOM as carrier. Journal 
oflmmunological Methods 98: 137-143 
LUCY, J. A., GLAUERT, M. (1964) Structure and assembly of macromolecular lipid 
complexes composed of globular micelles. Journal of Molecular Biology 8: 727-748 
MAHNKE, K., Guo, M., LEE, s., SEPULVEDA, H., SWAIN, s. L., NUSSENZWEIG, M., 
STEINMAN, R. M. (2000) The dendritic cell receptor for endocytosis, DEC-205, can 
recycle and enhance antigen presentation via major histocompatibility complex 
class II-positive lysosomal compartments. Journal of Cell Biology 151: 673-683 
MALE, D. (1991) Immunology. Gower Medical Publishing, London 
MALOY, K. J., DONACHIE, A. M., MOWAT, A. M. (1995a) Induction of Thl and Th2 CD4 T 
cell response by oral or parental immunization with Iscoms. European Journal of 
Immunology 25: 2835-2841 
MALOY, K. J., DONACHIE, A. M., MOWAT, A. M. (1995b) Induction of Thl and Th2 
Cd4( +) T-Cell Responses by oral or parenteral immunization with IS CO Ms. 
European Journal oflmmunology 25: 2835-2841 
MALOY, K. J., DONACHIE, A. M., 0' HAGAN, D. T., MOWAT, A. M. (1994) Induction of 
mucosa! and systemic immune-responses by immunization with ovalbumin 
entrapped in poly(Lactide-Co- Glycolide) microparticles. Immunology 81: 661-667 
MATTHEWS, C. K., VAN HOLDE, K. E. (1996) Biochemistry. The Benjamin/Cummings 
Publishing Company, Inc., Canada 
MAZER, N. A., CAREY, M. C., KWASNICK, F., BENEDEK, G. B. (1979) Quasielastic light 
scattering studies of aqueous biliary lipid systems, size, shape, and thermodynamics 






MCGHEE, J. R., MESTECKY, J., DERTZBAUGH, M. T., ELDRIDGE, J. H., HIRASAWA, M., 
KIYONO, H. (1992) The Mucosa! Immune-System - from Fundamental-Concepts to 
Vaccine Development. Vaccine 10: 75-88 
MENDOZA, L., BUBENIK, J., lNDROVA, M., BIEBLOVA, J., VONKA, V., SIMOVA, J. (2002) 
Freezing and thawing of murine bone marrow-derived dendritic cells does not alter 
their immunophenotype and antigen presentation characteristics. Folia Biologica 48: 
242-245 
MOREIN, B. (1991) Induction of Antibody and Cell-mediated Immune-Response by !scorns. 
Aids Research and Human Retroviruses 7: 152-153 
MOREIN, B., SIMONS, K. (1985) Subunit Vaccines against Enveloped Viruses - Virosomes, 
Micelles and Other Protein Complexes. Vaccine 3: 83-93 
MOREIN, B., BENGTSSON, K. L. (1998) Functional aspects of ISCOMs. Immunology and 
Cell Biology 76: 295-299 
MOREIN, B., BENGTSSON, K. L. (1999) Immunomodulation by ISCOMs, immune 
stimulating complexes. Enzymology 19: 94-102 
MOREIN, B., EKSTROM, J., LOVGREN, K. (1990) Increased immunogenicity of a 
nonamphipathic protein (BSA) after inclusion into ISCOMs. Journal of 
Immunological Methods 128: 177-181 
MOREIN, B., LOVGREN-BENGTSSON, K., Cox, J. (1996) Modem adjuvants. In: Kaufmann, 
S. H. E. (ed.) Concepts in Vaccine Development. Walter de Gruyter, Berlin, pp 243-
263 
MOREIN, B., VILLACRES-ERIKSSON, M., LOVGREN-BENGTSSON, K. (1998) ISCOM, a 
delivery system for parenteral and mucosa! vaccination. In: Brown, F., Haaheim, L. 
R. (eds) Modulation of the Immune Response to Vaccine Antigens. Karger, Basel, 
pp 33-39 
MOREIN, B., SUNDQUIST, B., HOGLUND, S., DALSGAARD, K., 0STERHAUS, S. (1984) 
ISCOM, a novel structure for antigenic presentation of membrane proteins from 
enveloped viruses. Nature 308: 457-460 
MOREIN, B., LOVGREN, K., RONNBERG, B., SJOLANDER, A., VILLACRES-ERIKSSON, M. 
(1995) Immunostimulating complexes - clinical potential in vaccine development. 









MOUGIN, B., BAKOUCHE, 0., GERLIER, D. (1988) Humoral immune-response elicited in 
rats by measles viral membrane-antigens presented in liposomes and ISCOMs. 
Vaccine 6: 445-449 
MOWAT, A. M., DONACHIE, A. M., REID, G., JARRETT, 0. (1991) Immune-stimulating 
complexes containing Quil-A and protein antigen prime Class-I MHC-restricted 
lymphocytes-T In-vivo and are immunogenic by the oral route. Immunology 72: 
317-322 
MOWAT, A. M., SMITH, R. E., DONACHIE, A. M., FURRIE, E., GRDIC, D., LYCKE, N. (1999) 
Oral vaccination with immune stimulating complexes. Immunology Letters 65: 133-
140 
NANDI, N., BAGCHI, B. (1996) Molecular origin of the intrinsic bending force for helical 
morphology observed in chiral amphiphilic assemblies: concentration and size 
dependence. Journal of the American Chemical Society 118: 11208-11216 
NESBURN, A. B., BENMOHAMED, L., SLANINA, S. M., PERNG, G. C., WECHSLER, S. L. 
(2002) Effect of the HSV-1 latency-associated transcript (LAT) on maturation of 
murine bone marrow derived dendritic cells. Investigative Ophthalmology & Visual 
Science 43: U1216-U1216 
NEW, R.R. C. (1990) Liposomes: A Practical Approach. Oxford University Press, London 
NICHOLS, J. W., OZAROWSKI, J. (1990) Sizing of lecithin-bile salt mixed micelles by size-
exclusion high-performance liquid-chromatography. Biochemistry 29: 4600-4606 
NISBET, A. D., SAUNDRY, R.H., MOIR, J. G., FOTHERGILL, L.A., FOTHERGILL, J.E. (1981) 
The complete amino-acid sequence of hen ovalbumin. European Journal of 
Biochemistry 115: 335-345 
0cm, H., TAZUMA, S., KAJIYAMA, G. (1996) Lecithin hydrophobicity modulates the 
process of cholesterol crystallization nucleation and growth in supersaturated model 
bile systems. Biochemical Journal 318: 13 9-144 
O'HAGAN, D. T. (1998) Recent advances in vaccine adjuvants for systemic and mucosa! 
administration. Journal of Pharmacy and Pharmacology 50: 1-10 
O'HAGAN, D. T., V ALIANTE, N. M. (2003) Recent advances in the discovery and delivery of 
vaccine adjuvants. Nature Reviews Drug Discovery 2: 727-735 
227 
L 
O'HAGAN, D. T., MACK.ICHAN, M. L., SINGH, M. (2001) Recent developments in adjuvants 
for vaccines against infectious diseases. Biomolecular Engineering 18: 69-85 
OLLIVON, M., LESIEUR, s., GRABIELLE-MADELMONT, c., PATERNOSTRE, M. (2000) Vesicle 
reconstitution from lipid-detergent mixed micelles. Biochimica Et Biophysica Acta-
Biomembranes 1508: 34-50 
OSTERHAUS, A., RIMMELZWAAN, G. F. (1998) Induction of virus-specific immunity by 
ISCOMs. In: Brown, F., Haaheim, L. R. (eds) Modulation of the Immune Response 
to Vaccine Antigens. Karger, Basel, pp 49-58 
OTT, G., RADHAKRISHNAN, R., FANG, J. H., HORA, M. (2000) The adjuvant MF59: A 10-
year perspective. In: O'Hagan, D. T. (ed.) Vaccine Adjuvants: Preparation Methods 
and Research Protocols. 42 edn. Humana Press, Totowa, NJ, pp 211-228 
OZEL, M., HOGLUND, S., GELDERBLOM, H. R., MOREIN, B. (1989) Quaternary structure of 
the immunostimulating complex (ISCOM). Journal of Ultrastructure and Molecular 
Structure Research 102: 240-248 
PARISH, C. R. (1999) Fluorescent dyes for lymphocyte migration and proliferation studies. 
Immunology and Cell Biology 77: 499-508 
PATEL, G. B., SPROTT, G.D. (1999) Archaeobacterial ether lipid liposomes (archaeosomes) 
as novel vaccine and drug delivery systems. Critical Reviews in Biotechnology 19: 
317-357 
PATERNOSTRE, M. T., Roux, M., RIGAUD, J. L. (1988) Mechanisms of membrane-protein 
insertion into liposomes during reconstitution procedures involving the use of 
detergents .1. Solubilization of large unilamellar liposomes (Prepared by reverse-
phase evaporation) by Triton X-100, Octyl Glucoside, and Sodium Cholate. 
Biochemistry 27: 2668-2677 
PAUL, A., CEVC, G., BACHHAWAT, B. K. (1995) Transdermal immunization with large 
proteins by and means of ultradeformable drug carriers. European Journal of 
Immunology 25: 3521-3524 
PEDERSEN, I. R., BOGHANSEN, T. C., DALSGAARD, K., HEEGAARD, P. M. H. (1992) Iscom 
Immunization with synthetic peptides representing measles-virus hemagglutinin. 







PEETERS, J.M., HAZENDONK, T. G., BEUVERY, E. c., TESSER, G. I. (1989) Comparison of 
four bifunctional reagents for coupling peptides to proteins and the effect of the 
three moieties on the immunogenecity of the conjugates. Journal of Immunological 
Methods 120: 133-143 
PERRIE, Y., 0BRENOVIC, M., McCARTHY, D., GREGORIADIS, G. (2002) Liposome 
(Lipodine (TM))-mediated DNA vaccination by the oral route. Journal of Liposome 
Research 12: 185-197 
PETSCHICK, R. (1998) MacDiff 4.0.5, Macintosh computer software. Institute of Geology 
and Paleontology, University of Frankfurt, Germany 
PITAKSUTEEPONG, T. (2003) Evaluation of nanocapsules for antigen delivery. PhD Thesis. 
University of Otago, Dunedin, New Zealand 
PYLE, S. W., MOREIN, B., BESS, J. W., AKERBLOM, L., NARA, P. L., NIGIDA, S. M., 
LERCHE, N. w., ROBEY, w. G., FISCHINGER, P. J., ARTHUR, L. 0. (1989) Immune-
response to Immunostimulatory complexes (ISCOMs) prepared from human 
immunodeficiency virus Type-1 (Hiv-1) or the Hiv-1 external envelope 
glycoprotein (Gp120). Vaccine 7: 465-473 
REECE, J.C., VARDAXIS, N. J., MARSHALL, J. A., CROWE, S. M., CAMERON, P. U. (2001) 
Uptake of HIV and latex particles by fresh and cultured dendritic cells and 
monocytes. Immunology and Cell Biology 79: 255-263 
REEVES, G., TODD, I. (1991) Lecture Notes on Immunology. Blackwell Scientific 
Publications, London, U.K. 
REID, G. (1992) Soluble-proteins incorporate into ISCOMs after covalent attachment of 
fatty-acid. Vaccine 10: 597-602 
RIMMELZWAAN, G., 0STERHAUS, A. D. M. E. (1997) ISCOMs: materials, preparation, 
antigen delivery and immune response. In: Gander, B., Merkle, H. P., Corradin, G. 
(eds) Antigen Delivery Systems: Immunological and Technological Issues. 
Harwood Academic Publishers, Amsterdam, pp 123-138 
RIMMELZWAAN, G. F., SIEBELINK, K. H. J., HUISMAN, R. c., Moss, B., FRANCIS, M. J., 
OSTERHAUS, A. (1994) Removal of the cleavage site of recombinant Feline 






glycoprotein in immune-stimulating complexes. Journal of General Virology 75: 
2097-2102 
RlMMELZWAAN, G. F., NIEUWKOOP, N., BRANDENBURG, A., SUTTER, G., BEYER, W. E. P., 
MAHER, D., BATES, J., 0STERHAUS, A. (2000) A randomized, double blind study in 
young healthy adults comparing cell mediated and humoral immune responses 
induced by influenza ISCOM (TM) vaccines and conventional vaccines. Vaccine 
19: 1180-1187 
RINGEL, Y., SOMJEN, G. J., KONIKOFF, F. M., ROSENBERG, R., GILAT, T. (1998) Increased 
saturation of fatty acids in the sn-2 position of phospholipids reduces cholesterol 
crystallization in model biles. Biochimica et Biophysica Acta 1390: 293-300 
ROBSON, N. C., BEACOCK-SHARP, H., DONACHIE, A. M., MOWAT, A. M. (2003a) The role 
of antigen-presenting cells and interleukin-12 in the priming of antigen-specific 
CD4+ T cells by immune stimulating complexes. Immunology 110: 95-104 
ROBSON, N. C., BEACOCK-SHARP, H., DONACHIE, A. M., MOWAT, A. M. (2003b) The role 
of antigen-presenting cells and interleukin-12 in the priming of antigen-specific 
CD4(+) T cells by immune stimulating complexes. Immunology 110: 95-104 
ROBSON, N. C., BEACOCK-SHARP, H., DONACHIE, A. M., MOWAT, A. M. (2003c) Dendritic 
cell maturation enhances CD8(+) T-cell responses to exogenous antigen via a 
proteasome-independent mechanism of major histocompatibility complex class I 
loading. Immunology 109: 374-383 
ROGERS, J. A., ANDERSON, K. E. (1998) The potential of liposomes in oral drug delivery. 
Critical Reviews in Therapeutic Drug Carrier Systems 15: 421-480 
ROITT, I., BROSTOFF, J., MALE, D. (1998) Immunology. Mosby International Limited, 
London 
ROSER, M., FISCHER, D., KISSEL, T. (1998) Surface-modified biodegradable albumin nano-
and microspheres. II: effect of surface charges on in vitro phagocytosis and 
biodistribution in rats. European Journal of Pharmaceutics and Biopharmaceutics 
46: 255-263 
ROTH, Y., OPATOWSKI, E., LICHTENBERG, D., KOZLOV, M. M. (2000) Phase behavior of 
dilute aqueous solutions of lipid-surfactant mixtures: Effects of finite size of 









RUNGLERTKRIANGKRAI, S. (1997) Preparation and characterisation of proliposomes. School 
of Pharmacy, University of Otago, Dunedin, New Zealand, MSc Thesis 
SALK, J., SALK, D. (1977) Control of influenza and poliomyelitis killed virus vaccines. 
Science 195: 834-846 
SCHAFER, V., VONBRIESEN, H., ANDREESEN, R., STEFFAN, A. M., ROYER, C., TROSTER, S., 
KREUTER, J., RUBSAMENWAIGMANN, H. (1992) Phagocytosis of nanoparticles by 
human-immunodeficiency-virus (HIV)-infected macrophages - a possibility for 
antiviral drug targeting. Pharmaceutical Research 9: 541-546 
SCHEICHER, C., MEHLIG, M., ZECHER, R., RESKE, K. (1992) Dendritic cells from mouse 
bone-marrow - In-vitro differentiation using low-doses of recombinant granulocyte-
macrophage colony-stimulating factor. Journal of Immunological Methods 154: 
253-264 
SELINGER, J. V., MACKINTOSH, F. C., SCHNUR, J. M. (1996) Theory of cylindrical tubules 
and helical ribbons of chiral lipid membranes. Physical Reviews W: Statistical 
Physics, Plasmas, Fluids and Related Interdisciplinary Topics 53: 3804-3818 
SHEN, D. F., HUANG, A., HUANG, L. (1982) An improved method for covalent attachment 
of antibody to liposomes. Biochimica et Biophysica Acta 689: 31-35 
SHEN, W., LOUIE, S. (1999) Immunology for Pharmacy Students. Harwood Academic 
Publishers, Amsterdam, The Netherlands 
SHIKATA, T., HIRATA, H., KOTAKA, T. (1990) Micelle formation of detergent molecules in 
aqueous-media .4. Electrostatic features and phase-behavior of 
cetyltrimethylammonium bromide salicylic-acid micellar solutions. Journal of 
Physical Chemistry 94: 3702-3706 
SINGH, M., O'HAGAN, D. (1999) Advances in vaccine adjuvants. Nature Biotechnology 17: 
1075-1081 
SINGH, M., O'HAGAN, D. T. (2002) Recent advances in vaccine adjuvants. Pharmaceutical 
Research 19: 715-728 
SINGH, M., O'HAGAN, D. T. (2003) Recent advances in veterinary vaccine adjuvants. 




SJOLANDER, A., VANTLAND, B., BENGTSSON, K. L. (1997a) ISCOMs containing purified 
Quillaja saponins upregulate both Thl-like and Th2-like immune responses. 
Cellular Immunology 177: 69-76 
SJOLANDER, A., Cox, J. C., BARR, I. G. (1998) ISCOMs: an adjuvant with multiple 
functions. Journal of Leukocyte Biology 64: 713-723 
SJOLANDER, A., BERZINS, K., PERLMANN, P., STAHL, S., UHLEN, M., LOVGREN, K. (1990) 
Immunization of Rabbits with Influenza-Virus ISCOMs containing a repeated 
malaria sequence. Scandinavian Journal oflmmunology 32: 415-415 
SJOLANDER, A., NYGREN, P. A., STAHL, S., BERZINS, K., UHLEN, M., PERLMANN, P., 
ANDERSSON, R. (1997b) The serum albumin-binding region of streptococcal protein 
G: A bacterial fusion partner with carrier-related properties. Journal of 
Immunological Methods 201: 115-123 
SJOLANDER, A., DRANE, D., MARASKOVSKY, E., SCHEERLINCK, J. P., SUHRBIER, A., 
TENNENT, J., PEARSE, M. (2001a) Immune responses to ISCOM (R) formulations in 
animal and primate models. Vaccine 19: 2661-2665 
SJOLANDER, A., LOVGREN, K., STAHL, S., ASLUND, L., HANSSON, M., NYGREN, P. A., 
LARSSON, M., HAGSTEDT, M., WAHLIN, B., BERZINS, K., UHLEN, M., MOREIN, B., 
PERLMANN, P. (1991) High antibody-responses in rabbits immunized with 
influenza-virus ISCOMs containing a repeated sequence of the Plasmodium-
falciparum antigen Pf155/Resa. Vaccine 9: 443-450 
SJOLANDER, S., DRANE, D., DAVIS, R., BEEZUM, L., PEARSE, M., Cox, J. (2001b) Intranasal 
immunisation with influenza-ISCOM induces strong mucosa! as well as systemic 
antibody and cytotoxic T-lymphocyte responses. Vaccine 19: 4072-4080 
SMALL, D. M. (1967) Phase equilibria and structure of dry and hydrated egg lecithin. 
Journal of Lipid Research 8: 551-557 
SMITH, R. E., DONACHIE, A. M., MCLAREN, F. H., MOWAT, A. M. (1998) Preservation of 
mucosa! and systemic adjuvant properties of ISCOMS in the absence of functional 
interleukin-4 or interferon-gamma. Immunology 93: 556-562 
SMYTH, H. D. C. (2000) Investigation into the mechanism of action and chemical 
enhancement of transdermal iontophoresis of LHRH. School of Pharmacy, 
University of Otago, Dunedin, New Zealand, PhD Thesis 
232 
\ 
SPICKLER, A. R., ROTH, J. A. (2003) Adjuvants in veterinary vaccines: Modes of action and 
adverse effects. Journal of Veterinary Internal Medicine 17: 273-281 
STAHL, S., NYGREN, P. A. (1997) The use of gene fusions to protein A and protein Gin 
immunology and biotechnology. Pathologie Biologie 45: 66-76 
STAROS, J. V., WRIGHT, R. W., SWINGLE, D. M. (1986) Enhancement by N-
hydroxysulfosuccimide of water-soluble carbodiimide-mediated coupling reactions. 
Analytical Biochemistry 156: 220-222 
STITES, D. P., TERR, A. I., PARSLOW, T. G. (1997) Medical Immunology. Appleton & 
Lange, Connecticut, USA 
STITTELAAR, K. J., BOES, J., KERSTEN, G. F. A., SPEIKSTRA, A., MULDER, P. G. H., DE 
VRIES, P., ROHOLL, P. J. M., DALSGAARD, K., VAN DEN DOBBELSTEEN, G., VAN 
ALPHEN, L., OSTERHAUS, A. (2000) In vivo antibody response and in vitro CTL 
activation induced by selected measles vaccine candidates, prepared with purified 
Quil A components. Vaccine 18: 2482-2493 
STRAUSS, G., SCHURTENBERGER, P., HAUSER, H. (1986) The interaction of saccharides with 
lipid bilayer vesicles: stabilization during freeze-thawing and freeze-drying. 
Biochimica et Biophysica Acta 858: 169-180 
SUNDQUIST, B., LOVGREN, K., HOGLUND, S., MOREIN, B. (1988) Influenza-vrus ISCOMs -
biochemical-characterization. Vaccine 6: 44-48 
SUNDQUIST, B. G., CZIFRA, G., STIPKOVITS, L. (1996) Protective immunity induced in 
chicken by a single immunization with Mycoplasma gallisepticum 
immunostimulating complexes (ISCOMS). Vaccine 14: 892-897 
SWAIN, S. L., Hu, H., HUSTON, G. (1999) Class II-independent generation of CD4 memory 
T cells from effecters. Science 286: 1381-1383 
SZOKA, F., PAPAHADJOPOULOS. (1981) Liposomes: Preparation and characterization. In: 
Knight, C. G. (ed.) Research monographs in cell and tissue physiology. Elsevier, 
North- Holland, pp 51-82 
TAO, S., TAZUMA, S., KAJIYAMA, G. (1993) Fatty acid composition of lecithin is a key 
factor in bile metastability in supersaturated model bile systems. Biochimica et 








TAZUMA, S., 0CHI, H., TERAMEN, K., YAMASHITA, Y., HORIKAWA, K., MIURA, H., 
HIRANO, N., SASAKI, M., AIHARA, N., HATSUSHIKA, S. (1994) Degree of fatty acid 
chain unsaturation in biliary lecithin dictates cholesterol nucleation and crystal 
growth. Biochimica et Biophysica Acta 1215: 74-78 
THIELE, L., ROTHEN-RUTISHAUSER, B., JILEK, S., WUNDERLI-ALLENSPACH, H., MERKLE, 
H.P., WALTER, E. (2001) Evaluation of particle uptake in human blood monocyte-
derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with 
macrophages? Journal of Controlled Release 76: 59-71 
THOMAS, B. N., LINDEMANN, C. M., CLARK, N. A. (1999) Left- and right-handed helical 
tubule intermediates from a pure chiral phospholipid. Physical Reviews E 59: 3040-
3047 
TORCHE, A. M., ALBINA, E., LE CORRE, P., JESTIN, A., LE VERGE, R. (1999) Flow 
cytometric and optical microscopic evaluation of poly(D,L-lactide-co-glycolide) 
microspheres phagocytosis by pig alveolar macrophages. Journal of Controlled 
Release 58: 289-301 
TROPINI, v., LENS, J. P., MULDER, w. J., SILVESTRE, F. (2000) Cross-linking of wheat 
gluten using a water-soluble carbodiimide. Cereal Chemistry 77: 333-338 
TRUDEL, M., NADON, F., SEGUIN, C., BOULAY, 0., LUSSIER, 0. (1987) Vaccination of 
rabbits with a bovine herpesvirus Type-1 subunit vaccine - adjuvant effect of 
ISCOMs. Vaccine 5: 239-243 
VAN BINNENDIJK, R. S., VANBAALEN, C. A., POELEN, M. C. M., DEVRIES, P., BOES, J., 
CERUNDOLO, v., OSTERHAUS, A., UYTDEHAAG, F. (1992) Measles-virus 
transmembrane fusion protein synthesized Denovo or presented m 
immunostimulating complexes Is endogenously processed for Hla Class-I-restricted 
and Class-II-restricted cytotoxic T-cell recognition. Journal of Experimental 
Medicine 176: 119-128 
VANDENABEELE, S., Wu, L. (1999) Dendritic cell origins: puzzles and paradoxes. 
Immunology and Cell Biology 77: 411-419 
V ASSILIOU, E., JING, H., GANEA, D. (2003) Prostaglandin E2 inhibits TNF production in 
murine bone marrow-derived dendritic cells. Cellular Immunology 223: 120-132 
VILLACRES-ERICSSON, M. (1993) Induction of immune response by ISCOMs. PhD Thesis 
234 
.. 
VILLACRES-ERIKSSON, M., BERGSTROMMOLLAOGLU, M., KABERG, H., MOREIN, B. (1992) 
Involvement of interleukin-2 and interferon-gamma in the Immune-response 
induced by influenza-virus ISCOMs. Scandinavian Journal oflmmunology 36: 421-
426 
VILLACRES-ERIKSSON, M., BERGSTROMMOLLAOGLU, M., KABERG, H., LOVGREN, K., 
MOREIN, B. (1993) The Induction of cell-associated and secreted Il-1 by ISCOMs, 
matrix or micelles in murine splenic cells. Clinical and Experimental Immunology 
93: 120-125 
VILLACRES-ERIKSSON, M., BEHBOUDI, S., MORGAN, A. J., TRINCHIERI, G., MOREIN, B. 
(1997) Immunomodulation by Quillaja saponaria adjuvant formulations: In vivo 
stimulation of interleukin 12 and its effects on the antibody response. Cytokine 9: 
73-82 
VINSON, P. K., TALMON, Y., WALTER, A. (1989) Vesicle-micelle transition of 
phosphatidylcholine and octyl glucoside elucidated by Cryo-transmission electron-
microscopy. Biophysical Journal 56: 669-681 
VITETTA, E. S., BERTON, M. T., BURGER, C., KEPRON, M., LEE, W. T., YIN, X. M. (1991) 
Memory-Band T-Cells. Annual Review oflmmunology 9: 193-217 
VOGEL, F. R., POWELL, M. F. (1995) A compendium of vaccine adjuvants and excipients. 
In: Powell, M. F., Newman, M. J. (eds) Vaccine Design. The Subunit and Adjuvant 
Approach. Plenum Press, New York, pp 141-228 
WAGNER, E. K., HEWLETT, M. J. (1999) Basic Virology. Blackwell Publishers, Oxford, UK 
WAKSMAN, B. H. (1979) Adjuvants and immune regulation by lymphoid cells. Springer 
Seminars in Immunopathology 2: 5-9 
WALDUCK, A. K., OPDEBEECK, J.P., BENSON, H. E., PRANKERD, R. (1998) Biodegradable 
implants for the delivery of veterinary vaccines: design, manufacture and antibody 
responses in sheep. Journal of Controlled Release 51: 269-280 
WALTER, A., VINSON, P. K., KAPLUN, A., TALMON, Y. (1991) Intermediate Structures in 
the cholate-phosphatidylcholine vesicle micelle transition. Biophysical Journal 60: 
1315-1325 
WANG, D. Q., CAREY, M. C. (1996) Complete mapping of crystallization pathways during 
cholesterol precipitation from bile model: influence of physical-chemical variables 
235 
of pathophysiologic influence and identification of a stable liquid crystalline state in 
cold, dilute and hydrophilic bile-salt containing systems. Journal of Lipid Research 
37: 606-630 
WANG, Q. X., ZHANG, M., DING, G. S., LIU, Y. S., SUN, Y. P., WANG, J. L., ZHANG, W. P., 
Fu, Z. R., CAO, X. T. (2003) Anti-ICAM-1 antibody and CTLA-4Ig synergistically 
enhance immature dendritic cells to induce donor-specific immune tolerance in 
vivo. Immunology Letters 90: 33-42 
WATSON, D. L., WATSON, N. A., FOSSUM, C., LOVGREN, K., MOREIN, B. (1992) 
Interactions between Immune-stimulating complexes (ISCOMs) and peritoneal 
mononuclear leukocytes. Microbiology and Immunology 36: 199-203 
WATSON, D. L., LOVGREN, K., WATSON, N. A., FOSSUM, C., MOREIN, B., HOGLUND, S. 
(1989) Inflammatory response and antigen localization following immunization 
with influenza-virus ISCOMs. Inflammation 13: 641-649 
WEDER, H. G., ZUMBUEHL, 0. (1983) The preparation of variably sized homogeneous 
liposomes for laboratory, clinical, and industrial use by controlled detergent 
dialysis. In: Gregoriadis, G. (ed.) Liposome Technology. CRC Press, Florida, pp 
79-107 
WEIJER, K., PFAUTH, A., VANHERWIJNEN, R., JARRETT, 0., MELOEN, R. H., TOMEE, C., 
OSTERHAUS, A. (1993) Induction of feline leukemia virus-neutralizing antibodies by 
immunization with synthetic peptides derived from the Felv Env Gene. Vaccine 11: 
946-956 
WEIS, H. P., STITZ, L., BECHT, H. (1990) Immunogenic properties of ISCOMs prepared 
with influenza virus glycoprotein. Archives ofVirology 114: 109-120 
WHYTE, J., ROBERTS, A. D. G., MORLEY, K. A., SHARP, R. J., MARSH, P. D. (2000) 
Phagocytosis of mycobacteria by U937 cells: a rapid method for monitoring uptake 
and separating phagocytosed and free bacteria by magnetic beads. Letters in 
Applied Microbiology 30: 90-94 
WINDHOLZ, M., BUDAVARI, S., BLUMETTI, R. F., OTTERBEIN, E. S. (1983) The Merck 
Index, An encyclopedia of chemicals, drugs, and biologicals (10th edition), 






WINDON, R. G., CHAPLIN, P. J., BEEZUM, L., COULTER, A., CAHILL, R., KIMPTON, W., 
DRANE, D., PEARSE, M., SJOLANDER, A., TENNENT, J.M., SCHEERLINCK, J. P. Y. 
(2000) Induction of lymphocyte recruitment in the absence of a detectable immune 
response. Vaccine 19: 572-578 
WINDON, R. G., CHAPLIN, P. J., MCWATERS, P., TAVARNESI, M., TZATZARIS, M., 
KIMPTON, W. G., CAHILL, R. N. P., BEEZUM, L., COULTER, A., DRANE, D., 
SJOLANDER, A., PEARSE, M., SCHEERLINCK, J.P. Y., TENNENT, J.M. (2001) Local 
immune responses to influenza antigen are synergistically enhanced by the adjuvant 
ISCOMATRIX((R)). Vaccine 20: 490-497 
YANAGAWA, H., OGAWA, Y., FURUTA, H., TSUNO, K. (1989) Spontaneous formation of 
superhelical strands. Journal of the American Chemical Society 111: 4567-4570 
ZASTAVKER, Y. V., ASHERIE, N., LOMAKIN, A., PANDE, J., DONOVAN, J.M., SCHNUR, J. 
M., BENEDEK, G. (1999) Self-assembly of helical ribbons. Proceedings of National 
Academy of Science, USA 96: 7883-7887 
ZILLIG, W., REITER, W. D., PALM, P., GROPP, F., NEUMANN, H., RETTENBERG, .M. (1988) 
Viruses of archaebacteria. In: Calender, R. (ed.) The Bacteriophages. Plenum Press, 





Appendix I: Formulae of various solutions used in the study (Chapters 2 to 5). 
>-
(A) Solutions used in the formulation and characterization of colloidal dispersions. 
(i) Tris buffer 
Tris(hydroxylmethyl)methylamine 7.27 g 
Sodium chloride 4.97 g 
Distilled water qs to 1000 ml 
• 
Adjust pH to 7.4 
~ 
(ii) Tris buffer containing 5% Triton X-100 
J, 
Tris(hydroxylmethyl)methylamine 7.27 g 
Sodium chloride 4.97 g 
.., Triton X-100 50.0 g 
Distilled water qs to 1000 ml 
.. Adjust pH to 6.6 
(iii) Phosphate Buffered Saline (PBS) 
Potassium chloride 0.2 g 
Potassium dihydrogen orthophosphate (anhydrous) 0.2 g 
Sodium chloride 8.0 g 
.. Disodium hydrogen orthophosphate (anhydrous) 1.15 g 
Distilled water qs to 1000 ml 
.. Adjust pH to 7.4 
)' 
(iv) Phosphate Buffered Saline (PBS) containing 5% Triton X-100 
Potassium chloride 0.2 g 
'fl 
Potassium dihydrogen orthophosphate (anhydrous) 0.2 g 
Sodium chloride 8.0 g 
I, 
Disodium hydrogen orthophosphate (anhydrous) 1.15 g 
.:,j 
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Triton X-100 50.0 g 
Distilled water qs to 1000 ml 
Adjust pH to 7.4 
(B) Solutions used in the conjugation of protein with fatty acids or phospholipids. 
(i) 50 mM carbonate buff er 
Sodium carbonate (Na2C03) 2.65 g 
Sodium hydrogen carbonate (NaHC03) 2.1 g 
Distilled water qs to 1000 ml 
~ 
Adjust pH to 9.0 
-!, 
(ii) 220 mM carbonate buff er 
Sodium carbonate (Na2C03) 11.66 g 
Sodium hydrogen carbonate (NaHC03) 9.24 g 
.. Distilled water qs to 1000 ml 
Adjust pH to 9.5 
(iii) 10% (w/v) octylglucoside solution 
Octylglucoside 100.0 g 
Distilled water qs to 1000 ml 
(C) Solutions used in cell cultures. 
(i) Complete IMDM (also referred as cIMDM) 
Penicillin/Streptomycin solution 1.0 ml 
2-mercaptoethanol 0.1 ml 
Foetal calf serum (FCS) 5.0 ml 
Glutamax 1.0 ml 
IMDMqs to 100 ml 
-· 
240 
N.B. 10, 000 units penicillin and 10, 000 µg Streptomycin/ml (GIBCO BRL, 
Life Technologies Limited, Melbourne, Australia) 
2-mercaptoethanol, 5.5 x 10-2 Min DPBS (GIBCO BRL, Life Technologies 
Limited, Melbourne, Australia) 
Glutamax (L-glutamine, 200 mM) (GIBCO BRL, Life Technologies 
Limited, Melbourne, Australia) 
IMDM (GIBCO BRL, Life Technologies Limited, Melbourne, Australia) -
the preparation was made according to instructions from the supplier. 
(ii) Red blood cell (RBC) lysis buff er 
Solution A: Ammonium chloride solution 
Ammonium chloride (NH4Cl) 
Distilled water q s to 
Solution B: Tris hydrochloride solution 
Tris HCl 





Mix 9 parts of solution A with 1 part of solution B and adjust pH to 7 .2 and filter through a 
0.22 µm filter. 
(iii) F ACS buff er 
Sodium azide (NaN3) 
Bovine serum albumin (BSA) 










Appendix II: SEM micrographs of pure powders, Quil A-lipid powder mixtures and 
the compressed pellets (Chapter 4) . 
Figure Al SEM micrographs of cholesterol. Compressed pellets were prepared 
by compressing cholesterol powder particles as received (ar) or following freeze-
drying process (fd). 
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Figure A2 SEM micrographs of Quil A. Compressed pellets were prepared by 
compressing Quil A powder particles as received (ar) or following freeze-drying 





Figure A3 SEM micro graphs of binary lipid powder mixtures and the compressed 
pellets (Formulation A in Figure 4.1, Quil A:PC mass ratio 2:1). Compressed 
pellets were prepared by compressing either lipid powder mixtures produced by 




Figure A4 SEM micrographs of binary lipid powder mixtures and the 
compressed pellets (Formulation B in Figure 4.1, Quil A:cholesterol mass ratio 
2: 1 ). Compressed pellets were prepared by compressing either lipid powder 
mixtures produced by physical mixing (pm) or lipid powder mixtures produced 





Figure AS SEM micrographs of ternary lipid powder mixtures and the 
compressed pellets (Formulation D in Figure 4.1, Quil A:cholesterol:PC mass 
ratio 3:6:1). Compressed pellets were prepared by compressing either lipid 
powder mixtures produced by physical mixing (pm) or lipid powder mixtures 
produced by freeze-drying (fd). 
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Appendix III: TEM micrographs of aqueous dispersions of compressed pellets 
containing PE-FITC-OV A (Chapter 4). 
Figure A6 TEM micrographs of aqueous dispersions of compressed pellets 
containing PE-FITC-OVA (Formulations A-D, Figure 4.1). The total polar 
lipid:protein mass ratio was 6.7: 1. A: Quil A:PC, mass ratio 2: 1, B: Quil 
A:cholesterol mass ratio 2: 1. All compressed pellets were prepared by 
compressing either lipid powder mixtures produced by physical mixing (pm) or 





Figure A6 (Continued) TEM micro graphs of aqueous dispersions of compressed 
pellets containing PE-FITC-OVA (Formulations A-D, Figure 4.1). The total 
polar lipid:protein mass ratio was 6.7: 1. C: Quil A:cholesterol:PC, mass ratio 
2: 1 :2, D: Quil A:cholesterol:PC, mass ratio 3:6: 1. All compressed pellets were 
prepared by compressing either lipid powder mixtures produced by physical 




Appendix IV: Composition of lipid mixtures of Quil A, cholesterol {Chol) and 
phospholipid (PC or PE) investigated to establish pseudo-ternary diagrams. 
The total mass lipid composition for each sample was 6. 7 mg. Volume of water or buffer 
solution used to disperse each sample was 1 ml. A total of 66 different samples was 
prepared per pseudo-ternary diagram. 
QuilA Chol PC or PE QuilA Chol PC or PE 
Single component systems 
100% 0% 0 % 6.7mg 0mg 0mg 
0% 100 % 0% 0mg 6.7mg 0mg 
0% 0% 100% 0mg 0mg 6.7mg 
Binary systems (Quil A+ Cholesterol) 
10 % 90% 0 % 0.67 mg 6.03 mg 0mg 
20% 80% 0% 1.34 mg 5.36 mg 0mg 
30% 70% 0% 2.01 mg 4.69 mg 0mg 
40% 60% 0% 2.68 mg 4.02 mg 0mg 
50% 50% 0% 3.35 mg 3.35 mg 0mg 
60% 40% 0% 4.02 mg 2.68 mg 0mg 
70% 30% 0% 4.69 mg 2.01 mg 0mg 
80% 20% 0% 5.36mg 1.34 mg 0mg 
90% 10% 0% 6.03 mg 0.67 mg 0mg 
Binary systems (Quil A+ Phosoholipid) 
10% 0% 90% 0.67 mg 0mg 6.03 mg 
20% 0% 80% 1.34 mg 0mg 5.36 mg 
30% 0% 70% 2.01 mg 0mg 4.69 mg 
40% 0% 60% 2.68 mg 0mg 4.02 mg 
50% 0% 50% 3.35 mg 0mg 3.35 mg 
60% 0 % 40% 4.02 mg 0mg 2.68 mg 
70% 0% 30% 4.69 mg 0mg 2.01 mg 
80% 0% 20% 5.36 mg 0mg 1.34 mg 
90% 0% 10% 6.03 mg 0mg 0.67 mg 
Binary systems (Cholesterol + Phospholipid) 
0% 10 % 90% 0mg 0.67 mg 6.03 mg 
0% 20% 80% 0mg 1.34 mg 5.36 mg 
0% 30% 70% 0mg 2.01 mg 4.69 mg 
0% 40% 60% 0mg 2.68 mg 4.02 mg 
0 % 50% 50% 0mg 3.35 mg 3.35 mg 
0 % 60% 40% 0mg 4.02 mg 2.68 mg 
0 % 70% 30% 0mg 4.69 mg 2.01 mg 
0% 80% 20% 0mg 5.36 mg 1.34 mg 
0% 90% 10% 0mg 6.03 mg 0.67 mg 
249 
Appendix IV (Continued.) 
Ii>- QuilA Chol PC or PE QuilA Chol PC or PE 
Ternary systems (Quil A+ Cholesterol+ Phospholipid) 
10% 10% 80 % 0.67 mg 0.67 mg 5.36 mg 
20% 10% 70 % 1.34 mg 0.67 mg 4.69 mg 
30% 10% 60 % 2.01 mg 0.67 mg 4.02 mg 
40% 10% 50 % 2.68 mg 0.67 mg 3.35 mg 
50% 10% 40 % 3.35 mg 0.67 mg 2.68 mg 
60% 10% 30 % 4.02 mg 0.67 mg 2.01 mg 
70% 10% 20 % 4.69 mg 0.67 mg 1.34 mg 
80% 10% 10 % 5.36 mg 0.67 mg 0.67 mg 
10% 20 % 70 % 0.67 mg 1.34 mg 4.69 mg 
20% 20 % 60 % 1.34 mg 1.34 mg 4.02 mg 
30% 20 % 50 % 2.01 mg 1.34 mg 3.35 mg 
40% 20 % 40 % 2.68 mg 1.34 mg 2.68 mg 
50% 20 % 30 % 3.35 mg 1.34 mg 2.01 mg 
60% 20 % 20 % 4.02 mg 1.34 mg 1.34 mg 
70% 20 % 10 % 4.69 mg 1.34 mg 0.67 mg 
10% 30 % 60 % 0.67 mg 2.01 mg 4.02 mg 
20% 30 % 50 % 1.34 mg 2.01 mg 3.35 mg 
30% 30 % 40 % 2.01 mg 2.01 mg 2.68 mg 
40% 30 % 30 % 2.68 mg 2.01 mg 2.01 mg 
50% 30 % 20 % 3.35 mg 2.01 mg 1.34 mg 
60% 30 % 10 % 4.02 mg 2.01 mg 0.67 mg 
10% 40% 50 % 0.67 mg 2.68 mg 3.35 mg 
20% 40% 40 % 1.34 mg 2.68 mg 2.68 mg 
\- 30% 40% 30 % 2.01 mg 2.68 mg 2.01 mg 
40% 40% 20 % 2.68 mg 2.68 mg 1.34 mg 
50% 40% 10 % 3.35 mg 2.68 mg 0.67 mg 
10% 50% 40 % 0.67 mg 3.35 mg 2.68 mg 
20% 50% 30 % 1.34 mg 3.35 mg 2.01 mg .. 30% 50% 20 % 2.01 mg 3.35 mg 1.34 mg 
40% 50% 10 % 2.68 mg 3.35 mg 0.67 mg 
10% 60% 30 % 0.67 mg 4.02 mg 2.01 mg 
20% 60% 20 % 1.34 mg 4.02 mg 1.34 mg 
30% 60% 10 % 2.01 mg 4.02 mg 0.67 mg 
10% 70% 20 % 0.67 mg 4.69 mg 1.34 mg 
20% 70% 10 % 1.34 mg 4.69 mg 0.67 mg 
10% 80% 10 % 0.67 mg 5.36 mg 0.67 mg 
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